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ABSTRACT 
 
While microbes inhabit a wide array of environments, their ability to live within host tissue and 
become tolerated as part of a select microbial community is perhaps one of the most impressive 
feats of microbial resilience and survival.  Host microbiome establishment and maintenance 
requires both host-microbe and microbe-microbe interactions.  Among plant hosts, benefits from 
associated microbiomes are known to include improved growth, development and resistance to 
abiotic and biotic stresses.  Mammalian microbiomes are known to improve host digestion, 
influence inflammation and even improve immune response to pathogens. While host-associated 
microbial communities across all domains of life are incredibly diverse, a growing number of 
studies are finding host-specific taxonomic trends, suggesting microbiome conservation and 
evolutionary selection.  However, we have come to recognize that there is often functional 
redundancy between taxa.  Therefore, investigative focus on microbiome composition potentially 
neglects pivotal and influential microbial players. Shifting focus to function over form creates the 
opportunity to tease apart the driving forces of unique microbiome constituents.  This allows for 
identification of strains and genes of interest as well as microbial selections.  To that end, here we 
describe the relationships between hosts and microbiomes as well as between microbes in two 
vastly different host systems (Figure 1.1).  First, we suggest that plant root-associated 
Streptomyces isolates harboring genes encoding an enzyme and its co-factor are more tolerant of 
phenolic compounds generated by roots.  Next, we address the capability of these Streptomyces 
isolates to employ their metabolic repertoires to influence the composition of the root microbiome.  
Finally, we define a previously under-described role for the gut microbiome in malaria 
immunology and suggest that gut microbial composition can modulate the severity of malarial 
disease.  Together, these findings demonstrate the broad implications of microbiome composition 
across diverse hosts and environments, revealing unexplored opportunities for therapeutic 
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I. MICROBIOMES ACROSS HOST SPECIES 
 
Microbiomes are formed when organisms assemble in communities.  Often these microbial 
communities live in close proximity to, or even within, complex host organisms.  Dynamic 
relationships develop between hosts and their microbiomes as well as among the microbial 
constituents [1].  Generally, maintenance of microbiome stability is fundamentally beneficial to 
the host.  In addition to protection from biotic stress, microbiomes also extend the host metabolic 
repertoire, nutrient acquisition and protection from abiotic stress [2-4].  Included here in describing 
host-microbiome and microbe-microbe dynamics are both the microbial organism and their 
respective genomes.   Recent improvements in sequencing technologies, data analysis techniques, 
and study design allow definition of the microbiota and potential functional implications of these 
intimate and important relationships with increasing accuracy.  Interestingly, microbiome studies 
are revealing patterns across various host species, providing valuable insight into microbiome 
influence on host development, metabolism, innate immunity, and even pathogen resistance [1, 5-
9].  These patterns are likely multivariate and may suggest evolutionary influences, as well as host 
and microbial assemblage pressures [1, 10-14].  While taxonomic characterizations are an essential 
foundation, transcriptional and protein community studies are now shedding light on functional 
overlaps and drilling down dominant species-specific tasks that may have once been unappreciated 
or overlooked.   
 
Regardless of host, most microbiomes are extremely diverse and often differ greatly from the 
microbes inhabiting their surrounding environment [15].  Interestingly the concept of a core 
microbiome is recognized within various hosts including invertebrates, humans, plants and others 
[9, 16-22].  Host selection is known to play a key role in selection of this core, with the host 
immune system being a fundamental component of selective pressure, employing a variety of host-
specific immune strategies influential in shaping the microbiome [23-25].  For example, when 
infected with a pathogen, the model plant Arabidopsis thaliana alters its root microbiome to 
selectively incorporate disease-suppressive and growth-promoting microbes [26].  Similarly, 
microbes in the gut can control pathogens by preferentially altering the environment via consuming 
nutrients the pathogen needs to replicate and survive [27]. In general, microbiome disruption can 
lead to dysbiosis and ultimately pathogenesis [28].  However, in addition to the microbiome, 
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homeostasis is reliant on host genetics and the environment, which can be disrupted by alteration 
of even one host gene [16].  Studies of germ-free animals demonstrate host microbiome importance 
for health and wellness including immune development [29, 30].  As we continue to gain insights 
into the complexities of microbiomes, the delicate yet resilient relationships between hosts, their 
microbiomes and microbes themselves become ever more evident.   
 
Importantly, the stable host genome is off-set by the rapid evolutionary capability of the inhabiting 
microbial genomes.  While potentially risky, the perceived host benefit must outweigh the 
inevitable risk of microbial evolution to pathogenicity.  As microbiomes can assemble with and 
without hosts, assimilation and maintenance with plants and animals suggests mutual benefit [2-
4, 31]. Although assemblage patterns are evident and resulting core microbiomes have been 
identified, the importance of individual taxa cannot be overlooked [15].  Interestingly, as yet, 
substantial taxonomic overlaps between plant roots and the mammalian gut have not been 
identified [3]. However, when microbiomes from diverse environments, including plants, were 
introduced into the guts of germ-free mice, the microbes successfully established residency and 
competed [32], suggesting the potential for discovery of common taxa.  It is also essential to 
recognize that in general, taxonomic abundance does not necessarily correlate with functional 
influence. In fact, transient or rare microbiome taxa sometimes disproportionately influence their 
host [33].   
 
In summary, microbiome assemblage requires host and microbe tolerance and energy, which 
transcends to which domain of life the host belongs [1, 3, 15].  The host immune system must 
tolerate non-self and microbiome members must tolerate one another. In many cases, the 
relationships between a host and its microbiome are crucial for hosts to thrive [11, 34].   In other 
cases, bacterial dysbiosis is associated with a variety of disease and immune complications [35-
39].  Microbiomes have been implicated in modulating host immune responses [19, 24, 40-45] and 
inclusion or exclusion of certain taxa within the microbiome can influence disease severity in 
mammals [41, 46, 47] and plants [2, 39].  Despite host and environmental pressures, microbial 
assemblages that have survived, thrived and evolved to become paramount in many domains of 
life, leading to the suggestion of the holobiont [16].  Thus, definition of general microbiome traits, 
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including composition and function are necessary for identification of knowledge gaps and 
potential areas for investigation. 
 
I. THE PLANT ROOT MICROBIOME 
 
Root microbiomes are formed from diverse microbial soil surroundings with extraordinary 
uniformity, suggesting consistent mechanisms of community assembly.  Complex soil 
communities house incredible potential for agricultural application and are known to contribute to 
plant health and protection [48].  Strategies to harness this potential with minimal environmental 
impact are underway [49-51]. In addition to expanding our understanding of microbiome 
establishment from complex soil communities, collections of plant-specific microbiomes are being 
established by laboratories across the world with varying goals for elucidating their forms and 
function [31, 50, 52-55]. Comparing datasets provides powerful insights into the overlap of plant 
microbiomes, as well as the impacts of surrounding plants and microbes on root microbiomes and 
long-term soil conditioning.  
 
The relationship between a plant and its microbiome may promote plant productivity by improving 
accessibility to nutrients, producing plant growth stimulating factors, outcompeting invading 
pathogens, and inducing protection against infection and various abiotic stresses [2, 3, 26, 56]. 
Only particular taxa are assembled and maintained within the phyllosphere (above-ground plant 
tissue), rhizosphere (surrounding the root) and root microbiomes. While there are overlaps, these 
plant fractions are known to house distinct sets of microbes [2, 57-59].  The composition of the 
whole (internal and closely adhering) root microbiome is influenced by various biotic interactions, 
but of particular interest here is its relevance to plant-microbe and microbe-microbe relationships 
(Figure 1.1).  Here we specifically address how recent studies tease apart the impact of these biotic 
interactions on plant root microbiome composition. 
Plant-microbe interactions  
While whole root microbiomes impact plant ecology with both negative feedback from plant 
pathogens and positive feedback from beneficial microbes, plants condition the soil microbiota 
[60, 61]. In fact, the pathogens of seasonal crops grown in monoculture fields are among the 
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considerations used to decide which crops will be in rotation with each other [60]. Specifically, 
pea and oat are often used as break crops in rotation schemes to promote yield of crops such as 
wheat [62]. When the rhizosphere communities of these three crops were examined in a common 
soil, it was revealed that both pea and oat appeared to exert strong selection on eukaryotic 
microbial communities [63].  Conversely, it has been suggested that plants can act as master 
manipulators, modulating microbial behaviors to their advantage [64, 65], and further that plant 
selection of co-residents can be influenced by “metabolic complementation,” in which plants may 
search for organisms that selectively supplement their carbon and nutrient profiles [58].    
 
Unique plant root exudate profiles result in preferential selection of microbial partners and the 
formation of “biased rhizospheres” [66], with both positive (e.g. carbon sources) and negative 
rhizosphere inputs (e.g. root antimicrobials).   Thus, metagenomic studies in rice found that 
endophytic root bacteria contain several groups of genes involved in: motility, plant polymer 
degradation, iron acquisition (e.g. siderophores), quorum-sensing, and detoxification of reactive 
oxygen species [67]. This targeted utilization of natural rhizosphere ecology has proven valuable 
in bio-energy, agriculture and bio-energy [68] potentially altering critical plant phenotypes.   
Hence, when rhizospheres were selected over ten generations in A. thaliana, promotion of either 
early or late flowering time was observed [69]. This control over plant traits was even transferable 
by inoculating other genotypes with the microbiome [69], highlighting the tight interaction of plant 
and microbe adaptation. In addition, plant immune system inducing beneficial microbes were 
shown to stimulate the plant transcription factor MYB72, resulting in the production of coumarins, 
a class of phenolic compounds that include scopoletin, which was shown to influence microbiome 
composition [70].  Further, a root exudate and microbiome assembly study in the grass Avena 
barbata demonstrated metabolic harmony between root exudates and microbiome uptake, 
suggesting a mechanism for rhizosphere microbiome assembly [71].  Attracting preferred bacteria, 
fungi and other microbes to the host root is largely influenced by the plant root itself via release 
of volatiles and other metabolites [72]. Plant-mediated regulation of exudates such as malic acid 
and flavonoids were shown to recruit bacterial species capable of helping plants tolerate 
environmental stress [73, 74].  To better understand the dynamics of these relationships, time 
course studies have been carried out that connect changes in A. thaliana rhizosphere communities 
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at four developmental stages with differences in the composition of root exudates at those times, 
especially sugars and phenolic compounds [75, 76].  Additional work to weave together the 
mechanisms and intricate relationships between individual root exudates to control rhizosphere 
community formation will require further understanding of plant-microbe interactions.  
 
Realization of common immune targets for extraordinarily diverse plant pathogen effectors [77, 
78] facilitated a parsed and often targeted approach to understanding plant-microbe interactions.   
Rhizobia, nitrogen-fixing soil microbes that commonly associate with plant roots, are known to 
use type 3 secreted effector (T3E) proteins to promote establishment of plant beneficial nitrogen-
fixing nodules and suppress the plant immune response [79].   Interestingly, T3Es are also used by 
pathogenic microbes, but for infection, not establishment of beneficial relationships [79].  While 
there is a need to explore host-beneficial and host-pathogen interactions concordantly [80], there 
is strong evidence that both beneficial and pathogenic microbes can activate a number of plant 
immune responses, including: programmed cell death, cell wall thickening, antimicrobial 
compound expression, reactive oxygen species generation, and defense phytohormones production 
individually [81, 82]. Plant hormonal modulators that integrate induction of immune system output 
responses [83] such as salicylic acid-jasomonic acid crosstalk often a common target to facilitate 
colonization.  
 
As obligate mutualistic biotrophs, arbuscular mycorrhizal (AM) fungi are reliant on plant hosts for 
survival while plants can gain fitness benefits from the cortical invasion [84]. In order for the plant-
mycorrhizal relationship to become established, either the plant immune system must adapt to 
colonization or the fungus must evade or modify the inevitable host immune attack during and 
post-colonization [84].  Symbiosis is most often achieved via modulation of the host immune 
response, first with initiation of microbe-associated molecular pattern (MAMP) triggered 
immunity (MTI) [85], then with defense-related gene suppression. Recent studies suggest that 
alteration of MAMP-triggered defense-related phytohormone synthesis is essential to allow 
establishment of AM symbioses [86].  Specifically, salicylic acid (SA) and jasmonic acid (JA), 
known antagonistic plant defenders, are dynamically regulated to achieve colonization [72, 83, 
84].  A phytohormone with both beneficial and detrimental effects, stringlolactone (SL), is 
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important in AM colonization and is also known to cue parasitic plants and increase susceptibility 
to pathogenic fungi and bacteria [87].  Other mechanisms involve utilization of host enzymes, such 
as chitinases to remodel fungal cell walls to allow for symbiont establishment [88].  Glomus 
intraradices, an AM colonizer, secretes specific effector proteins, such as SP7, which directly 
interferes with the transcription factor ERF19, leading to suppression of effector-triggered genes 
to allow colonization [89].  The molecular crosstalk of host and symbiont illustrate the importance 
of this evolutionarily driven relationship.  
 
Following colonization, beneficial microbes can also induce immune “priming”, which refers to 
acceleration of subsequent defense responses to pathogens [90], even in distal tissues. Thus, 
protective rhizobacteria trigger induced systemic resistance (ISR) and AM can produce 
mycorrhizal induced resistance (MIR) [84, 85]. In addition, the discovery of mycorrhizae helper 
bacteria (MHB), demonstrates the ability of select Pseudomonas strains to aid in mycorrhizal 
colonization, seemingly benefitting the host plant, fungus and bacteria [91].  Specific MHB are 
known to protect from pathogens, aid in nutrient acquisition and assist with nitrogen fixation [92].  
Also significant in mediating the plant-microbe relationship is systemic induced susceptibility 
(SIS) [93].  Prior plant infection with a pathogenic strain of Pseudomonas, P. syringae, results in 
SIS to a species of moth larva [93].  Together, these findings suggest that certain bacterial strains 
can be beneficially selected for plant inoculation, subsequent mycorrhizae establishment, and 
result in improved host competition [91], or manipulated for pathogenic infection [93], 
highlighting the integration of immune suppression and priming by AM in mutualistic 
relationships.  
 
Interestingly, a recent survey of global fungal diversity revealed that plant and fungal diversity 
could not be directly correlated [94]. Another study found that while alpha diversity, or the number 
of types of archaeal, bacterial, and fungal species within samples did not correlate with plant alpha 
diversity, plant beta diversity, or the comparison of types of microbes between samples, was 
significantly correlated with bacterial and fungal beta diversity [95]. The ancient symbiotic 
relationship between plants and microbes reveals that plants and fungi have long shared biological 
niches, suggesting plants engage in careful and intentional selection of their microbial partners.  
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Microbe-microbe interactions 
Simultaneously exploring fungal, archaeal, and bacterial root microbiome composition through 
genomic profiles can allow for further understanding of the most effective methods for 
distinguishing microbial life, niches in which organisms live and grow, host benefit or detriment, 
and general ecological diversity indices. For these reasons, Shakya et al. [96] compared 
metagenomic and gene-specific techniques for identification of mixed synthetic archaeal/bacterial 
communities and found that metagenomic data were more representative than amplicon 
sequencing by both 454 and Illumina technology [96]. This idea has also been demonstrated with 
the uncoupling of fungal and microbe diversity from the predictive indicators host species and soil 
origin. Multiplex 454 amplicon sequencing of four loci from three unique plant species grown in 
soils from three exclusive geographic sites revealed that fungal community composition is more 
influenced by soil rather than plant host species whereas the inverse is true for bacterial community 
composition [97]. Further, microbial gene dynamics (i.e. loss, lateral transfer, etc.) have also been 
identified as a driver of microbiome contouring [98], demonstrating another mechanisms microbes 
may use to influence other members of root microbiomes. 
 
While understanding colonization by a single microbe is helpful in deciphering colonization and 
functional root microbiome mechanisms, such relationships do not depict environmentally 
relevant scenarios. A comparison of plants colonized with Streptomyces mixtures of 1-, 4-, 8-, or 
16-species revealed bacterial co-associations unique to individual plant species [64]. An additional 
strategy examines co-association matrices; these studies are capable of eliminating the inherent 
noise of relative abundance amplicon census surveys, since they require microbes to be present in 
multiple samples for a co-occurrence to be identified [54, 64, 99]. Community-level co-association 
studies have been successfully applied to human microbiota to show that dominate commensal 
bacteria likely compete with each other, while potential pathogens might co-occur, possibly due 
to habitat sharing [100]. A similar approach was used to examine the composition of the rhizoplane 
and root endosphere of lettuce cultivars [54]. In this case, more positive interactions were revealed 
than negative interactions. In fact, only a single negative interaction between Streptomycetaceae 
and Acidobacteriaceae was discovered [54]. Streptomycetaceae, which belongs to the order 
Actinomycetales, is commonly enriched in root endosphere (within root) compared to rhizosphere 
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and surrounding soil, while Acidobacteria is depleted in A. thaliana and other Brassicaeceae grown 
in diverse soils [18, 19, 101].  A study of the maize root microbiome used a novel approach to 
identify Entrobacter cloacae as a keystone species and further describe specific community 
assembly mechanisms via selective removal of individual strains [102].  A genomic approach to 
exploring selection pressures among a variety of Actinobacteria genera revealed different 
evolutionary rates in secretory protein gene evolution between species, suggesting a ‘genetic 
marker’ indicative of host tolerance [103]. Together these data potentially highlight a specific root 
microbiome control mechanism used by Streptomycetaceae and other Actinobacteria to exclude 
microbes from the root endosphere. 
 
Among the positive interactions between microbiota in the lettuce root tissue, many existed 
between closely related taxa [54]. The validation for these findings was performed using 
fluorescent in situ hybridization (FISH), and two major observations were made: 1) mixed colonies 
on the surface of the root, indicating possible symbiosis between the microbes and 2) segregated 
colonies in close proximity, suggesting habitat sharing [54]. These studies demonstrate that models 
based on census data can be validated and provide additional insight into how microbes might 
inhibit or promote co-resident microbe growth in the root microbiome.  
 
II. THE MAMMALIAN GUT MICROBIOME 
 
Genes comprising the human microbiome and other mammals are known to exponentially 
outnumber those of its hosts [104].  Therefore, not surprisingly, the trillions of cells housing these 
genes perform functions critical for human life.  Countless organisms assemble and inhabit various 
mammalian body structures and organs [4, 30].  Like plants, mammalian microbiomes have been 
implicated in a number of essential functions, including nutrient acquisition and metabolism, 
protection from pathogens, and protection from abiotic stress (Figure 1.1) [3].  The gut microbiome 
has been linked to many of these functions, with likely the most studied being that of immune 
modulation and development of disease [4].  As has been described in plant microbiome dynamics 
via systemic induced susceptibility, individual gut microbes, and even a distinct microbial genes, 
can lead to problematic vulnerabilities and shifts [105].  In contrast, inflammation in the 
mammalian gut microbiome can be reduced by altering the metabolic potential of a single family 
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via introduction of a specific cofactor [106].  Thus, the host immune-gut commensal balance is 
critical to maintain homeostasis.  A recent study of long-term drivers of mammalian gut microbial 
composition found that host phylogeny was predictive of more recent bacterial lineages, while host 
dietary shift predicted acquisition of ancient bacterial clades [107].  Interestingly, this study found 
distinct older clades associated with herbivory as opposed to more recent clades linked with 
carnivory [107].  These findings prompt questions about the implications of these shifts on host 
health and, in particular host immune adaptation to the introduction of new bacterial clades.  The 
human microbiome project has characterized common gut microbiome taxa [104] and other studies 
have explored dysbiosis and its implications on a variety of gastrointestinal diseases [106, 108, 
109].  Continuously, new studies are emerging exploring links between the gut microbiome and 
diseases, either chronic or infectious. 
 
The mammalian gut microbiome is known to be an influential determinant in various physiological 
and disease outcomes, including liver diseases [38] irritable bowel disorders [110], osteoporosis 
[111], obesity [112], allergy/asthma [113], influenza [114], and even malaria [46].  Gut dysbiosis 
has been implicated in many of these diseases, including identification of specific taxa found to be 
either protective or contributory.  Furthermore, probiotics, consisting of one or various 
combinations of bacterial isolates, continue to be studied for their therapeutic potential with 
promising and ever evolving findings [30, 115].  In many cases, mechanisms remain unknown, 
but recent studies are beginning to reveal potential disease-contributory and protective 
mechanisms between isolates and the host immune system [4].   
Chronic diseases 
As the population grows and ages, long term illness afflicts a greater proportion of these 
individuals, opening the door for identification of opportunities to harness the power of the gut 
microbiome for intervention and prevention.  It is known that genes responsible for gut 
development and immunity influence the composition of the gut microbiome [116].  In alignment 
with the concept of symbiotic plant-microbe co-evolution [16], the human body is considered a 
holobiont in which its microbiomes, and thus including the gut microbiome, function as one unit, 
with neither the microbes nor gut functioning autonomously [20].  Therefore not surprisingly, the 
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gut microbiome is established immediately following birth and continues to adapt and change 
according to varying environmental stimuli, stresses and host diet [20].  Considering its early 
establishment and therefore potential for longitudinal impact,  it is essential we understand 
connections between the gut microbiome and progression to chronic disease.  Several select 
chronic diseases with known links to gut microbiome dynamics are addressed here.   
 
Crohn’s disease and other inflammatory diseases of the intestinal tract are known to be associated 
with gut dysbiosis [106, 117].  While these are likely among the most studied diseases linked with 
gut dysbiosis, the inherent complexities of the gut-microbe system leave room for further 
exploration and development of effective interventions.  Depletion of commensal taxa from the 
phyla Bacteroidetes and Firmicutes has long been associated with various disease states, and 
inflammatory bowel diseases (IBD) in particular [117].  Interestingly, as compared to plants, 
addition of members from the Actinobacteria and Proteobacteria phyla is associated with IBD risk 
[116].  Individual genes and immune proteins/processes have been identified as regulators of IBD.  
For example, mice lacking nod2, a gene involved in innate immune regulation, are more 
susceptible to IBD, and specifically Crohn’s disease [118]. In addition, recent study of the gut 
microbiome and the innate immune signaling complex, NLRP6 found that plant-derived flavones, 
and specifically apigenin, is protective against colitis via apigenin-mediated modulation of gut 
microbe inflammation and proliferation [119]. Interestingly, our prior understanding of the 
concurrence of general dysbiosis and IBD pathology expanded to include more targeted volatile 
disruptive events. Recent studies of dysbiosis and inflammatory bowel disease (IBD) found that 
IBD is characterized by abnormal violent fluctuations of the gut microbiome, rather than general 
dysbiosis [109, 120].  A longitudinal cohort study of clinical data from 29 IBD patients and healthy 
individuals allowed for statistical establishment of a healthy gut microbiome plane (HP) [120].  
IBD patients sporadically, but sometimes drastically, deviated from the HP, further informing gut 
microbiome-disease dynamics [120].  Overall, complex dynamics regulate the host gut 
microbiome and potential IBDs, with host genetic variations becoming increasingly significant 
[116].  However, our expanding knowledge has proven incredibly useful in treatment and 
therapeutic interventions. 
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While it is not surprising that the gut microbiome plays an essential role in modulating localized 
infections and pathology, increasingly evident is the influence of the gut microbiome in distal 
pathologies.  It is thought that microbiome-derived metabolites like short chain fatty acids 
(SCFAs), such as butyrate, play an essential role in signaling to these sites [121].  One example of 
this is lung disease.  Study of the gut-lung axis is newly emerging, but thus far, trends strongly 
suggest that gut microbiota extend their metabolic reach to the lung [37, 121, 122].  Specifically, 
a recent review describes the role of SCFAs originating in the gut microbiota, as stimulators of 
signaling to immune cells essential in protection from lung and airway inflammation [123].  
Similarly, Gray et al. described the importance of the exposure of neonatal mice to commensal 
microbes for lung mucosal immunity development and protection against various infections [124].  
A recent study of pneumonia in newborns implicates the importance of the gut microbiome in 
establishing mucosal lung immunity [125].  Several of these studies are summarized in a new 
review of the gut-lung axis that describes a shared mucosal immune system in which signals are 
transmitted from gut microbiota to the lungs and airways, resulting in immune modulation, 
response and largely protective phenotypes [126].  While there is still much to be explored, new 
studies are defining the roles of specific metabolite and genes involved in signaling and 
development of mucosal immunity [121].   
   
Finally, of recent interest is the connection between the gut microbiome and osteoporosis.  Studies 
describing the impacts of gut composition on bone health are beginning to take shape and mounting 
evidence suggests the importance of intestinal microbes and post-menopausal osteoporosis (PMO) 
[111].  In fact, it is know that the gut microbiome is responsible for bone physiology, with SCFAs 
essential in immune signaling and promotion of bone formation and resorption [121].  SCFAs are 
thought to influence proteins involved in calcium absorption [111].  Beyond PMO, links between 
healthy bone formation and the gut microbiome are emerging.  Bone formation is influenced by 
the production of insulin-like growth factor 1 (IGF-1), a hormone known for involvement in 
skeletal formation [127, 128].  Specifically, gut microbiome colonization is correlated with IGF-1 
production and was found to be directly associated with SCFA availability [129].  These studies 
provide valuable opportunities for probiotic and other therapeutic interventions.  In particular, 
highlighted here are the complexities of mammalian physiology and the interwoven dependencies 
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of the gut microbiome across systems.  Of particular interest and common to many of the diseases 
described is the necessity for gut microbiome metabolites in distal immune response.  
Infectious diseases 
Infectious diseases are highly studied and use a variety of animal models and systems.  The 
opportunities to study the role of the gut microbiome in infectious pathologies are broad and 
ongoing.  Multitudes of data exist in many facets of immunology describing these phenotypes.  
Despite the abundance of data, new niches are being explored, leading to valuable insights and 
therapies.  As in plants, protection from pathogens is among the most valuable of the benefits from 
host-microbe assimilation.  Described here are examples of a viral, bacteria and parasitic infection 
whose severity or infectivity is modulated in some way by the gut microbiome, the final example, 
malaria, will be described fully in Chapter IV. 
 
Influenza is a serious viral respiratory infection, causing annual morbidity and mortality involving 
3 to 5 million people.  Immunologic studies of mice treated with a broad spectrum antibiotic 
cocktail in their drinking water demonstrated the significance of the gut microbiome in mediating 
infection from influenza [130]. mRNA expression of TLR7, an innate immune receptor important 
in recognizing viruses and expressing pro-inflammatory cytokines, was decreased in mice treated 
with the broad spectrum antibiotic neomycin, suggesting the importance of the gut microbiome in 
effective pulmonary immune function [131].  Additionally,  various sets of immune modulated, 
compromised and specific pathogen free (SPF) mice were shown to develop incomplete immunity 
when administered seasonal influenza vaccine [132].  This was discovered to be a result of 
decreased TLR5 expression, an innate immune receptor essential to bacterial flagellin recognition.  
In summary, commensal gut microbes activated the TLR5 pathway, resulting in reduced 
immunoglobulin G (IgG) and IgM antibody responses, and therefore incomplete protection from 
influenza virus [132].  Together, these studies demonstrate the significance of the gut microbiome 
on a specific respiratory pathogen and suggest a role for therapies resulting in minimal gut 
disturbance, and careful administration of vaccines post antibiotic treatments.    
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Nosocomial infections with Clostridium difficile ravage immunocompromised patients, with 
significant detrimental outcomes, including spread of infection to other patients and increased 
morbidity and mortality.  The infection is most often associated with antibiotic treatment in 
combination with hospitalization.  Controlling these infections is essential to improving outcomes 
for hospitalized and other patients.  While part of the normal gut flora, C. difficile can become 
problematic during gut dysbiosis [133-135].  Importantly, presence and absence of select taxa are 
known to be influential in C. difficile infection [136, 137], and profiling of the gut microbiome 
via16S rRNA gene sequencing has shed light on distinct strains of the bacterium associated with 
varying pathologies and risks for initial and reinfection [138] Evidence suggests that the cause of 
significant infection and inability of the immune system to adequately control the infection is 
related to the absence of key gut metabolites and bacterial components important in stimulating 
immune function [134]. Some of these include SCFAs and a variety of other nutrients [133]. 
Modulation of the gut taxa allowing exploitation by C. difficile can be devastating, and therapies 
to prevent and control infection are continuously emerging.  Among the most controversial of these 
is fecal microbiota transplant (FMT).  Mounting evidence lauds the benefits of recolonization, but 
additional studies are needed to fully explore the options for effective and simulated FMT [139].  
 
Parasitic infections plague much of the population, particularly in the developing world, with 
Plasmodium infection, which causes malaria, being a very significant public health burden.  There 
are few studies of the gut microbiome and malaria infections, but newer studies have described 
associations between decreased severity of malarial illness and specific taxa, such as 
Bifidobacterium, Streptococcus, and Lactobacillus, and even specific strains such as Eshcheria 
coli O86:B7  [46, 140].  Interestingly, Plasmodium and E. coli O86:B7 both stimulate production 
of the same antibody, therefore inducing cross-reactivity [135, 141, 142].  Generally, many studies 
suggest that the host immune system and gut microbiome insight corollary efforts to mediate the 
parasitic infection.  A recent review of the gut microbiome’s influence on malarial illness found 
trends consistent with Plasmodium’s ability to reversibly alter the composition of the gut 
microbiome [142].  Fundamental dynamics of malarial infection makes identification of any one 
mechanism of this relationship difficult to tease out. Mammalian Plasmodium infection is 
multivariate, and the immune system is stimulated to regulate multiple malarial antigens at varying 
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stages of infection, presenting significant challenges for vaccine.  Thus, it is essential that we 
continue to examine the potential for microbiome-related therapies in malaria prevention. 
 
III. OBJECTIVES 
Microbiome studies broadly designed to characterize operational taxonomic unit (OTU) or 
amplicon sequence variant (ASV) relative abundances have provided characterization of these 
abundances and allowed for hypothesis generation.  More focused studies of microbiome 
community members can suggest functional influences of bacterial members.    While undeniably 
complex, the contribution of individual strains should not be overlooked.  Multidimensional 
studies (i.e. in vitro, in vivo, and in silico) taking into account individual strain roles may redefine 
host-microbe or microbe-microbe relationships in the context of a microbiome.  The following 
chapters address some of the microbiome assembly cues shared across kingdoms, as well as a 
detailed look at dynamics within the plant root microbiome and a foray into the complexities of 
the influence of the mammalian gut microbiome on a pathogenic infection.   
  
The use of co-occurrence matrices and mixed synthetic communities to explore microbe-microbe 
and host-microbe interactions is proving more feasible and can be used as a tool of comparison to 
environmentally relevant analyses.  Technical advances in 'omics approaches have vastly 
expanded our understanding of microbiome composition and function [143]. The declining cost of 
sequencing has substantially contributed to improved comparative genomics [144].  Continued 
reduction in costs associated with sequencing will allow for consistent contribution to sequence 
databases and the corollary improvement of genome and metagenome comparisons.  As this access 
to multi-kingdom microbiome datasets improves, the integration of these datasets will provide 
powerful insights into the physiology of microbiomes.  Aligning these data and mining large 
datasets for overlapping functions will allow for identification of impacts that other plants and 
microbes have on root microbiomes and long-term soil conditioning with mammalian 
microbiomes, and how taxa within mammalian microbiomes contribute to disease severity, will 
allow the development of sustainable, tractable, therapies improving crop health and productivity 
as well as reducing disease burdens worldwide. 
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Figure 2.1. Model of host-microbiome interactions. 
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I. ABSTRACT 
 
Streptomyces assemble into the root microbiomes of a wide variety of plants grown in soils 
worldwide, suggesting their ability to survive during root microbiome assembly by an array of 
robust molecular mechanisms. A previous student found that among four non-pathogenic, root-
associated Streptomyces strains, only two colonized Arabidopsis thaliana roots consistently when 
inoculated in a complex bacterial synthetic community. Here we characterize genomic and 
biochemical differences between these four non-pathogenic root-associated Streptomyces strains. 
Notably, in vitro studies provide evidence that the two isolates with more successful root 
colonization produce melanin. Genome investigation of these strains identified two copies of the 
gene that encodes Streptomyces tyrosinase, an enzyme necessary for extracellular melanin 
biosynthesis, but which oxidizes other plant-relevant phenolic compounds. Enzymatic assays of 
whole cell extracts and supernatants revealed tyrosinase activity, which could be inhibited with 
the chemical inhibitor kojic acid (KA), indicating that these isolates produced functional 
extracellular and intracellular enzymes. When challenged in vitro with phenolic compounds 
present in root exudates, salicylic acid (SA) and ferulic acid (FA), strains harboring two functional 
tyrosinases demonstrated increased protection. Monoinoculation of A. thaliana seedlings with 
each of four Streptomyces strains demonstrated that melanin-producing Streptomyces also had 
significantly more seedling colonization, which was significantly lower with the addition of KA. 
Overall, we observe a previously unappreciated consequence of microbial melanin production 
and/or tyrosinase activity to increase seedling colonization of Streptomyces isolates, which we 
propose protects against plant-produced phenolic compounds. These findings emphasize the 
importance of considering innovative roles for previously characterized natural products within 
the context of the microbiome. 
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I. INTRODUCTION 
 
The mechanisms of plant microbiome assembly are complicated and interweaving with both hosts 
and microbes driving composition [1]. The microbial members of these communities likely 
efficiently scavenge resources and nutrients [2, 3], withstand abiotic and biotic assault [4, 5], 
and/or act aggressively toward competing microbes [6]. Microbiome assembly is likely influenced 
by cooperation and competition between microbes vying for niches within the root. Additionally, 
negotiation of the host immune system requires specific microbial abilities, as well as host 
accommodation. Hosts drive microbiome composition by recruiting subsets of the soil microbial 
reservoir, resulting in host-specific microbiome assemblages that are often rich in certain taxa and 
deplete in others. While defined assemblages facilitate the detection of community composition 
shifts, which may result in a net benefit or cost to the host and other microbes [7], it is still critical 
to define the finer scale influence of individual members on host health [1, 8]. Understanding 
incentives for specific host-microbiome establishment will facilitate consistent community 
manipulation to improve plant health and growth through defined agricultural practices [5, 9].  
 
Deciphering the mechanisms that promote colonization of individual microbial strains within a 
complex microbial inoculum is essential for the development of successful biological products to 
improve plant health. Although Streptomycetaceae are not a dominant root-associated family, they 
are consistently enriched within the roots of various plant species compared to the surrounding 
soil and are highly regarded for their metabolic potential [10-16]. While strains of Streptomyces 
scabiei and Streptomyces ipomoeae are plant pathogens [17], most other strains are non-pathogenic 
and consistent root microbiome members. Many Streptomyces contribute or are correlated to 
agriculturally important traits, such as drought resistance, improved plant growth, disease 
resistance through exhibition of distinct biocontrol capabilities, and plant growth-promoting 
rhizobacteria (PGPR) [18-20]. Because they need to be present to exert sustainable direct or 
indirect influence on plant health, it is critical to tease apart unique mechanisms that facilitate 
Streptomyces root colonization.  Further, we must define Streptomyces strain-specific mechanisms 
that might potentiate survival advantages during root microbiome assembly.   
 
  34 
Previous experiments inoculated axenic Arabidopsis thaliana with a synthetic community of 38 
taxonomically diverse bacterial isolates, which included four Streptomyces isolates, and found that 
their colonization of 6-8 week-old A. thaliana roots differed [21].  Specifically, two Streptomyces 
isolates, 299 and 303, were found to be significantly more abundant in the endophytic 
compartment (EC) than inoculum and were thus indicated as “EC-enriched”. One other 
Streptomyces isolate, CL18, did not significantly change in abundance in root compared to the 
inoculum while the fourth, 136, was significantly less abundant in the roots than in the inoculum 
[21]. These phenotypes were influenced by salicylic acid (SA), a phenolic compound, which 
inhibits microbial growth [22, 23], acts as a plant defense phytohormone [24, 25], and is 
measurable in root tissue, seedlings and exudates [21, 26-28]. Isolate 136 colonized significantly 
better in pad4 plants, which are unable to trigger SA accumulation, while 303 displayed 
significantly increased levels of root colonization in plants sprayed with exogenous SA [21]. Thus, 
Streptomyces colonization appears to be influence by at least one phenolic compound present in 
the root-soil interface. Here we explore distinct phenotypic and genomic characteristics of these 
four non-pathogenic A. thaliana root-associated Streptomyces strains (Table 2.S1). We investigate 
the strain-specific kinetics and products of an enzyme present in the two EC-enriched strains, 299 
and 303, but not CL18 or 136.  Further, we suggest inhibition of this enzyme can influence 
protection against phenolic compounds during root association.  These studies present a unique 
opportunity to elucidate microbial determinants of root-associated strains within a single genus. 
 
Streptomyces’ fall within the Actinobacteria phylum, a group with vast and varied metabolic 
potential [29]. We propose that one influential product made by plant colonizing Streptomyces 
strains is melanin, a pigment ranging in color from tan to black. Melanin is also produced by other 
bacterial taxa, fungi, plants, insects, and mammals [30-34].  While function and synthesis vary by 
organism, it is generally hypothesized to provide protection from stresses such as reactive oxygen 
species (ROS), antibiotics, and antimicrobial peptides [34-36], thereby providing a potential 
survival advantage [37]. The production of melanin in Streptomyces is conferred by the melC 
operon, which contains two genes, melC1 and melC2.  melC2 encodes a tyrosinase enzyme critical 
for oxidizing compounds at multiple steps during melanin production from tyrosine [38-40]. 
melC1 encodes a helper protein that adds the required copper ions for tyrosinase function and 
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contains a secretion signal that facilitates the export of both MelC1 and MelC2 proteins into the 
extracellular space, where the MelC2 enzyme participates in melanin production [41, 42]. A 
previous study discovered that a collection of melanin producing Streptomyces isolates contained 
two predicted copies of the melC operon, each containing the two required genes [35]. The second 
copy of the operon (termed melD) resulted in an intracellular enzyme, oxidizing phenolic 
compounds within the cell and preventing toxic ROS generation [35]. Here we describe that our 
Streptomyces isolates capable of producing melanin also possess both a melC and a melD operon, 
exhibit increased resistance to phenolic compounds, and that the well-defined chemical tyrosinase 
inhibitor, kojic acid (KA) [43, 44] is capable of preventing enzymatic activity.  Ultimately, this 
strategy could contribute to self-preservation and subsequent enhanced opportunity for root 
colonization by Streptomyces strains. The experimental system we use allows us to determine the 
potential survival advantage of mel-harboring isolates via hypothesized protective tyrosinase or 
melanin activities. Advancing our understanding of how Streptomyces spp. colonize the A. 
thaliana root microbiome will provide future opportunities to understand their activities in the root 
microbiome and determine if they manipulate microbiome composition to improve plant health, 
growth, and ultimately yield. 
 
II. MATERIALS AND METHODS 
 
Streptomyces culture preparation 
Streptomyces isolates were grown in Lysogeny Broth (LB) at 30 oC with shaking at 150 rpm for 
four to seven days.  Cultures were vortexed vigorously for 5 seconds and beaten with 3 mm glass 
beads for 2.5 minutes to disrupt bacterial aggregates.  A spectrophotometer measured the optical 
density at 600 nm (OD600) and cultures were normalized to an OD600 of 0.01. 100 µL of all 
normalized isolate resuspensions were plated on LB solid media, incubated at 28 oC for four to 
seven days and colony forming units (CFUs) were counted.  Inoculum ranged from 1x102 to 3x104 
CFU/mL.  LB medium was used because each of the isolates has extremely consistent and 
differential colony morphology when grown on this medium, which allows us to accurately detect 
contamination with another Streptomyces or other faster growing bacteria. 
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Extracellular pigment extraction 
Pigment extraction from the two pigment-producing strains was adapted from Drewnowska et al 
[45]. Two hundred mL of cultures of 299 and 303 were split between four, 50 mL sterile conical 
tubes each and centrifuged for 15 min at 3200 x g (4000 rpm).  Supernatants of both isolates were 
transferred to two 100 mL glass bottles respectively.  The pH of the supernatants was adjusted to 
2.0 via addition of 1 M HCl.  Samples were incubated at room temperature for one week in the 
dark.  Following incubation, the acidified supernatants were boiled in the glass bottles for one hour 
at 240 °C. Cooled supernatants from each isolate were transferred to four, 50 mL conical tubes 
and centrifuged for 15 minutes at 3200 x g.  After supernatants were removed, approximately 1 
mL pellets remained in each tube.  Pellets were resuspended and combined into a single 15 mL 
tube per isolate.  The two tubes were then centrifuged again for 7 minutes at 3200 x g and 
supernatants were discarded.  Pellets were washed and centrifuged for 7 minutes at 3200 x g three 
times in 15 mL of 0.1 M HCl and a final time in 15 mL of water.  After each wash, supernatants 
were discarded.  After washing, 10 mL of absolute ethanol was added to the 15 mL tubes 
containing the pellets and resuspended.  The tubes were placed in a boiling water bath for 10 
minutes and then removed and incubated at room temperature for one day. Following incubation, 
the suspensions were centrifuged for 7 minutes at 3200 x g and the supernatant was discarded.  
The pellets were washed twice with absolute ethanol and centrifuged for seven minutes at 3200 x 
g between washings.  After the second wash, the pellets were allowed to air dry. 
Liquid-chromatography mass spectrometry  
Pigment pellets were digested following the protocol established by Ito et al. [46]. Briefly, 
approximately 1 mg portions of the dried pigments were weighed and transferred to glass vials (4 
dr) for digestion. The solid samples were suspended in 100 µL of HPLC-grade H2O, which was 
then sonicated for 2 minutes to increase dispersion of pigments in the aqueous solution. To the 
suspension of pigment in H2O, 30 µL 30% H2O2 and 375 µL of 1 M K2CO3 was added. The vials 
were capped and secured on an orbital shaker set to ~200 rpm to digest at room temperature for 
about 20 hours. At this time, excess peroxide was destroyed with the addition of 50 µL 10% 
Na2SO3 and the sample was acidified with 140 µL 6N HCl. These digested and quenched samples 
were centrifuged at 4000 rpm for 5 min and 300 µL of supernatant was transferred into an 
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autosampler vial. The LC-MS analyses were performed on an Ultimate 3000 UPLC system 
(Thermo Scientific, Pittsburgh, PA) coupled to an Exactive™ Plus Orbitrap mass spectrometer. 
Separations were conducted on an Accucore HILIC HPLC column (150 x 2.1 mm; 2.6 µm particle 
size, Thermo Scientific) kept at 25 °C and 10 µL of sample was injected onto the column for each 
analysis. The chromatographic method employed used 0.1% formic acid in ACN and 0.1% formic 
acid in H2O as mobile phases A and B, respectively. The chromatographic conditions were as 
follows: 0 minutes, 80% A; 10 minutes, 80% A; 10.1 minutes, 100% A; 20 minutes, 80% A; 25 
minutes, 80% A. The MS experiments were all conducted in negative ion mode using an 
electrospray ionization (ESI) source. The ESI parameters used were a spray voltage of -4.0 kV, an 
aux gas flow rate of 10 units, sheath gas flow rate of 25 units, and capillary temperature set to 320 
°C. The mass spectrometer scan range was set to 120-1800 m/z with a resolution of 140,000 and 
an automatic gain control (AGC) target of 3.0x106, and maximum injection time of 200 ms. The 
high-resolution mass spectrometric data was analyzed and processed using the MAVEN [47] 
software and Microsoft Excel to generate the bar graphs. Extracted ion chromatograms (EICs) 
were generated in MAVEN [47] with an extraction window of 10 ppm. 
Pangenomic visualization.  
Genomes for strains 299, 303, CL18, 136, and Streptomyces scabiei 87.22 (Table 2.S1 and 2.S2) 
were downloaded from JGI IMG/M ER [48].  Genomes were mined using JGI IMG/M ER query 
tools and Anvi’o v2.1.0  (a platform used to analyze and visualize genomic data)[49]. Pangenomic 
analysis was performed with Anvi’o, as outlined by Eren et al [29].  Homologs were identified 
using similarity searches through NCBI’s BLASTP and protein clusters were resolved with the 
MCL algorithm (inflation parameter 10)[50] using the minbit scoring method (score 0.5). 
Annotations were done with Pfam [51] and SUPERFAMILY [52].  Manual “binning” of protein 
clusters shared between subsets of genomes facilitated identification of group-specific gene 
clusters. Analyses resulted in a visual representation of the pangenome and a database of protein 
family annotations from the Pfam database [51].  
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Phylogenetic trees and identification of mel operons 
A concatenated alignment of the amino acid sequences of five housekeeping genes (trpB, gyrB, 
rpoB, atpD, and recA) from ten Streptomyces strains and one Kitasatospora strain, which 
represents another genus in Streptomycetaceae (Table 2.S1), was used to build a Maximum 
Likelihood (RAxML v7.2.8) phylogenetic tree using 100 bootstrap replicates [53]. Alignment 
(using MAFFT v7.017 [54] and tree-building was performed in Geneious version R7 
(http://www.geneious.com) (48). Melanin genes (melC1 (SCAB85691), melC2 (SCAB85681), 
melD1 (SCAB59231), melD2 (SCAB59241)) from Streptomyces scabiei 87.22 identified by Yang 
et al. were used as queries for NCBI BLASTP searches to identify melanin genes in all strains 
[35].   A separate concatenated alignment (MAFFT v7.394)[54] of amino acid sequences of the 
melC2, melD2, melC1, and melD1 genes from ten Streptomyces strains (Supplemental Table 1) 
was used to build a Maximum Likelihood tree using RAxML-HPC Black Box using 500 bootstrap 
replicates (version 8.2.10). Alignment and tree-building was done through CIPRES Science 
Gateway V. 3.3 [55]. Housekeeping and mel trees were visualized in iTOL [56].  All seven strains 
encoded the extracellular melC2 gene, whereas only six strains encoded the intracellular melD2 
(Figure 2D). 
Tyrosinase Assay 
Enzymatic oxidation of L-3,4-dihydroxyphenylalanine (L-DOPA) by tyrosinase  was monitored 
spectrophotometrically [57] using the BioTekâ Synergyâ Multi-Detection Microplate Reader. 
Synthesis of Dopachrome was monitored at an absorbance of 475 nm.  To prepare the assay, liquid 
cultures of each Streptomyces isolate were grown in 100 mL standard glucose-minimal salts 
medium with Tiger’s Milk (MMT) at 30 oC with shaking for 5-7 days, according to Keiser et al 
[58].  Approximately 20 mL of each culture was harvested and split between two, 15 mL conical 
tubes, which were centrifuged for 7 minutes at 3200 x g.  Supernatants were collected and kept on 
ice while pellets were resuspended and washed with 10 mL of 0.1 M sodium phosphate (131 mg 
Na2HPO4•7H2O / 70 mg NaH2PO4•H2O) pH 6.8.  Resuspended cells were then centrifuged for 7 
minutes at 3200 x g and supernatants were discarded.  Following resuspension of cell pellets in 10 
mL of 0.1 M sodium phosphate pH 6.8, suspensions were split between two tubes and sterile glass 
beads were added to each 15 mL tube and bead beaten for 5 minutes at 1500 rpm.  Bead beaten 
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cell extracts were then combined in one 15 mL tube and sonicated with a microtip for six cycles 
of 15 seconds of sonication at an amplitude of 15 and 45 seconds rest on ice.  Cells were then 
centrifuged for 7 minutes at 3200 x g and supernatants were collected, which was considered the 
cell extract fraction. For protein extracts, these cell extracts and culture supernatants were then 
treated with 70% ammonium sulfate ((NH4)2SO4)  and incubated on ice until dissolved.   After 
dissolution, both cell and extracellular protein extracts were centrifuged at 4 oC for 30 minutes at 
3200 x g.  Supernatants were discarded and protein pellets were resuspended in 2.5 mL of 0.1 M 
sodium phosphate.  To remove the salt from the protein pellets, samples were applied to PD 10 
desalting columns and allowed to pass through via gravity.  Before application, columns were 
washed with 4 applications of 0.1 M sodium phosphate pH 6.8.  After desalting, total protein 
concentrations were determined via the microtiter Bio-Rad Protein Assay. Extracellular extract 
protein concentrations ranged from 26.4 µg/mL to 601.8 µg/mL while intracellular extract protein 
concentrations range from 453.3 µg/mL to 1201.9 µg/mL. Samples were loaded into a 96-well 
microtiter plates, which included: 100 µL cell extract or extracellular extract all resuspended in 
0.1 M sodium phosphate, 100 µL 6.8 mM L-DOPA, and additions with and without, 5 mM of a 
tyrosinase inhibitor KA [44].  KA is known to inhibit the enzymatic activity of tyrosinase [43, 44].   
KA has been shown to have a competitive inhibitory effect on monophenolase activity via copper 
chelation.  Additionally, KA is known to have a mixed inhibitory effect on dephenolase activity 
of tyrosinase and likely inhibits tyrosinase via copper chelation at the enzyme’s active site [43].  
Controls included three replicates wells without protein containing combinations of 0.1 M sodium 
phosphate, L-DOPA, and 5mM KA.  Absorbance at 475 nm was measured every minute for 8-10 
hours.  
Phenolic compound challenges on agar 
To determine strain resistance to phenolic compounds, standard glucose-minimal salts medium 
(MM) was prepared according to Keiser et al. [58] with the addition of 0.01 g copper (II) sulfate 
(CuSO4) and 100 mL of phosphate buffer (138 g/L NaH2PO4 and 142 g/L Na2HPO4) per liter. 
Filter sterilized phenolic compounds were added to cooled, autoclaved media at concentrations of 
either 0, 0.125, 0.5, 1, or 5 mM for salicylic acid (SA), catechol, and ferulic acid (FA) or 0, 2, 5, 
6, 8, 10 and 12 mM for benzoate.  25 mL of phenol-containing agar was pipetted or poured onto 
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petri dishes. Once solid, 100 µL of Streptomyces strains 299, 303, CL18 and 136 standardized to 
OD600 of 0.01 (see above) and diluted 1:10 was pipetted onto solidified plates and spread with 
sterile beads (CFU range: 4x103 to 4x104).  Plates were incubated at 30 °C and checked daily for 
CFU formation.  CFUs were counted and recorded.  
Salicylic acid challenge in liquid media 
Liquid cultures of each isolate were prepared as described above with the exception of growth 
medium type. Cultures were grown in MM with copper (II) sulfate (CuSO4), rather than solid LB. 
A spectrophotometer measured the optical density at 600 nm (OD600) and cultures were normalized 
to an OD600 of 0.1. 100 µL of all normalized isolate resuspensions was added to sterile 125 mL 
flasks containing 75 mL MM and concentrations of either 0.0 mM or 0.5 mM SA. These 
concentrations were chosen based on results from solid media as well previous findings from 
Lebeis et al [21].  In addition, a separate complete set of flasks was inoculated exactly as described, 
with the addition of 1.5 mM KA.  Three technical replicates were prepared.  Erlenmeyer flasks 
were incubated at 30 °C with shaking at 125 rpm for 6 days.  After the 6-day incubation, biomass 
was collected via 10 second vacuum filtration of each 75 mL culture on 0.2 µm filter paper.  Filters 
were allowed to dry overnight.  Three filter paper controls with filtered media only were weighed 
and biomass was calculated based on the difference between the average of the control filter paper 
and those with culture.   
Seed sterilization and germination 
For all seedling experiments, we used Col-0 accession, wild-type (WT) A. thaliana plants. sid2 
seedlings, which cannot produce SA [59] were obtained from the Arabidopsis Biological Resource 
Center (ABRC) seed collection at The Ohio State University. All seeds were surface sterilized via 
treatment in 70% ethanol with 0.1% Triton-X100 for one minute, 10% household bleach with 0.1% 
Triton-X100 for 15 minutes, and three washes with sterile distilled water.  Seeds were stratified 
for 3 days in the dark at 4 oC and subsequently germinated at 24 oC with 18 hours of light for 6- 
days on agar plates containing half strength (2.22 g/L) Murashige & Skoog (MS) vitamins, 1% 
sucrose, and 1% Phytoagar (Bioworld).  
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Plant colonization experiments 
To inoculate plates, 150 µL of individual isolate resuspensions were spread on prepared half 
strength MS 150 mm x 150 mm square agar plates with no sucrose.  Plates were allowed to dry 
and four to five seedlings were aseptically transferred onto each plate with flame-sterilized 
tweezers.  Plates were sealed with Parafilm® M Laboratory Film and randomly stacked vertically 
in open wire trays, which were grown at 24 oC with 18 hours of light for 14 days.  Every two days, 
root length was observed, phenotype was assessed, and plates were shuffled.  After 14 days, the 
seedlings from each plate were aseptically harvested and pooled in sterile previously weighed 1.5 
mL centrifuge tubes. Tubes were weighed again after tissue was added to determine seedling 
biomass. To quantify internal levels of colonization, roots were rinsed and vortexed 5 seconds 
three times with sterile distilled water to determine combined level of colonization for internal and 
tightly attached external bacteria. Alternatively, seedlings were surface sterilized by treating with 
freshly made 10% household bleach with 0.01% Triton-X100 for 15 minutes. Seedlings were then 
rinsed with sterile distilled water, residual bleach was neutralized with sterile 2.5% sodium 
thiosulfate (Na2S2O3•5H2O) for 5 minutes, and finally washed with sterile distilled water twice 
more. For homogenization of weighed seedlings, sterile 3 mm garnet or glass beads were 
aseptically transferred to tubes containing the pooled, surface sterilized whole seedlings in each 
tube, 1 mL of sterile water was added to each tube, and samples were homogenized in a 2010 
Geno/Grinder® at 1500 rpm for 2.5 minutes. 100 µL of homogenized tissue was spread on LB 
plates and incubated at 28 oC for 4-7 days.  CFUs were counted and recorded.  For experiments in 
pots, 64 mL of sterile calcined clay (Pro’s Choice Rapid Dry) in three-inch square pots was 
inoculated with 49mL normalized culture suspended in half strength MS buffered with sterile 2-
(N-morpholino) ethanesulfonic acid (MES).  Six-day old seedlings were aseptically transferred to 
inoculated pots. An additional 1mL of suspended inoculum was used to bury the seedling roots. 
Plants were watered every 2-3 days from the top with sterile distilled water and grown in growth 
chambers (Percival, model: AR41L3C8) with 10 hours of light at 22oC and 14 hours of dark at 
18oC.  Beginning at six weeks of growth, plants were aseptically harvested when inflorescence 
began to emerge. Whole plants were submerged in 25mL of sterile harvesting phosphate buffer 
with 0.01% Silwet (Lehle Seeds) and vortexed vigorously for ten seconds.  Roots and rosettes were 
separated with sterile forceps and transferred to sterile centrifuge tubes and weighed.  Roots were 
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either rinsed three times with sterile distilled water, or treated with bleach to remove external 
microbes, as aforementioned. Sterile glass or garnet beads were added to each tube containing 
roots, which were homogenized as described above.  Once homogenized, 100µL of tissue was 
spread on LB plates and incubated at 28oC for four to seven days.  CFUs were counted and 
recorded.  
Statistical analysis 
Enzyme assay, phenolic compound challenge, culture biomass, and seeding colonization and plant 
biomass, results were statistically analyzed with Prism version 7.0a for Mac (GraphPad Software, 
La Jolla California USA, www.graphpad.com) using the nonparametric Kruskal-Wallis test, 
including one-way ANOVA followed by Dunn’s multiple comparisons.  When appropriate, 
analysis included two-way ANOVA and Tukey’s multiple comparisons, or the Wilcoxon matched-




Melanin production is associated with root-enriched Streptomyces strains 
While Streptomycetaceae are not a dominant root-associated family, they are consistently present 
within the roots of various plant species [10-16, 18].  In previously reported findings, when A. 
thaliana was inoculated with a defined bacterial community of isolates and grown for 6-8 weeks, 
two Streptomyces isolates, 299 and 303, displayed enriched root endophytic compartment 
colonization while another two, CL18 and 136, did not [21]. Strikingly, 299 and 303 liquid and 
solid media, but not the bacteria themselves, developed distinct pigmentation in vitro, which never 
appear in CL18 or 136 cultures (Figure 2.1A).  Pigment produced by strain 299 was delayed and 
lighter in color than that produced by 303 (Figure 1A).  The brown/black pigmentation suggested 
the potential production of melanin. 
 
To determine its identity, pigment was extracted from 299 and 303 spent liquid media.  LC-MS 
analysis of pigments extracted from 299 and 303 indicated molecular similarity to a synthetic 
melanin standard by the presence of three distinct melanin degradation products (pyrrole-2,3-
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dicarboxylic acid (PDCA), pyrrole-2,3,5-tricarboxylic acid (PTCA), 1,3-thiazole-4,5-dicarboxylic 
acid (TDCA)) (Figure 2.1B-C).  In addition, while both extracted pigment samples were consistent 
with synthetic melanin, the normalized relative intensities of melanin degradation products from 
isolates 299 and 303 were not identical, consistent with pigment distinctions observed in liquid 
(Figure 2.1A) and solid media (data not shown).  Overall, our findings suggest that when grown 
in/on LB and MM, 299 and 303 produce an extracellular pigment, which CL18 and 136 do not, 
and this pigment is melanin.  We next sought to determine if pigment production was associated 
with genome distinctions between the four Streptomyces strains. 
Genomes of melanin-producing strains contain genes essential for melanin production 
A phylogenetic tree constructed from a concatenated alignment of five housekeeping genes 
indicated our four non-pathogenic, root-associated Streptomyces strains showed phylogenetic 
similarity with a variety of previously characterized soil-derived Streptomyces, with 136 diverging 
the most from 299, 303, and CL18 (Figure 2.2A and Table 2.S1).  Included in this comparison for 
its robust colonization of A. thaliana roots and melanin pigment production, Streptomyces scabiei 
87.22 proved more closely related to 299 and 303 than CL18 or 136, although neither 299 nor 303 
showed evidence of pathology even 6-8 weeks post-infection (Figure 2.S1). Thus, we set out to 
determine genome regions and more specifically, individual genes shared by phenotypically 
similar strains.  
 
Besides the genome of S. scabiei 87.22, which is complete, all genomes were estimated to be >99% 
complete by Anvi’o identification of four sets of bacterial single-copy gene collections [29].  
Annotations were assigned using the Pfam and [51] SUPERFAMILY [52] databases (Figure 2.2B-
C). Interestingly, 299, 303, and S. scabiei 87.22 had larger genomes than CL18 and 136 (Table 
2.S2), leaving room for exploration of genes and potential gene products involved in root 
association (Figure 2.2B-C).  Comparative genomics of our four isolates and S. scabiei 87.22 
revealed homologous genes shared among different subsets of all of the genomes. Specifically, we 
investigated homologous regions shared among 299, 303 and S. scabiei, but not CL18 or 136 
(Figure 2.2B).  The cluster unique to 299, 303 and S. scabiei 87.22 (Figure 2.2B-C) indicated the 
presence of two genes encoding tyrosinase in the genomes of 299 and 303 and one such gene in 
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the genome of S. scabiei 87.22, although BLASTP searches returned two copies for S. scabiei 
87.22 (Figure 2.2C pink boxes).  While Pfam annotations identified only one copy of the tyrosinase 
co-factor MelC1 in 299, 303 and S. scabiei 87.22 genomes, BLASTP searches returned two copies 
of this helper gene for each of these isolates respectively. The annotated co-factor is the helper 
protein responsible for copper ion addition to tyrosinase allowing enzymatic function [35].  As 
discussed, tyrosinase is an enzyme critical to melanin production, aligning with our previous 
finding of extracellular melanin production, suggesting that at least one tyrosinase/co-factor pair 
is active in 299 and 303.  However, we needed to investigate the potential role an active second 
tyrosinase/co-factor pair might confer. 
To further characterize the genes encoding tyrosinases and their co-factors, proteins identified in 
Anvi’o (Figure 2.2B-C), we searched for the presence of distinct melC and melD operons in select 
Streptomyces genomes with a BLASTP search using S. scabiei 87.22 protein sequences identified 
by Yang et al as queries [35]. Tyrosinase genes (Figure 2.2D bottom) and helper genes with at 
least 97% homology (Figure 2.2D top) were identified in six additional Streptomyces strains that 
produce a brown pigment in the medium (Table 2.S1).  Components of the melanin operon were 
not identified in the genomes of CL18 or 136. A phylogenetic tree of the tyrosinase genes from 
only Streptomyces genomes encoding two copies shows general clustering and divergence of the 
two genes (Figure 2.2D bottom and Table 2.S1).  This was also true for the annotated tyrosinase 
helper genes (Figure 2.2D top). Finally, the predicted melC1 and melC2 genes were contiguous 
within each genome, which was also true for the melD1 and melD2 genes.  While 299 and 303 
tyrosinase and helper genes share homology, they were not identical, which correlates with the 
strain-specific melanin pigments produced (Figure 2.1A, C).  Together, these findings necessitated 
investigation of strain-specific tyrosinase kinetics.  
Enzyme kinetics differentiate tyrosinase activity between Streptomyces strains 
We next sought to determine if 299 and 303 did indeed produce functional intracellular and 
extracellular tyrosinases by performing an enzymatic activity assay on whole cell extracts and 
culture supernatants. Whole cell (intracellular) and supernatant (extracellular) protein extracts 
from all four strains were combined with tyrosinase substrate L-DOPA, and enzymatic activities 
were observed as production of Dopachrome via spectrophotometry absorbance at 475 nm.  While 
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strain 303 showed enzymatic activity in both intracellular and extracellular protein extracts (Figure 
2.3B), strain 299 did not demonstrate statistically significant tyrosinase activity using this assay 
(Figure 2.3E) without the addition of copper sulfate (data not shown).  However, both 303 and 299 
produced melanin (Figure 2.1), indicating that each of their extracellular tyrosinase is active at 
least in vitro.  CL18 and 136 extracts did not show any activity above the L-DOPA alone control 
and neither strain produced a pigment in vitro (Figure 2.3, 2.S2, 1.1A).  Interestingly, the tyrosinase 
activity demonstrated in both 303 intracellular and extracellular protein extract could be 
significantly inhibited by KA (Figure 2.3B, 2.3E, 2.S2). Together, our results support our earlier 
findings that while 299 and 303 both produce melanin, the tyrosinase required for its production 
has different activity (Figure 2.3), resulting in distinguishable melanins (Figure 2.1).   
Survival and growth in the presence of phenolic compounds is improved in better colonizers 
Microorganisms living close to and within plant roots must contend with root exudates, potentially 
including phenolic compounds such as salicylic acid (SA) and ferulic acid (FA), which inhibit 
Streptomyces growth [35].  Thus, SA is measurable in A. thaliana roots and seedlings while both 
SA and FA are present in root exudates of A. thaliana and Avena barbata [21, 27, 28].  Specifically, 
this evidence suggests that plant-associated strains living on or near roots may need to resist 
phenolic root exudates to successfully colonize.  Beyond their role in melanin production, 
tyrosinase enzymes encoded by Streptomyces are capable of oxidizing various phenolic 
compounds, including SA and FA, into their quinone form [35].  To determine Streptomyces 
isolate phenolic compound tolerance, we compared growth of all isolates on solid medium with 
the addition of varying concentrations of SA, FA, catechol, and benzoate (Figure 2.4A and 2.S3). 
As seen on the left in Figure 2.4A, at a concentration of 0.5mM SA, 303 grew significantly better 
than 299, CL18 and 136.  When challenged with FA, a lignin degradation product [60], at a 
concentration of 0.125mM, 303 survived significantly better than 299, CL18 and 136 (Figure 2.4A 
right). At 0.5mM FA, 303 grew better than both CL18 and 136, but not 299 (Figure 2.4A right) 
while at 1mM, 303 grew better than all other strains. Catechol challenge only at the lowest 
concentration (0.125mM) resulted in significant growth differences, in which 299 grew better than 
303, CL18 and 136 (Figure 2.S3).  We propose that differential results between 299 and 303 
phenolic compound stress tolerance may be due to variable tyrosinase substrate preferences, which 
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have been demonstrated even between MelD2 and MelC2 of the same Streptomyces strains [35]. 
Notably, 303 also encodes enzymes in a previously characterized Streptomyces SA degradation 
pathway and can use SA as its sole carbon source [21].  Similar genes were not found in the 
genomes of 299, CL18 and 136 [21]. Therefore, we needed to further distinguish if the increased 
colony forming units on solid medium was due to increased growth of 303, or increased protection 
of the oxidative stress induced by SA. 
 
To determine if the apparent protection of 303 against SA in vitro is mediated directly by bacterial 
tyrosinase activity, we added the tyrosinase inhibitor KA (1.5 mM) to liquid minimal medium 
(MM) with the significant concentration of 0.5 mM SA and measured biomass accumulation after 
6 days. Interestingly, biomass comparisons of 299 and 303 indicated that biomass was not 
influenced by SA presence at the concentrations tested (Figure 2.4B), suggesting that these strains 
do not have increased growth under these in vitro conditions, but rather are protected from phenolic 
compounds. Because only 303 contained a functional intracellular tyrosinase, both solid and liquid 
media challenges indicate that intracellular activity does not necessarily mediate oxidative stress 
protection (Figure 4A-B). While this protection correlates with extracellular tyrosinase activity, it 
was not eliminated under these conditions with the addition of 1.5 mM KA (Figure 4B), which 
was sufficient to inhibit enzymatic activity (Figure 2.3B and E).  Of note, addition of KA halted 
visible 299 and 303 pigment production (data not shown). Thus, we could not conclude that 
extracellular tyrosinase activity independent of melanin production protects 299 and 303 from SA 
induced stress. Likewise, the addition of synthetic melanin to CL18 and 136 cultures grown with 
SA did not affect biomass (Figure 2.4C). However, our evidence suggested that together tyrosinase 
and melanin can protect these strains from phenol-induced oxidative stress.  Thus, our in vitro 
growth experiments propose that neither tyrosinase nor melanin pigment alone are sufficient to 
provide Streptomyces with protection from SA, suggesting that both may be necessary to increase 
plant colonization. Additionally, we cannot rule out other mechanisms of protection, such as the 
tyrosinase-independent functional SA degradation pathway in strain 303 [21] or other tyrosinase 
products. To determine if tyrosinase-dependent protection from phenolic compounds might 
increase survivability near the root, we performed seedling colonization assays. 
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Seedling colonization is Streptomyces strain and tyrosinase identity dependent 
In a mixed bacterial community, the presence of predicted mel operons positively correlates to root 
enrichment of our two melanin-producing strains 299 and 303 [21], suggesting a potential role for 
tyrosinase or products of its enzymatic activity (such as melanin) in host colonization. Thus, to 
distinguish influences of mixed bacterial communities from individual strain capabilities, 
Streptomyces isolates 299, 303, CL18, and 136 were screened for their ability to colonize 6-day 
old A. thaliana seedlings as the sole inoculum for 14 days (Figure 2.5A). After two weeks, 
seedlings were colonized with significantly more of isolate 299 and 303 than 136, whereas CL18 
colonization was not significantly different than any other isolate (Figure 2.5A).  This pattern was 
also observed in bleached seedlings (Figure 2.S4A). Thus, in addition to increased root 
colonization of mature plants in a competitive context, 299 and 303 also colonize seedlings better 
than 136 14 days following monoinoculations, while CL18 is not significantly different from 
others (Figure 2.5A)[21]. Importantly, monoinoculated plants show no signs of pathology or 
change in biomass even after 6-8 weeks of growth (Figure 2.S1), confirming that they are not 
pathogens.  
 
We hypothesized that tyrosinase or its products could influence seedling colonization via 
conferring protection from common phenolic compounds in root tissues, seedlings, and exudates 
[21, 27, 28].  Thus, we again performed the monoinoculations described above, but introduced the 
tyrosinase inhibitor KA [43] to the assay to prohibit immediate tyrosinase-conferred protection.  
When KA (1.5 mM) was spread on plates prior to addition of each isolate, only seedling 
colonization by 303 was influenced by KA (p<0.0705)(Figure 2.5B), which correlates with the 
inhibition of intracellular and extracellular 303 tyrosinase activity (Figure 2.3B,E). Synthetic and 
bacterially-derived melanin were added to monoinoculations to determine if CL18 or 136 
colonization would improve, but it did not at 7 days (Figure 2.S4B-C).  Together with the previous 
finding that in vitro liquid growth of 303 with SA remained unchanged when tyrosinase was 
inhibited (Figure 2.4B), our results do not distinguish the importance of tyrosinase activity from 
melanin production in the context of seedling colonization.   
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To determine if SA production by seedlings influences Streptomyces isolate colonization, wild-
type Col-0 and sid2 A. thaliana seedlings, which are unable to biosynthesize SA, were inoculated 
with each of the four isolates (Figure 2.5C). While there were no significant differences in level of 
colonization for 299, 303, and 136, CL18 colonized significantly better in sid2 seedlings, 
indicating that SA production partially limits its colonization (Figure 2.5C). Together these 
experiments demonstrate that Streptomyces isolates are differentially sensitive to SA during 





Streptomyces’ metabolic potential in the root microbiome 
Streptomyces are capable of colonizing the roots of a wide variety of plant species [11-16, 21] in 
geographically and geologically diverse soils [62], emphasizing the need to understand their 
assembly into the root microbiome. Select Streptomyces strains have been identified as plant 
growth promoting and even disease suppressive [18], highlighting their potential applications in 
agriculture. Yet, likely due to their complex arsenal of natural products, including a variety of 
small molecules and antimicrobials such as volatile organic compounds, indole acetic acid, 
hydrogen sulfide, ammonia, and many currently uncharacterized products. Although microbial 
activities associated with root colonization for other more predominant taxa, such as 
Proteobacteria, have been uncovered, specific functions involving root microbiome assembly 
mechanisms for less abundant microbes, such as Streptomyces spp. is largely unexplored [18, 19, 
63, 64]. Overall, these studies shed light on the root microbiome colonization potential of specific 
Streptomyces strains and represent a shift towards defining multiple functional mechanisms 
microbes use for colonization from a complex microbial inoculum.  
Streptomyces’ employ distinct tyrosinase enzymes 
Based on our ability to distinguish Streptomyces strains by degree of seedling colonization, we 
hypothesized genomic differences would explain strain variation. Our comparative genomic 
analyses suggest distinct differences between our Streptomyces isolates. These findings highlight 
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that functional conclusions based on genus-level abundance from 16S rRNA gene amplicon 
studies inadequately capture the organisms’ potential, as previously described for plant-associated 
Pseudomonas strains [65]. Further, including the plant pathogen S. scabiei 87.22 in our genomic 
comparisons revealed shared genetic factors contributing to increased seedling colonization in our 
non-pathogenic, melanin-producing Streptomyces isolates. In addition to these findings, 
Beausejour and Beaulieu [61] found that melanin plays a role in S. scabiei 87.22 virulence and 
colonization. Genomic analyses identified potential phenolic compound resistance genes in 299 
and 303, leading to in vitro challenges with phenolic compounds that induce ROS production 
[66,67]. On solid media, 303 was able to withstand SA and FA better than CL18 and 136 (Figure 
2.4A), while 299 grew better than all other strains when challenged with the lowest concentration 
of catechol (Figure 2.S3).  In SA-containing inoculated liquid media, KA did not significantly 
influence 299 or 303 biomass accumulation, suggesting that there are other mechanisms to 
alleviate SA induced stress, such as the previously identified SA degradation pathway in 303 [21].  
Taken together, our genomic, in vitro, and in vivo findings emphasize 299 and 303 differential 
enzymatic structures, substrates and products, supporting strain-specific survival mechanisms. 
Further, neutralizing phenolic compounds is likely just one of many potential selective pressures 
imposed by the plant host.   
Comparative genomics inform benchtop experimentation 
As critical genome features in plant microbiomes continue to be defined, we propose the discovery 
power added via incorporation of genomic tools (i.e. comparative genomics) into benchtop 
exploration of microbial functional similarities and differences found to be predictive of 
colonization or host health. Studies are required to further define strain-specific Streptomyces 
natural products conferring potential survival advantages, which might also impact host or 
microbiome co-inhabitant growth.  The presence of Streptomyces in the core root microbiome from 
a diverse collection of plants [11-16] suggests strong selection for microbiome members with a 
diverse arsenal of secondary metabolic functions. This highlights the necessity to define the 
activities associated with strains in this genus. 
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A new role for a common microbial product 
Here we offer an approach to begin to disentangle phylum and family level generalizations about 
bacterial functions and roles within the host microbiome.  We have used this approach to define a 
new role for a widely studied enzyme, tyrosinase, and one of its products, melanin.  Together, 
melanin pigment production and tyrosinase gene identification unique to genomes of root-enriched 
strains suggests melanin or the tyrosinase enzyme required for its production may influence host 
colonization. We propose that during plant colonization, melanin-producing strains are protected 
against phenolic compounds commonly found in the root-soil interface [26-28, 60, 68, 69]. The 
impact of this finding is particularly interesting given that it is produced by a range of other soil 
isolated fungi and bacteria. Defining this new context for melanin production will ultimately 
inform our understanding the complex processes of root microbiome assembly and manipulation. 
 
As we look for new strategies to tackle the challenges of climate change-induced crop decline, we 
look toward the potential of the plant microbiome.   Recently, plant drought resistance bacterial 
community studies have identified Actinobacteria and Streptomyces as root enriched in drought 
conditions [19, 20]. We propose that continued strain-level investigation of overlapping genome 
regions and robust in vitro and in vivo studies will help further inform results from microbiome 
studies.  Thus, we suggest the power of moving beyond taxonomic identification and abundances 
to distinct strain gene comparisons and product exploration.  Together our findings provide 
opportunities for harnessing their power to improve plant health and more broadly enhance 
agricultural applications and crop productivity. 
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VII. APPENDIX:  TABLES 
 
Table 2.S1.  Strains referenced in this study.  
This table provides a link between the Streptomyces strains that were used in these experiments 












299 Streptomyces canus 299MFChir4.1 2521172643 NA 1,2,3,4 
303 Streptomyces sp. 303MFCol5.2 2521172626 NA 1,2,3,4 
CL18 Streptomyces sp.UNC401CLCol 2522572047 NA 1,2,3,4 
136 Streptomyces sp. 136MFCol5.1 2636416059 NA 1,2,3,4 
S. scabiei Streptomyces scabiei 87.22 646564576 NA 3,4,5 
OV308 Streptomyces mirabilis OV308 2582581313 NA 5 
YR139 Streptomyces mirabilis YR139 2582581314 NA 5 
OK006 Actinobacteria bacterium OK006 2639763183 NA 5 
OK461 Streptomyces mirabilis OK461 2616644814 NA 5 





S. galbus Streptomyces galbus NRRL B-2283 NA Streptomyces galbus NRRL B-2283 3 
S. 





S. avermitilis Streptomyces avermitilisMA-4680 NA Streptomyces avermitilis MA-4680 3 
S. coelicolor Streptomyces coelicolor A3(2) NA Streptomyces coelicolor A3(2) 3 
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Table 2.S2. Streptomyces’ genome investigation reveals divergent properties and 
biosynthetic predictions.   
Genome features include estimated size, GC content, number of scaffolds in the permanent draft 
genome, and estimated gene numbers. 
 
Streptomyces Isolate 










299 10.5 70% 116 9620 9710 
303 9.5 71% 77 8387 8480 
CL18 7.3 72% 49 6591 6677 
136 7.8 70% 31 6905 6991 
Streptomyces scabiei NCPPB 4086 10.5 71% 295 9050 9151 
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VIII. APPENDIX: FIGURES 
 
 
Figure 2.1. Streptomyces strains 299 and 303 produce a pigment consistent with synthetic 
melanin.  
(A) 299 and 303 cultures on the left and middle left produce an extracellular pigment in the LB 
medium. (B) A schematic showing the products expected from eumelanin degradation, including 
pyrrole-2,3-dicarboxylic acid (PDCA), pyrrole-2,3,5-tricarboxylic acid (PTCA), and 1,3-thiazole-
4,5-carboxylic acid (TDCA). The figure was adapted from Greco, G. [70]. (C) LC-MS of 
pigmented bacterial extracts indicate degradation components were present consistent with 
melanin (n=3, blanks subtracted, normalized to mass digested, mean displayed, and standard 
deviation indicated by error bars). 
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Figure 3.2. Phylogenetic and pangenomic comparison of Streptomyces spp. indicate distinct 
phylogeny and overlapping genes consistent with melanin production.   
(A) Concatenated alignment of the 5 amino acid sequences for housekeeping genes trpB, gyrB, 
rpoB, atpD,  and recA from 8 Streptomyces strains and one outgroup (Kitasatospora sp. OK780) 
(Maximum Likelihood, bootstrap consensus values based on 100 replicates) (B) Pangenomic 
comparison of Streptomyces isolates (listed from inside out: 136 (orange), CL18 (purple), S. 
scabiei (blue), 303 (green), and 299 (red). The fan with the pink bar on the end highlights those 
genes only present in S. scabiei, 303, and 299 genomes. (C) Heat map of Pfams predicted from 
Anvi’o (pink indicates tyrosinase Pfams). The scale on the left indicates how many copies (0-9). 
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Figure 2.3. Strain-specific tyrosinase activity and kojic acid (KA) inhibition is demonstrated 
via dopachrome production from L-DOPA with the addition of cell and extracellular 299, 
303, CL18 and 136 protein extracts. 
Dopachrome production as observed by the mean change in absorbance from the time 0 absorbance 
at 475 nm for 3 replicates for L-DOPE with protein extracts from 299 (A, red: 1143.3 µg/mL 
intracellular protein (top) and 601.8 µg/mL extracellular protein (bottom)) 303 (B, green: 903.3 
µg/mL intracellular protein (top) and 475.5 µg /mL extracellular protein (bottom)), CL18 (C, 
purple: 1201.9 µg/mL intracellular protein (top) and 62.3 µg/mL extracellular protein (bottom)), 
or 136 (D, orange: 453.3 µg/mL intracellular protein (top) and 26.4 µg/mL extracellular protein 
(bottom)) with and without the addition of the tyrosinase inhibitor, kojic acid (KA). Control E) 
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by the time required for the change indicating enzyme (tyrosinase) and substrate (L-DOPA) 
binding for 299 (above the red bar) and 303 (above the green bar) intracellular and extracellular 
extract, as well as the L-DOPA alone controls. * indicates KA samples were significantly lower at 
p<0.05, multiple t-test with Holm-Sidak multiple correction method. (F) The mean change in 
absorbance from time 0 absorbance at 475 nm for 3 replicates of L-DOPA alone with no protein 
addition. 
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Figure 2.4. Phenolic compound tolerance differs by Streptomyces strain.  
 (A) CFUs after 5-7 days of growth on solid glucose minimal medium containing the indicated 
concentration of salicylic acid (SA, left) or ferulic acid (FA, right). "a" indicates 303 was 
significantly different than 299, CL18, and 136. "b" indicates 303 was significantly different than 
CL18 and 136 (n=12, Kruskal-Wallis, Tukey’s multiple comparison, (p<0.05)) (B) Biomass of 
75mL liquid culture grown for 6 days in MM with and without kojic acid, with and without SA 
(0.5mM) (n=3). (C) Biomass of 75mL liquid cultures grown for 6 days in MM, MM with SA 
(0.5mM), or MM with synthetic melanin (20mg/mL) (n=3) (Figure 2.S3).  
FA (mM) 
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Figure 2.5. Differential colonization of Arabidopsis thaliana seedlings by Streptomyces strains. 
(A) 7 day old sterile, wild-type (WT) A. thaliana seedlings were inoculated with nothing (blue), 
299 (red), 303 (green), CL18 (purple), or 136 (orange) for 7 days to determine level of 
Streptomyces strain colonization. "a" indicates significantly different from 136 (p<0.05). "b" 
indicates significantly different from no bacteria (NB) (p<0.05), Dunn’s multiple comparison) (B) 
WT seedlings again inoculated with each Streptomyces strain in the presence (open symbols) and 
absence (closed symbols) of kojic acid. * indicates significantly different seedling colonization 
with and without kojic acid (p<0.05), Holm-Sidak multiple t-test (C) WT seedlings and sid2 
seedlings ("x" symbols), which are unable to biosynthesize SA, were inoculated with each 
Streptomyces strain.   
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Figure 2.S1. Streptomyces strains 299, 303, CL18, and 136 do not alter plant biomass, even 8 
weeks after inoculation.  
 
Biomass of: (A) above-ground biomass (phyllosphere), (B) below-ground root, and (C) total plant 
material was measured in plants grown for 6-8 weeks in sterile clay substrate inoculated with a 
single Streptomyces strain (n=7-10). No significant differences were observed. 
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Figure 2.S2. Intracellular and extracellular protein extracts from 303 are inhibited by kojic 
acid (KA). 
The mean change in absorbance at 475 nm 25 minutes into the assay with the standard error of the 
mean shown for intracellular and extracellular protein extracts from 299 (red bar), 303 (green bar), 
CL18 (purple bar), and 136 (orange bar) cultures with (white bars) or without (black bars) the 
addition of tyrosinase inhibitor, kojic acid (KA). * indicates KA samples are significantly lower 
absorbance than those without, p<0.002, multiple t-tests, Benjamini, Krieger, and Yeutieli multiple 
test correction. ** indicates KA samples are significantly lower absorbance than those without, 
p<0.0002, multiple t-tests, Benjamini, Krieger, and Yeutieli multiple test correction.  
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Figure 2.S3. Challenge of all strains with catechol and benzoate indicate variable differences 
in CFU formation. 
CFUs after 5-7 days of growth on solid glucose minimal medium containing the indicated 
concentration of catechol (A) or benzoate (B) were measured. "c" indicates 299 was significantly 
different than CL18 and 136 (n=9-12, Kruskal-Wallis, Tukey’s multiple comparison, (p<0.05)) 
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Figure 2.S4. Colonization of Arabidopsis thaliana seedlings by Streptomyces strains when 
grown with melanin compounds indicates no differences (n=3, 7 days germination, 7 days 
seedling growth) 
 (A) Monoinoculated seedlings rinsed with bleach (B) Monoinoculated seedlings grown in the 
presence of 4 mg/mL synthetic melanin (DMSO, melanin solvent control) (C) Monoinoculated 
seedlings grown in the presence of bacterial-derived melanin (DMSO, melanin solvent control). 
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CHAPTER THREE - MULTI-SCALE DESIGN TRANSLATES 
COMPARATIVE GENOMIC PREDICTIONS AND IN VITRO 
MICROBIAL INTERACTIONS INTO DEFINED ROOT 
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I. ABSTRACT 
 
Complex interactions of hosts and microbiomes continue to prove difficult to define.  In part, this 
is due to the nature of the interaction, but investigative approach has also proved a limiting factor.  
Streptomyces are metabolically productive, ubiquitous soil-dwelling organisms known to inhabit 
the microbiome of a wide variety of plant cultivars.  When introduced to plants, certain taxa 
promote growth, induce disease suppression, and even improve drought tolerance.  Their 
multifactorial benefits offer exciting opportunities for agricultural applications, but they require 
careful testing of their effect, prior to deployment.  Here we explore activities of four Streptomyces 
isolates in root microbiome assembly using a combination of approaches encompassing 
comparative genomics, in vitro co-culture challenges, and in vivo colonization with a low 
complexity bacterial synthetic community (SynCom) or a high complexity microbial community 
derived from wild soil (Wild).  We discovered the vast and sometimes divergent biosynthetic 
potential of these four Streptomyces strains and other root-associated taxa is not necessarily 
correlated with competitiveness either in co-culture or with a complex community in vivo.  Two 
of our Streptomyces isolates had biosynthetic gene clusters for indole; when tested in vitro, these 
strains proved capable of making indole acetic acid (IAA).  Interestingly, in vitro competition 
assays between the Streptomyces isolates as well as with other non-Streptomyces isolates indicated 
that resistance and susceptibility phenotypes do not always correlate with in vivo competitive 
colonization phenotypes with the same isolates. As Amplicon Sequence Variant (ASV) sample 
divergence and even phyla data did not provide the resolution necessary to detect potential 
differences, analysis and comparison of individual and averaged ASV relative abundances 
emphasized the importance of family-level investigation of samples. Our methods help tease apart 
plant and environment selective influence from microbe-microbe competition on microbiome 
assemblage. Overall, our findings confirm Streptomyces as consistent members of root 
microbiomes and suggest that nuance strain-level influences can be better targeted and detected 
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I. INTRODUCTION 
 
As sessile organisms, plants are reliant on their surrounding environment, including air, soil and 
water, for microbial introduction.  Significantly, soils are among the most microbially diverse 
environments on Earth, serving as rich inocula for host plants [1].  The selection process for host 
microbiome inclusion is mediated by microbe-microbe and host-microbe interactions [2].  The 
endosphere (internal) and rhizosphere (external) root-associated microenvironments present 
varying levels of host-microbe and microbe-microbe selection pressures, which significantly shape 
microbial inclusion from soil to within plant root [3].  The resulting bacterial assemblages have 
significant influence on host health and growth [4].  The limited internal root microbial diversity 
relative to surrounding soil presents an unique opportunity for studies manipulating soil 
microbiomes to achieve optimal plant health [5].  The assembled organisms must both invade and 
also persist, surviving host immune pressures, competition for resources, and environmental 
changes [5, 6].  Greater microbial diversity is correlated with increased nutrient acquisition, 
metabolism and plant growth [7], which would result from complex microbiome assembly 
processes.  Community construction dynamics are teased apart via progressive individual and 
community-level approaches, including next-generation sequencing technologies, co-occurrence 
network analyses, molecular techniques and pangenomic analyses.  These efforts are shedding new 
light on potential mechanisms driving community assemblies and resistance.   
 
To meet agricultural demands, fundamental strategies harnessing the power of microbiome 
manipulation and maintenance must be made.  Thus far, multiple microbiome studies including 
those exploring the influence of the host immune system [8], diversity [7], pathogen resistance [9], 
disease suppressive soils [10], beneficial consortia [5] and many others are contributing to our 
understanding of microbiome establishment.  For example, via a randomly barcoded transposon 
mutagenesis sequencing (RB-TnSeq) screen of Pseudomonas simiae, 115 bacterial genes 
important for Arabidopsis thaliana root colonization were identified, including 44 unannotated 
genes [11].  To determine functions of these genes, the researchers compared their findings to a 
RB-TnSeq library screening using 90 distinct in vitro conditions representing a proportion of the 
environmental root colonization conditions [11].  Salicylic acid (SA), a plant phytohormone that 
helps protect against microbe-induced stress, influenced bacterial commensal root colonization of 
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A. thaliana [8].  In addition, previous work performed by our lab suggests genes involved in 
tyrosinase production, an enzyme important for production of melanin, were Streptomyces-strain 
specific and influenced tolerance to common phenolic root exudates (Chapter 2).  While studies 
of whole microbiomes and individual strains are essential, neither allows for simultaneous 
discovery of complex community dynamics while also the fine resolution necessary to determine 
roles of individual microbes.  Thus, the remaining options suggest refined study of a set of 
microbes or use of a synthetic community (SynCom).   
 
16S rRNA gene survey studies suggest common members of root microbiomes across a variety of 
plant species [12-18].  While soil type is known to be the primary determinant of root-associated 
plant microbiomes and is considered the major inoculum, plant phylogeny has also proven to be 
an influential determinant of microbiome taxa [19].  Further, the root microbiome is distinct from 
that of other plant fractions, independent of host genotype [20].  Plant microbiome studies focused 
on determining relative abundances of all taxa or those belonging to a core potentially overlook 
the contribution of less abundant, but influential taxa.  To provide tractable and reproducible 
findings, recently highlighted is the value added via use of lower complexity SynCom rather than 
high complexity mixed communities [21].  Lower complexity studies, including use of reductionist 
approaches, which often include pared-down designs such as host-mediated selection of SynCom 
members [15], allow for mechanistic interspecies studies.  Marriage of previous knowledge gained 
from studies of conserved core endophytes with value gained from lower complexity studies 
allows for intentional construction and investigation of SynCom and resulting tractable plant-
microbe and microbe-microbe interactions.   
 
Access to genome repositories, sequencing technologies and protein/metabolite predictive 
applications allows intentional selection of microbes to include in in vitro and in vivo plant-
microbe and microbe-microbe interaction studies. Because plant roots winnow soil bacteria from 
the rhizosphere to include a distinct set of endophytes, the withstanding organisms are commonly 
defined in complex microbiome studies.  This set includes: Actinobacteria, Proteobacteria, 
Bacteroidetes, and Firmicutes [12, 14, 17, 22].  Among the Actinobacteria, common, but low 
abundance, residents of various soil and root microbiomes are bacteria in the Streptomycetaceae 
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family, including Streptomyces spp. [13, 23, 24].  Streptomyces’ metabolic capabilities [25], 
contribution to disease suppressive soils [26, 27], and plant growth-promoting potential [28] 
suggest their function as root microbiome members may exceed their numbers.  Further, their 
distinct biocontrol capabilities against plant pathogens [29] elude to root microbiome sculpting 
potential. Thus, defining their role in microbe-microbe interactions provides an interesting 
comparison of in vitro interaction potential that can be compared to plant monoinoculation 
phenotypes.  These findings can then be compared to more complex studies of sustainability and 
sculpting potential while competing with a low complexity SynCom and an inoculum made from 
a slurry of wild soil (Wild).   
 
Here we take a multi-faceted approach to determine plant microbiome interactions and functions 
that contribute to community assembly.  Capitalizing on access to varying levels of inoculum 
complexity, we apply our previous findings to inform novel microbe-microbe and plant-microbe 
studies of four Streptomyces strains with discriminate root colonization abilities.  These strains 
were previously included in microbiome studies of axenic A. thaliana colonization with a complex 
SynCom of 38 taxonomically diverse soil isolates [8].  In addition, monoinoculation studies 
indicated distinct A. thaliana root colonization phenotypes consistent with the complex SynCom 
studies (Chapter 2). Using an 11-member SynCom, we examine host and microbe interactions and 
phenotypes.  Consistent with previous suggestions of benefit [21], we find that lower complexity 
SynCom lends to more resolute conclusions about microbe-microbe and plant-microbe 
interactions whereas our studies with a wild soil slurry were valuable for additional hypothesis 
generation. Thus, each method yielded new information. We individually competed select 
SynCom isolates with the four Streptomyces strains in vitro followed by in vivo inoculations with 
communities of increasing complexity to determine if the microbe-microbe interactions we predict 
in silico and observe in vitro actually occur during root microbiome assemblage.  This approach 
provided valuable distinctions allowing separation of microbe-driven and plant-driven pressures, 
setting the stage for targeted functional studies.  Together with in silico genomic tools, our findings 
suggest the value of tiered-approach microbiome studies to optimize opportunities for conclusive 
determinants of microbiome assembly.   
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II. MATERIALS AND METHODS 
 
Genome comparison and biosynthetic gene cluster identification 
 Genomes of all strains for which we had genomes (i.e. 299, 303, CL18, 136, 181, 273, 40, 50, 
CL11 and Streptomyces scabiei 87.22 ) were downloaded from JGI IMG/M ER [30].  Genomes 
were mined using JGI IMG/M ER query tools and the antibiotics and Secondary Metabolites 
Analysis Shell (antiSMASH, v4), with all options selected (i.e. ClusterFinder, KnownClusterBlast, 
smCoG analysis, whole-genome Pfam analysis, ClusterBlast, ActiveSiteFinder, SubClusterBlast, 
Detect TTA codons) [31]. AntiSMASH utilizes profile Hidden Markov Models of genes to identify 
all gene clusters encoding potential secondary metabolites from all known chemical classes. Gene 
clusters were generated from complete IMG fasta nucleic acid sequences of genomes from 299, 
303, CL18, 136, and Streptomyces scabiei 87.22.   
Bacterial culture preparations  
Streptomyces isolates were grown in Lysogeny Broth (LB) at 30oC with shaking at 150 rpm for 4-
7 days.  Cultures were vortexed and bead beaten to disrupt bacterial aggregates.  All other isolates 
were grown in LB at 30oC with shaking at 150 rpm for 1-2 days. A spectrophotometer measured 
the optical density at 600nm (OD600) and cultures were normalized to an OD600 of 0.01. 100µL of 
all normalized isolate resuspensions were plated on LB, incubated at 28oC for 4-7 days and colony 
forming units (CFUs) were counted.  Inoculum ranged from 1x102 to 3x104 CFU/mL.  SynCom 
inoculum was created by growing each member until turbid (1-2 days), normalizing to an OD600 
of 0.01, and creating a mixed inoculum of containing 1mL of each member.  Frozen stocks of this 
SynCom were created with 200µL of the mixed bacterial community and 200µL 40% glycerol, 
snap frozen in liquid nitrogen, and stored at -80 oC.  Prior to experimental inclusion, a frozen stock 
was thawed and grown in LB at 30oC with shaking at 150 rpm for 2 days. After 2 days, mixed 
culture was normalized to an OD600 of 0.01.  
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Molten overlay experiments 
To create two-layer agar plates, 1.5% and 0.75% LB agar was prepared.  For the bottom layer, 
5mL of sterile 1.5% agar was pipetted into 50mm petri dishes.  While the bottom agar was 
solidifying, log growth phase Streptomyces cultures were prepared for top layer inoculation by 
bead beating 1mL of each culture in sterile centrifuge tubes with sterile 3 mm glass beads.  The 
OD600 was measured using a spectrophotometer.  These measurements were used to calculate the 
volume of culture to add to 0.75% LB agar to achieve an OD600 of 0.01, which was the same 
concentration used for our vertical plate assays.  The appropriate volume of culture was added to 
the cooled (approximately 50°C), but not solidified 0.75% LB agar.  Culture additions were mixed 
well into the agar by pipetting.  5mL of each inoculated 0.75% agar was pipetted onto the top of 
the solidified 1.5% LB agar in each petri dish. After the top layer solidified, 15µL of prepared 
challenge isolates (standardized to OD600 of 0.01) were spotted on top of the 0.75% agar layer.  
These spots were allowed to dry and all petri dishes were incubated at 30°C and checked daily for 
growth.  Zones of inhibition (ZOI) were measured at 5-7 days.   
Co-culture assays  
Streptomyces isolates were grown as described above in LB liquid medium. After 4-7 days 
incubation, 2 mL of each culture were taken and bead beaten with 3 mm glass beads for 2.5 minutes 
using the Geno/Grinder SPEX Sample Prep. Optical density at 600 nm (OD600) was measured 
using a spectrophotometer and cultures were normalized to an OD600 of 0.1. Using a Rainin Pipet-
Lite XLS multichannel, five 2µL spots of each Streptomyces isolate were placed onto solid LB 
medium 1 cm apart from each other. The plate was then incubated overnight at 28 oC. After 16-20 
hours, the challenge isolates were normalized to an OD600 of 0.1 without bead beating due to the 
turbidity of cultures. The Rainin multichannel pipet was used to place four 2µL spots of the 
challenge isolates 1 cm apart and perpendicular to the Streptomyces spots. Plates were placed back 
into the incubator at 28 oC for one week. After one week, the plates were removed, scanned and 
ImageJ was used to measure colony sizes (ImageJ). 
 
 
  78 
Seed sterilization and germination 
For all experiments, we used Col-0 accession, wild-type (WT) A. thaliana plants. For the auxin 
insensitivity experiment, we also used two genotypes, axr4-2 [32] and axr1-7axr4-2 double mutant 
[32], obtained from the Arabidopsis Biological Resource Center (ABRC) seed collection at The 
Ohio State University. All seeds were surface sterilized via treatment in 70% ethanol with 0.1% 
Triton-X100 for 1 minute, 10% household bleach with 0.1% Triton-X100 for 15 minutes, and three 
washes with sterile distilled water.  Seeds were stratified for 3 days in the dark at 4 oC and 
subsequently germinated at 24 oC with 10 hours of light for 6-7 days on agar plates containing 
half strength (2.22g/L) Murashige & Skoog (MS) vitamins, 1% sucrose, and 1% Phytoagar 
(Bioworld). 
Vertical plate assays 
To inoculate plates for 14 day experiments, 150µL of individual Streptomyces isolate 
resuspensions were spread on 150 mm x 150 mm prepared half strength MS square agar plates 
with no sucrose.  Plates were allowed to dry and 4-5 6-day old axenic seedlings were aseptically 
transferred onto each plate with flame-sterilized tweezers.  Plates were sealed with Parafilm® M 
Laboratory Film and randomly stacked vertically in open wire trays, which were grown at 24 oC 
with 18 hours of light for 14 days.  Every two days, root length was observed, plant health was 
assessed, and plates were shuffled.  Finally, plates were scanned and roots measured. 
Colorimetric auxin assay  
Indole-3-acetic acid production was determined as described by Szkop et al [33].  Briefly, 
Streptomyces isolates were grown in 35mL of LB broth with 1% Tryptophan added at 30oC with 
shaking at 150 rpm for 4-7 days.  After incubation, cells were removed from culture by 
centrifugation at 4,000 x g for 10 minutes.  After centrifugation, 1mL of supernatant was removed 
from each tube and incubated with 2mL of Salkowski reagent in the dark at room temperature for 
30 minutes.  Following incubation, 100µL of each supernatant mixture or uninoculated medium 
was added to a clear, flat-bottom 96-well plate and absorbance was measured at l = 530 nm for 
each sample (n=6 per condition).       
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Wild soil slurry preparation   
Wild soils were collected from a field on the campus of Oak Ridge National Lab in Oak Ridge, 
TN and an aliquot was prepared via filling  a sterile conical tube to 20 mL.  Soils were A glass 
bottle containing 100 mL of water and a stir bar were sterilized by autoclave.  Once cooled, the 20 
mL of soil was added to the water and placed on a stir plate to stir uninterrupted for 1.5 hours.  The 
soil settled for 1-2 minutes  and 250µL aliquots of the suspended slurry were added to sterile 
freezer stock tubes with 250µL 60% glycerol, snap frozen in liquid nitrogen, and stored at -80 oC.  
The day of secondary inoculations, freezer stocks were thawed and spun at 13,000 x g for 1 
minutes.  Glycerol supernatants were removed and the wild soil slurry (Wild) pellet was 
resuspended in 2mL sterile water.  Optical density at 600nm (OD600) was measured using a 
spectrophotometer and Wild inocula were normalized in half strength MS buffered with sterile 2-
(N-morpholino) ethanesulfonic acid MES to an OD600 of 0.01.  These resuspensions were then 
used as secondary inocula as described below.   
Plant inoculations   
For primary inoculation of seedings, vertical plate assays were performed as described above, 
except 100 µL of each isolate resuspension were spread on 100 mm x 100 mm plates containing 
half strength MS square agar plates with no sucrose.  Following 7 days of vertical growth, seedlings 
were aseptically transferred to individual three-inch square pots, with 64 mL of sterile calcined 
clay (Pro’s Choice Rapid Dry) inoculated with secondary inocula of 49 mL MES normalized Wild 
or SynCom.  Control no bacteria (NB) pots contained only sterile MES. An additional 1mL of 
suspended inoculum was used to bury the seedling roots. For experiments in which there was not 
primary inoculation, 6-day old sterile seedlings were aseptically transferred directly from 
germination plates to individual three-inch square pots, with 64 mL of sterile calcined clay (Pro’s 
Choice Rapid Dry) 49 mL MES.   
Plant growth and harvest 
Plants were watered every 2-3 days from the top with sterile distilled water and grown in growth 
chambers (Percival, model: AR41L3C8) with 10 hours of light at 22oC and 14 hours of dark at 
18oC.  After 8 weeks of growth, plants were aseptically harvested when inflorescence began to 
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emerge. Whole plants were submerged in 25mL of sterile harvesting phosphate buffer with 0.01% 
Silwet (Lehle Seeds) and vortexed vigorously for 10 seconds.  Roots and rosettes were separated 
with sterile forceps and transferred to sterile centrifuge tubes and weighed.  Roots were rinsed 
three times with sterile distilled water and snap frozen. Once snap frozen, roots were lyophilized 
overnight (LABCONCO FreeZone 6 catalog number 7753020 ; drying chamber: short clear 
chamber with valves, catalog number 7318802).  After lyophilizing, roots were homogenized via 
bead beating in the Geno/Grinder SPEX Sample Prep with sterile 3mm glass beads or garnet beads 
for 2.5 minutes. 
DNA extraction and 16S rRNA gene community sequencing 
DNA was extracted from homogenized plant roots using the Mo Bio PowerSoil kit (now a Qiagen 
product). DNA concentration was determined with the Quant-iT PicoGreen dsDNA Assay Kit and 
fluorospectrometer. The University of Tennessee, Knoxville Genomics Core performed library 
preparation and sequenced the samples.  Based on previous findings of high-quality reads, 16S 
rRNA gene barcoded V4 (515F, 806R) primer sets with Illumina adapters were utilized for PCR 
reactions and sequenced via Illumina MiSeq® pyrosequencing [24, 34, 35]. Polymerase chain 
reaction (PCR) was performed in triplicate and with a negative control to ensure absence of 
contamination. A mixture of two peptide nucleic acid (PNA) blockers, which bind to plant host 
plastid and mitochondrial 16S rRNA genes, were used to minimize amplification of plant DNA.  
16S rRNA gene amplicon QIIME 2 analysis  
The in silico tool used to perform the 16S rRNA gene microbial analysis was QIIME 2. QIIME 2 
is an open source, extensible, and decentralized microbiome analysis package with a focus on data 
and analysis transparency [36](www.qiime2.org). Data were imported into the .qza file format 
using the QIIME tools import command. The software package FastQC was used to visualize the 
quality metrics of the sequences and determine the appropriate places to trim and truncate the reads 
in order to ensure the highest quality reads. From the visualizations, it was determined that the first 
15 base pairs should be trimmed from the beginning of the reads while all reads should be truncated 
at 250 base pairs. To perform trimming and truncating, the QIIME dada2 [37] denoise-paired 
command was run and two tables, an Amplicon Sequence Variant (ASV) table and a representative 
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sequences table, were generated [38]. The QIIME alignment MAFFT and QIIME alignment mask 
commands were run to perform a multiple sequence alignment of the representative sequences file 
and to mask any highly variable regions seen in the alignment. The QIIME phylogeny FASTREE 
command was run to generate an unrooted phylogenetic tree. The QIIME phylogeny midpoint-
root command was run to create a mid-point rooted phylogenetic tree. The QIIME diversity core-
metrics-phylogenetic command was carried out with a uniform sampling depth of 2,000, allowing 
inclusion of 98% of samples, which generated alpha and beta diversity metrics, as well as plotting 
capabilities (e.g. Shannon’s diversity index, weighted UniFrac, principal coordinate analyses). 
Taxonomy was generated by building a Naïve-Bayes classifier. This classifier was built by first 
importing raw SILVA V132 taxonomy and sequence files. The classifier files were imported and 
files trimmed to the standard 16S forward and 16S reverse Illumina primers with a truncation 
length of 250 base pairs. The classifier was trained to the new reference sequences with the QIIME 
feature-classifier fit-classifier-naive-bayes command and then used to build taxonomy using the 
QIIME feature-classifier classify-sklearn command on the representative sequences file. Although 
mitochondrial and plastid PNA blocker were used, plant reads remained, and thus manually 
removed.  Taxonomy visualization was achieved via the QIIME metadata tabulate command.  
Statistical analyses  
Molten overlay, root growth, auxin production, 16S rRNA gene amplicon sequencing, results were 
statistically analyzed with Prism version 7.0 for Mac (GraphPad Software, La Jolla California 
USA, www.graphpad.com) using the nonparametric Kruskal-Wallis test, including one-way 
ANOVA followed by Dunn’s multiple comparisons.  When appropriate, analysis included two-
way ANOVA and Tukey’s multiple comparisons.  Molten overlay growth influence was analyzed 
visually in ImageJ [39] and then statistically compared by 2-way ANOVA, Dunnett’s multiple test 
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III. RESULTS 
 
Identification of biosynthetic gene clusters from bacterial genomes predict microbe-microbe 
interactions during root microbiome assemblage  
Because we sought to better understand how microbe-microbe interactions influence community 
dynamics, we included in our genomic and experimental studies isolates from our collection from 
a 38-isolate complex SynCom designed by Lebeis et al. [8], as well as new isolates from lab 
collection (Table 3.1).  Among those were four Streptomyces isolates 299, 303, CL18, and 136, 
which colonize A. thaliana roots and seedlings at various degrees as part of the 38-member 
SynCom and in monoinoculation (Chapter 2).  We also included a common root pathogen 
Streptomyces scabiei 87.22, as it is known for robust root colonization and disease induction in 
plants [40].  To predict how they would interact in subsequent in vitro and in vivo studies, in our 
in silico genome investigations, we included 5 of the 11 isolates from our SynCom with completed 
draft genomes (Table 3.1).  
 
Isolate genome sequences were downloaded from where they are curated at the U.S. Department 
of Energy’s Joint Genomes Institute, Integrated Microbial Genomes and Microbiome Samples 
(JGI IMG/M ER) database and analysis tool (Table 3.2) and analyzed with the Antibiotic and 
Secondary Metabolite Analysis Shell (antiSMASH) [31] to identify predicted microbial products 
(Figure 3.1). Interestingly, the strains that previously colonized roots better when in a 38-member 
SynCom (299 and 303) had larger genomes and a greater percentage of genes predicted to be 
involved in biosynthetic gene clusters (BGCs) than those that did not (CL18 and 136) (Table 3.2). 
In comparison, S. scabiei 87.22 had a genome size between that of 299 and 303, but the largest 
proportion of predicted biosynthetic genes.  
 
Previous pangenomic comparisons of our 4 Streptomyces strains (Chapter 2) potentiated 
biosynthetic similarities between 299 and 303.  In addition, phylogeny showed similarity with 
previously characterized soil-derived Streptomyces, with 136 diverging the most from 299, 303, 
and CL18 (Chapter 2). Previously described monocolonization trends led us to hypothesize that 
299 and 303 may have overlapping genomic characteristics (Chapter 2).  In addition, 
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Actinobacteria are known to share intra-phylum primary and secondary metabolic pathways often 
requiring the same nutrients for synthesis of precursors and products [41].  Thus, we suspected 
299 and 303 might harbor similar biosynthetic genes allowing employment of strategies to acquire 
physical space and nutrients within the plant root.  Interestingly, antiSMASH predicted largely 
similar biosynthetic clusters between the genomes of 299 and 303, including several involved in 
biotic and abiotic stress, as well as candidate antimicrobial gene clusters with the potential of 
influencing microbial growth (Figure 3.1).  Interestingly, 303 was predicted to have distinct indole 
and phenazine clusters (Figure 3.1).  Obvious antimicrobial clusters suggested the possibility of 
productive findings from competitive microbial assays.   
 
In addition to the four Streptomyces strains, we compared the genomes and biosynthetic potential 
of 6 additional isolates, one of which was an Actinobacteria, four Proteobacteria, one in the phylum 
Firmicutes and the last Bacteroidetes (Table 3.1).  Interestingly, the pathogen and robust root 
colonizer, S. scabiei 87.22 was predicted to have the most biosynthetic clusters in common with 
299 and 303 (Figure 3.1).  Many of the non-Streptomyces isolates either had few clusters (e.g. the 
Paenibacillus isolate 181) or more putative clusters (e.g. the Pseudomonas isolate 50).  This can 
be attributed either to reduced biosynthetic potential or lack of annotation.  While not providing 
conspicuous evidence of select gene clusters correlated with microbiome assembly, the results set 
precedence for multiple avenues of investigation, and potential plant-microbe and microbe-
microbe interactions. Thus, we next designed challenge experiments to determine isolates’ 
susceptibility and inhibitory capabilities. 
In vitro microbe-microbe challenges suggest Streptomyces strains can both co-exist and also 
compete 
To determine Streptomyces interaction with other strains of similar biosynthetic potential as well 
as with non-Actinobacteria endophytic commensals of varying biosynthetic potential (Figure 3.1), 
we designed co-culture molten overlays and cross-spots on agar to determine microbe-microbe 
growth influence in vitro. We hypothesized that these in vitro binary microbial challenges may 
inform more complex community level interactions during plant colonization. Because both 299 
and 303 colonized A. thaliana roots similarly (Chapter 2) and shared predicted gene clusters 
(Figure 3.1), we suspected these two isolates might employ strategies to acquire physical space 
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and nutrients within the plant root.  Thus, microbial competition experiments were intended to 
inform growth inhibition between strains. 
 
Molten overlays allowed for metabolite perfusion through the semi-solid agar and potentially 
induced production of metabolites unique to a reduced oxygen environment.  We previously found 
that our four Streptomyces strains were capable of growing anaerobically (data not shown) and 
thus, each of the 4 isolates was inoculated into LB media and challenged with another isolate 
spotted on the solid agar surface.  Interestingly, when spotted on the surface, 303 influenced each 
competing Streptomyces isolate’s growth (Dunnett’s multiple comparison test, p<0.05) (Figure 
3.2). 299 grew well when spotted on 303-inoculated agar but did not grow well when 303 was 
spotted on agar inoculated with 299 (Figure 3.2), highlighting that antibiosis varies with growth 
conditions. Isolates CL18 and 136 did not appear to prohibit the growth of other strains tested. We 
then challenged each Streptomyces strain with the other 3 via co-culture cross spotting on agar 
plates.  Among all interactions tested, only 303 minimally inhibited CL18 (Table 3.3), suggesting 
differential metabolite biosynthesis by oxygen availability.      
 
To determine if Streptomyces might influence or be influenced by the growth of other members of 
our bacterial collection, we then co-cultured our four Streptomyces strains on agar and some of the 
11 soil-resident bacterial isolates from our collection, several of which were previously included 
in a study of root microbiome colonization (Table 3.1) and include members of the phyla 
Proteobacteria, Firmicutes, Bacteroidetes and Deinococcus-Thermus (Table 3.1 and Table 3.2).  
Previously defined colonization phenotypes for the 11 isolates ranged from robust to poor with 
several others unknown (Table 3.2).  Co-culture cross-spots indicated that Paenibacillus strain 181 
inhibited the growth of all 4 Streptomyces isolates (Table 3.3).  This finding was especially 
interesting as 181 is from the family Paenibacillaceae, which has been linked to disease 
suppressive soils [42].  However, when included in a 38-member SynCom, this particular strain 
doesn't colonize roots well [8].   Additionally, 299, 303, and CL18 inhibited growth of isolate 2, 
from the family Rhizobiaceae (Table 3.3).  In previous complex SynCom experiments of A. 
thaliana in which 299 and 303 are known to colonize the root, Rhizobium strain 2 also robustly 
colonize the root [8], suggesting that either microenvironments separating the organisms allow co-
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colonization or the plant and other organisms are influencing colonization capabilities.  
Additionally, only CL18 inhibited the growth of the Burkholderiaceae CL11 (Table 3.3).  This was 
particularly interesting as compared to the other 3 Streptomyces strains, CL18 has only one unique 
predicted biosynthetic gene cluster, an oligosaccharide, which could be a result of incomplete 
biosynthetic cluster characterization or related to this product.  Growth of Bacillus strain A415 
was inhibited by both 303 and CL18 (Table 3.3), highlighting exciting future directions potentiated 
by these results.  Also of note, 136 co-culture with E. coli resulted in a very distinct and unique 
pigment production (Table 3.3).  Overall, Streptomyces strains are capable of influencing growth 
of competing intra- and extra-genus microbes, helping to inform intentional construction of 
community level studies. Despite their metabolic repertoire, including antimicrobial products, in 
vitro, Streptomyces did not consistently out-compete each other or other strains.  This led us to 
believe that Streptomyces-microbe interactions were not representative of their behavior in a more 
complex community, such as a SynCom or root microbiome.  
Root phenotypes are Streptomyces strain-specific  
Streptomycetaceae root colonization has been well documented in a variety of plant systems 
species [29, 43, 44].  Besides influencing the growth of other microbes, Streptomyces may produce 
compounds that influence the health of their plant host. Our lab previously described Streptomyces 
isolate-specific monocolonization of A. thaliana seedlings with strains 299, 303, CL18 and 136 
(Chapter 2).  Additionally, when these strains were included in a 38-member mixed bacterial 
community, they differentially colonized A. thaliana roots [8].  Significantly, plant root structure 
and function are often linked, creating unique root-microbe interactions and trigger a variety of 
host responses [45].  Thus, we hypothesized root-associated colonization distinctions may 
correlate with root structural differences.  Accordingly, we established two week plant-microbe 
colonization of A. thaliana seedlings inoculated with each of the four Streptomyces strains to reveal 
distinct isolate-induced root phenotypes (Figure 3.3). As compared to control uninoculated 
seedlings and those inoculated with isolate CL18, seedlings grown with 299 and 303 resulted in 
more lateral roots, commonly referred to as cluster roots, and less primary root growth (Figure 
3.3A and 3.3B). Interestingly, seedlings grown with 136 resulted in primary roots that were longer 
than those associated with 299 and 303 but had more lateral root growth than those associated with 
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CL18 (Figure 3.3A). To quantify the ability of different Streptomyces isolates to affect plant root 
growth, we measured primary root length every other day for 14 days. Beginning at 4 days after 
inoculation, statistical analysis revealed a significant difference (p<0.05, Figure 3.3B) in primary 
root length from the uninoculated control in isolates 299, 303 and 136.  However, root biomass, 
leaf biomass, and leaf size did not significantly differ between control and inoculated plants, even 
after 8 weeks of growth (Chapter 2), suggesting that Streptomyces strains do not individually 
influence plant biomass accumulation in the conditions tested.  Importantly, plant growth, biomass, 
and survival after 8 weeks of growth suggests that these isolates are not pathogens.  
Root morphology phenotypes are not solely dependent on microbial indole-3-acetic acid 
production 
Plant- and microbe-derived auxins are known to increase lateral root growth and inhibit primary 
root growth [46]. Hence, the phenotype of plants colonized with 299, 303, and 136 appeared to 
mimic the effects produced by auxin exposure (Fig 3.3A).  To determine if the microbially-
produced auxin compound indole-3-acetic acid (IAA) drove root morphology phenotypes, the 
colorimetric IAA assay described by Szkop et al. was performed on the supernatant of each isolate 
grown in liquid media supplemented with tryptophan [33]. 303 produced significantly more IAA 
than 299, CL18, and 136, although 299 produces significantly more auxin than the media control 
(Figure 3.4A).  Further, although 299 and 303 are both capable of IAA production (Figure 3.4A), 
only 303 is also predicted to synthesize indole in our AntiSMASH results (Figure 3.1), which is a 
tryptophan-independent precursor for IAA.  Together, these findings suggest 299 and 303 may 
produce an auxin compound capable of influencing root structure.  
 
We performed monoinoculation with each of the four Streptomyces strains in Col-0 and two 
additional A. thaliana genotypes, axr4 and axr1/axr4, which have decreased auxin sensitivity [32].  
As compared to wild-type, observed patterns in root morphology phenotypes induced by each 
strain were remarkably consistent for all plant genotypes (Figure 3.4B), indicating that 
microbially-produced IAA detection via axr1 and axr4 pathways are not solely responsible for 
altered root morphology observed following 303 or 299 binary associations. Interestingly, 136 did 
not appear to produce auxin in vitro and induced similar root morphology changes in all A. thaliana 
genotypes, indicating that its influence is independent of auxin. These results provide evidence 
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that microbially-derived IAA does not fully explain the root morphology differences between 
seedlings inoculated with each isolate in the binary associations. Together with our previous 
monoinoculation and co-culture findings, we next moved beyond individual interactions to 
determine if genomic analyses or one on one interactions were indicative of isolate phenotypes in 
assembly from a larger microbial community.   
16S rRNA gene amplicon sequencing of A. thaliana with three distinct inoculation events indicates 
inoculum complexity contributes to community assembly 
Recently spotlighted are the potential benefits of varying levels of SynCom complexity and 
correlation with robust experimental conclusions [21].  Thus, we chose three distinct A. thaliana 
seedling inoculation points with varying levels of complexity (Figure 3.5) to extend application of 
our earlier in silico, in vitro, and monoinoculation in vivo experimental findings.  We hypothesized 
that due to the biosynthetic potential of our Streptomyces strains; pre-inoculation with each strain 
could influence the community assemblage.  To test this hypothesis, we first grew sterile A. 
thaliana seedlings as described earlier on vertical plates with a single Streptomyces strain, as well 
as a no inoculum control, providing the first inoculation event.  After 6 days, individual seedlings 
were transferred to pots containing sterile calcined clay that received secondary inoculation with 
nothing, a SynCom of the 11 bacterial isolates (Table 3.2) or our Wild inoculum, providing the 
second inoculation event.  Figure 3.5 provides an experimental schematic of each point of 
inoculation, the inoculum, and the time between inoculations.  Plants were grown open-air in the 
same plant growth chamber for 6 to 8 weeks, providing the third inoculation event, and the 
assembled root microbiome was determined.  
 
There were a total of 143 samples included in our analysis, grouped according to primary (e.g. no 
bacteria (NB), 299, 303, CL18, or 136) and secondary (e.g. NB, SynCom, or Wild) inoculum, 
resulting in 15 types of root microbiomes (Table 3.4).  Also included in our analysis for comparison 
were the SynCom and Wild inoculum.  PCR blanks were run for quality control and generated less 
than 100 reads.  Samples ranged in read depth from 8,8375 reads to 10,976 reads (Table 3.4). We 
calculated diversity among samples via Shannon’s Index testing alpha diversity (Figure 3.6).  Wild 
soil inoculum had highest diversity, as expected. We found that in general, samples with secondary 
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inoculum of wild soil were distinct from those inoculated with SynCom or only open air (Figure 
3.6).  Interestingly, with the exception of primary inoculation with 303 or NB, all samples 
inoculated with 299, CL18 or 136 and with secondary inoculum of either SynCom or Wild were 
significantly different from one another, suggesting that primary inoculation with 303 influences 
post-secondary and tertiary inoculation sample diversity (Figure 3.6).  Thus, we suspected that 
primary inoculation with 303 may influence species richness and closer investigation of phyla and 
families may provide additional insight into Streptomyces-specific root microbiome assemblages. 
 
We next used a weighted UniFrac distance matrix to generate a principle coordinate analysis 
(PCoA) for comparison of different types of samples (Figure 3.7). Figure 3.7.A includes all 
samples color-coded by secondary inoculum.  In general, when inoculation with SynCom (purple) 
and Wild (blue) the root microbiome communities shifted.  Because SynCom and Wild root 
microbiomes are distinct, we suggest that in this setting, community structure was influenced by 
the secondary inocula.  Root microbiome samples labeled orange (NB, no secondary inoculum) 
were generally scattered. We next separated root microbiome samples by secondary inoculum and 
color-coded samples by primary inoculum (Figures 3.7B-D).  Primary inoculation with neither of 
our four Streptomyces isolates nor absence of primary inoculum (NB) altered root microbiome 
community assemblage.   
 
We then analyzed average relative abundances of each root microbiome sample type at varying 
taxonomic levels.  To start, we determined the relative abundance of phyla in each root microbiome 
sample type (Figure 3.8).  At this higher taxonomic level, root microbiome relative abundance of 
Proteobacteria was significantly different from Wild inoculum for 299 and 136 primary inoculum 
and Wild secondary inoculum samples (Figure 3.8).  Interestingly, these were the only sample 
types in which Actinobacteria relative abundance did not differ significantly from  Wild (Figure 
3.8). Next, we selectively created a subset of those samples inoculated with SynCom, allowing us 
to compare sample compositions to a defined set of SynCom families (Figure 3.9).  Interestingly, 
relative abundances of Burkholderiaceae and Enterobacteriaceae in all root microbiome samples 
differed significantly from SynCom inoculum (Figure 3.9).  Specifically, Enterobacteriaceae, 
consisting of E. coli in our SynCom (Table 3.1), are known to be poor colonizers and thus were 
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not surprisingly significantly different in root microbiome samples.  Burkholderiaceae are known 
to colonize well (Table 3.1), which is reflected in their relative abundances in root microbiome 
samples (Figure 3.9).  In general, the relative abundances in SynCom inoculum itself did not reflect 
sample root microbiome SynCom inclusion, suggesting influence of other microbes (i.e. tertiary 
open-air inoculum), plant influence in shaping the microbiome, or a combination of both (Figure 
3.9).   
 
Next, we sought to understand relative abundances of select families across all sample types for 
Actinobacteria, Alphaproteobacteria and Gammaproteobacteria.  Among Actinobacteria, 
Micrococcaceae were more abundant in all root microbiome samples than in Wild inoculum alone 
(Figure 3.10A).  We then considered one of our central early hypotheses, that select Streptomyces 
modulate colonization of other isolates.  Looking at individual family abundances within each 
sample, we found that Streptomycetaceae relative abundance significantly differed by primary 
inoculum (Figure 3.10A).  299 colonized significantly better than CL18 or 136 and 303 better than 
136 when secondary inoculum was SynCom (Figure 3.10B), providing evidence that regardless of 
microbial competition, these two isolates seem to colonize better than our other Streptomyces 
strains. Next, we assessed Alphaproteobacteria relative abundances by family and sample type 
(Figure 3.11A-D). Among families of Alphaproteobacteria, as compared to SynCom and Wild 
inocula, relative abundances of Beijerinckiaceae generally varied by primary inoculation with 303, 
CL18 and 136 and secondary inoculation with Wild or NB (Figure 3.11A).  Interestingly, as this 
family was not included in our SynCom and has extremely low relative abundance in Wild 
inoculum, we suspect that either this family comes from tertiary inoculation in open air or prefers 
growth conditions present within the plant.  Not surprisingly, those samples with SynCom 
secondary inoculum had overall greater relative abundances of Rhizobiaceae as compared to NB 
or Wild secondary inoculum (Figure 3.11B).  Because robust colonizer Rhizobiaceae isolate 2, 
was included in the SynCom, we expected colonization of this family in these samples.  However, 
of note, SynCom inoculum alone did not have significantly more Rhizobiaceae, suggesting 
Rhizobiaceae in our samples prefer growth in planta (Figure 3.11B).  Finally, we compared family 
relative abundances among Gammaproteobacteria (Figure 3.11A-B).  Enterobacteriaceae and 
Burkholderiaceae abundances were significantly different from abundances in other samples 
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(Figure 3.11A).  As compared to SynCom inoculum alone, samples with Wild or SynCom 
secondary inoculation had different abundances of Enterobacteriaceae (Figure 3.11A).  SynCom 
inoculum relative abundance of Burkholderiaceae was different from all other samples with NB, 
SynCom and Wild secondary inoculum (Figure 3.11A).  While not statistically significant, distinct 
and selective presence of Moraxellaceae in specific root microbiome sample types (Figure 3.11B) 
suggests a previously unexplored relationship with our root-associated Streptomyces strains that 
will be investigated further with isolate co-culture experiments.   
 
Collectively, our in silico, in vitro, and in vivo studies of Streptomyces provide evidence that while 
not the most abundant microbiome members, biosynthetically rich Streptomyces species persist 
when challenged 1) individually with other organisms of the same species 2) selectively in co-
culture studies with vastly divergent taxa (e.g. E. coli, Burkholderiaceae, etc.) 3) with a SynCom 
of few, but diverse bacteria and 4) with more complex Wild inoculum.  In addition, we found that 
in vitro Streptomyces co-culture phenotypes were not always indicative of in vivo relative 
abundances, suggesting colonization capability is likely a more important determinant of isolate 




Actinobacteria and specifically Streptomyces and their abundant metabolic products are being 
evaluated for implementation in agricultural practice [47].   Root colonization and manipulation 
of plant-microbiome assembly are in their spheres of influence [28].  They are known to be 
cosmopolitan organisms, colonizing the roots of a wide variety of plant species [44, 48-50] in 
geographically and geologically diverse soils [13, 24].   Disease suppressive capabilities are plant 
growth promotion round out Streptomyces potency making them ripe for a wide variety of 
applications [29]. Their potential has not gone unnoticed, yet their complexity has limited 
definitive mechanisms of assembly and isolate-level functional applications.  We suggest that the 
role of individual Streptomyces strains should not be overlooked and exploiting the power of one 
can pack a hearty metabolic punch, influencing the entirety of the microbiome.   
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Previous Streptomyces colonization experiments, both monoinoculation and SynCom, indicated 
strain-specific colonization capabilities, prompting comparative genomic analyses and analysis of 
predicted secondary metabolite products.  Our comparative genomic analyses suggest distinct 
differences in secondary metabolism may differentiate colonization capabilities between strains. 
These findings highlight that functional conclusions based on genus-level grouping inadequately 
capture the organisms’ potential, as previously described for plant-associated Pseudomonas strains 
[51]. Further, including the plant pathogen S. scabiei 87.22 in our genomic comparisons revealed 
shared genetic factors contributing to increased root colonization in our non-pathogenic 
competitive colonizers. Discovering vast differences in genomes and biosynthetic products 
invoked anticipation of complex in vitro microbe-microbe interactions.    
 
Our in vitro co-culture experiments reveal Streptomyces strains influence each other's growth and 
other strains, yet largely inhibitory phenotypes were not represented in the 16S rRNA amplicon 
community studies in which ASVs representing both are present in the same root samples.  For 
example, in co-culture experiments, 299, 303 and CL18 inhibited growth of the Rhizobiaceae 
isolate 2 (Table 3.3), yet relative abundance data did not reflect this inhibition (Figure 3.11A-B).  
Interestingly, these findings suggest the dominant influence of the host, the environment, and 
likely the collective microbiome.  While monoinoculation interactions are essential to tease apart 
fundamental microbe-microbe interactions, our findings emphasize that they are not always 
indicative or even suggestive of phenotypes in the context of a host or more diverse community.   
For these reasons, we suggest that a multi-tiered approach including various levels of comparison, 
competition, and colonization are necessary for more representative applications.   
 
Perhaps of greatest significance is our use of multiple levels of complexity to study microbiome 
interactions. The use of monoinoculation, low complexity SynCom, wild soil and open air inocula 
allows for otherwise obscure distinctions not evident in the absence of one or more of these 
approaches or lower resolution.  We found that in general, isolates that are historically good 
colonizers (Table 3.1) maintain their colonization phenotype despite primary inoculation with our 
Streptomyces strains.  This suggests that microbe-microbe competition in the context of the 
microbiome likely influences resulting abundances.  However, despite competition, 299 and 303 
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withstood metabolic pressures from other SynCom members (Table 3.1), and persisted, ultimately 
maintaining their previous attributes as good colonizers, although when compared to others, not 
the most abundant.  Thus, reliance on relative abundances, especially when competed with a highly 
complex SynCom or wild soil, may negate the role of the less abundant, but important taxa.  
Streptomyces’ large repertoire of secondary metabolites may amplify their importance and 
motivates understanding the roles for previously identified low abundance taxa in microbiomes as 
potential keystone community members. Recently, an Enterobacteria strain was defined as a 
keystone member in maize synthetic community experiments [52].   While the influence of soil 
type is often a primary root-microbiome determinant [53], this study reiterates that there is still 
room to explore novel drivers of microbiome establishment and stability, such as those inherent to 
metabolically rich Streptomyces spp.   
 
Community balance may hinge on one or a small number of influential species. Their  influence 
on community structure may not be reflected in abundance matrices and thus overlooked or 
underestimated [52, 54-56].  Previously emphasized reductionist approaches or additional use of 
lower complexity SynCom may help to inform the roles of individual taxa with higher resolution.  
Recent emphasis on the need to build more sustainable agroecosystems [57] highlights the 
importance of maximizing benefits of microbiomes and the vast utility they provide.  We propose 
multi-tiered and multi-disciplinary microbiome studies are an essential component in achieving 
these goals.  Advancing our understanding of how Streptomyces spp. potentiate colonization and 
sculpt the A. thaliana root microbiome will provide additional opportunities to manipulate 
microbiome composition to achieve tractable and sustainable agricultural applications. 
 
  




The four strains of Streptomyces as well as several SynCom isolates were originally isolated in the 
laboratory of Jeffery Dangl at the University of North Carolina.  
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VII. APPENDIX: TABLES 
 
Table 3.1. Strains included in SynCom*, coculture^, and/or comparative genomics# 
List of bacteria isolated from A. thaliana used in these studies, which include representatives from 
4 phyla: 7 Proteobacteria (purple), 2 Firmicutes (green), 1 Bacteroidetes (blue), and 1 
Deinococcus-Thermus (pink). Six of these isolates have permanent draft genome sequences 
available at the U.S. Department of Energy’s Joint Genomes Institute, Integrated Microbial 
Genomes and Microbiome Samples (JGI IMG/M ER) 
Phylum Family Genera Label EC Enrichment Colonization Strain name 
IMG 
Genome ID 
Proteobacteria Rhizobiaceae Rhizobium 2*^# Enriched Robust Rhizobium sp. 2MFCol3.1 2517572231 
 Burkholderiaceae Burkholderia CL11*^#  Robust Burkholderia CL11 2546825541 
 Burkholderiaceae Burkholderia TN8*^  Unknown   
 Pseudomonadaceae Pseudomonas TN19*^  Unknown   
 Enterobacteriaceae Escherichia E. coli*^ Deplete Poor   
 Pseudomonadaceae Pseudomonas 50*^# Deplete Sporadic Pseudomonas sp. KD5 2228664007 
 Calobacteriaceae Brevundimonas 374*  Sporadic Brevundimonas  sp. 2596583649 





 Bacilliaceae Bacillus A415^     
Bacteroidetes Weeksellaceae Flavobacterium 40*^#  Sporadic Flavobacterium sp. 40S8 2563366720 
Deinococcus Deinococcaceae Deinococcus TN56*^  Poor   
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Table 3.2. Genome statistic and biosynthetic gene proportion. 
Genome features in our isolates including: estimated genes and the percent that are predicted to be 
in biosynthetic gene clusters. 
 























299 Actinobacteria 9620 9710 120 1490 15.35 
303 Actinobacteria 8387 8480 101 1432 16.89 
CL18 Actinobacteria 6591 6677 69 742 11.11 
136 Actinobacteria 6905 6991 47 755 10.80 
2 Proteobacteria 6294 6365 29 303 4.76 
40 Bacteroidetes 4727 4820 27 276 5.73 
50 Proteobacteria 5832 5920 28 272 4.59 
181 Firmicutes 4949 5066 36 464 9.16 
CL11 Proteobacteria 7562 7478 48 604 8.08 
Streptomyces scabiei 
NCPPB 4086 Actinobacteria 9050 9151 92 1638 17.90 
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Table 3.3. Co-culture cross spots indicate microbe-microbe growth influences. 
Isolates were co-cultured on solid LB plates. Were each Streptomyces isolate was inoculated 2-3 
days before each non-Streptomyces isolate. Differential growth patterns were observed. If no 













299 CL18  Streptomycetaceae NI NI NI  
303 CL18  Streptomycetaceae 303--|CL18 Minimal 
 
 
136 CL18  Streptomycetaceae NI NI NI  
303 136  Streptomycetaceae NI NI NI  
299 136  Streptomycetaceae NI NI NI  
303 299  Streptomycetaceae NI NI NI  
299 181 Sporadic Paenibacillaceae 299|--181 Intermediate 
 
 
303 181 Sporadic Paenibacillaceae 303|--181 Intermediate 
 
 
CL18 181 Sporadic Paenibacillaceae CL18|--181 Intermediate 
 
 
136 181 Sporadic Paenibacillaceae 136|--181 Intermediate 
 
 
299 TN19 Unknown Pseudomonadaceae NI NI NI  




















Inhibition Phenotype  
303 TN19 Unknown Pseudomonadaceae NI NI NI  
CL18 TN19 Unknown Pseudomonadaceae CL18|--TN19 Intermediate 
 
 
136 TN19 Unknown Pseudomonadaceae NI NI NI  
299 2 Robust Rhizobiaceae 299 --|2 Intermediate 
 
 
303 2 Robust Rhizobiaceae 303--|2 Major 
 
 
CL18 2 Robust Rhizobiaceae CL18--|2 Major 
 
 
136 2 Robust Rhizobiaceae NI NI NI  
299 A415 Robust Intrasporangiaceae NI NI NI  
303 A415 Robust Intrasporangiaceae 303--|A415 Major 
 
 
CL18 A415 Robust Intrasporangiaceae CL18-|A415 Major 
 
 
136 A415 Robust Intrasporangiaceae NI NI NI  
299 CL11 Robust? Burkholderiaceae NI NI NI  




















Inhibition Phenotype  
303 CL11 Robust? Burkholderiaceae NI NI NI  
CL18 CL11 Robust? Burkholderiaceae CL18-|CL11 Major 
 
 
136 CL11 Robust? Burkholderiaceae NI NI NI  
299 E. coli Poor Enterobacteriaceae NI NI NI  
303 E. coli Poor Enterobacteriaceae NI NI NI  
CL18 E. coli Poor Enterobacteriaceae NI NI NI  
136 E. coli Poor Enterobacteriaceae  Color Change 
 
 
299 TN56 Poor Deinococcaceae NI NI NI  
303 TN56 Poor Deinococcaceae NI NI NI  
CL18 TN56 Poor Deinococcaceae NI NI NI  
136 TN56 Poor Deinococcaceae NI NI NI  
299 40 Sporadic Flavobacteriaceae NI NI NI  


















Inhibition Phenotype  
303 40 Sporadic Flavobacteriaceae NI NI NI  
CL18 40 Sporadic Flavobacteriaceae NI NI NI  
136 40 Sporadic Flavobacteriaceae NI NI NI  
299 50 Sporadic Pseudomonadaceae NI NI NI  
303 50 Sporadic Pseudomonadaceae NI NI NI  
CL18 50 Sporadic Pseudomonadaceae NI NI NI  
136 50 Sporadic Pseudomonadaceae NI NI NI  
*Level "NI" = no inhibition 
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Table 3.4.16S rRNA amplicon community sequencing root microbiome sample 
information. 
The total number of replicates for each type of sample, as well as basic information about the 
samples, including: average, minimum, and maximum number of reads in our sequencing run. 
 
  
Sample Type N Average Reads Minimum Reads Maximum Reads Read Range
NB/NB 9 88375.44444 23861 176400 152539
299/NB 6 107704.6 61047 208813 147766
303/NB 9 104922.6667 39464 176113 136649
CL18/NB 6 78786.66667 28494 147048 118554
136/NB 4 101045.75 47954 156785 108831
SynCom 3 78187.66667 62150 98170 36020
NB/SynCom 11 109765.3636 38600 243232 204632
299/SynCom 15 71306.33333 13781 140184 126403
303/SynCom 14 67878.42857 11852 199865 188013
CL18/SynCom 14 65215.28571 38643 144613 105970
136/SynCom 16 79271.3125 17790 167139 149349
Wild 3 10005 4399 15335 10936
NB/Wild 6 53561.2 24147 95046 70899
299/Wild 11 66037.58333 55353 149287 93934
303/Wild 3 54455.66667 49313 60953 11640
CL18/Wild 5 40904.8 13176 74089 60913
136/Wild 8 57556.125 10259 147136 136877
  106 
VIII. APPENDIX: FIGURES 
 
 
Figure 3.1. antiSMASH [31] strain genome analysis reveals unique biosynthetic gene clusters 
and potential metabolites.  














































S. scabiei Actinobacteria 





When 303 is spotted on top, growth of each other isolate is significantly inhibited.  When 299 is 
spotted on top, growth of 303 and CL18 is inhibited.  When spotted on top, CL18 inhibits the 
growth of 136.  (2-way ANOVA, multiple comparisons, mean of 6 technical replicates, (p<0.05) 
*= p<0.05,    **=p<0.005, ****=p<0.0005, indicates significance as compared to control n=6) 
 
  
Figure 3.2. Streptomyces interactions demonstrate potential growth inhibition. 




Figure 3.3. Streptomyces spp. differentially influence A. thaliana root morphology  
Axenic 7-day old A. thaliana seedlings were inoculated with each of the four Streptomyces isolates 
and grown for 14 additional days. (A) Exemplar A. thaliana seedling root morphology following 
14 day monoculture on agar plates of the strain listed above the seedling (B) Primary root length 
of 14 day old seedlings (1-Way ANOVA, multiple comparisons, mean of 9 replicates * indicates 
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(A) (1-way ANOVA, multiple comparisons, mean of 6 replicates, (p<0.0001) (B) As compared to 
WT, auxin resistant mutants axr4 and axr1/4 show remarkably consistent root phenotypes.  
 
 
Figure 3.4. Microbial auxin production does not fully explain root phenotypes. (A) (1-way 
ANOVA, multiple comparisons, mean of 6 replicates, (p<0.0001) (B) As compared to WT, auxin 
resistant mutants axr4 and axr1/4 show remarkably consistent root phenotypes.  
 
Figure 3.4. Microbial auxin production does not fully explain root phenotypes. 






A schematic of the experimental design to determine how different times and complexity of 
inoculum contribute to root microbiome assembly. First, axenic A. thaliana Col-0 seedlings were 
inoculated with a single Streptomyces strain or no bacteria (NB), Second, wild soil inoculum is 
wild soil slurry in sterile water (see Methods section), SynCom inoculum is detailed in Table 1.1, 
or NB was used to inoculate seedlings. Finally, all pots shared the same plant growth chamber 
where they could acquire inoculum from the air. 
. 
  
Figure 3.5. Experimental schematic for 16S rRNA amplicon sequencing samples.   
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Figure 3.6. Alpha diversity indicates species richness by root microbiome sample.  
Shannon indices calculated for each sample type (index calculated via QIIME2, accounts for 
ASV abundance and eveness).  The x axis includes each sample type increasing in secondary 
inoculum complexity from left to right (NB, SynCom, then Wild).  Blue boxes indicated NB 
primary inoculum, red boxes indicate 299 primary inoculum, green boxes indicated 303 primary 
inoculum, purple boxes indicated CL18 primary inoculum, orange boxes indicate 136 primary 
inoculum, the olive green box indicates SynCom inoculum alone, and the brown box indicates 
Wild inoculum alone. Box and whisker plots indicate average sample ASVs for each sample 
type, as well as standard deviations.  * indicates that the Shannon index calculated for 
303/SynCom and 303/Wild samples do not differ significantly whereas Shannon index differs 












































































































(A) All samples, color indicates secondary inoculum (orange = NB, purple = SynCom, green = 
Wild)  (B) Subset of all samples (orange samples in A), no secondary inoculum, color indicates 
primary inoculum (C) Subset of all samples (purple samples in A) SynCom secondary inoculum, 
color indicates primary inoculum (D) Subset of all samples (green samples in A) Wild secondary 
inoculum, color indicates primary inoculum (All samples given tertiary inoculum (i.e. open air)) 
Secondary colors are as follows:  orange = 136, red = 299, green = 303, purple = CL18, and blue 
= NB. 
 
Figure  3.7. Principle coordinate analysis (PCoA) generated via weighted UniFrac distances 
shows diversity between samples.  




Figure 3.8. Relative abundance of phyla in root microbiome samples with Wild secondary 
inoculum differ.  
Histogram shows the distribution of the relative abundances of each type of sample for the phylum-
level ASV taxonomic assignment. ^ indicates relative abundance of Proteobacteria was 
significantly different from Wild inoculum alone. *  indicates relative abundance of Actinobacteria 
differed significantly from  Wild inoculum alone (Tukey’s multiple comparisons p<0.05).   
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Figure 3.9. Relative abundance of families from samples secondarily inoculated with 
SynCom are different than the SynCom inoculum. 
Histogram shows the distribution of the relative abundances of only samples that were 
inoculated with the SynCom for the family-level ASV taxonomic assignment for just 
families in the SynCom * indicates significant difference in relative abundance between 
SynCom inoculum and root microbiome sample. Dunnett’s multiple comparisons, p<0.05.  
 
 





Figure 3.10. Relative abundance of Actinobacteria families in all samples.  
Histogram shows the distribution of the relative abundances of each type of sample for only 
Actinobacteria families from the ASVs taxonomic assignment. Micrococcaceae are more abundant 
within root microbiomes as compared to Wild inoculum, Tukey’s multiple comparisons, p<0.05 
(A). * 299/SynCom samples have significantly different relative abundances of Streptomycetaceae 
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abundance as compared to 136/SynCom alone (Dunn’s multiple comparisons, p<0.05) (B) 
Relative abundance of Micrococcaceae within each sample (C) Relative abundance of 
Microbacteriaceae within each sample (D).





Figure 3.11. Relative abundances of Alphaproteobacteria families.   
Histogram shows the distribution of the relative abundances of each type of sample for only 
Alphaproteobacteria families from the ASV taxonomic assignment Beijerinckiaceae relative 
abundances vary by primary inoculation with 303, CL18 and 136 and Wild or NB secondary 
inoculum, * Tukey’s multiple comparisons, p<0.05 (A). Relative abundances of Rhizobiaceae in 
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Wild and NB secondary inoculum, ^ Dunn’s multiple comparisons, p<0.05 (B). Relative 
abundances of Xanthobacteraceae (C) Relative abundances of Azospirillaceae (D).   
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Figure 3.12. Gammaproteobacteria family relative abundances.  
Histogram shows the distribution of the relative abundances of each type of sample for only 
Gammaproteobacteria families from the ASV taxonomic assignment. Relative abundances of 
Enterobacteriaceae are different in samples with Wild and SynCom secondary inoculum, and 
relative abundance of Burkholderia are different than samples with secondary Wild, SynCom or 



































































































  120 
CHAPTER FOUR - COMPOSITION OF THE GUT 
MICROBIOME REGULATES THE SEVERITY OF MALARIA  
  121 
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I. ABSTRACT 
 
Infectious diseases plague much of the developing world.  Current efforts to advance our 
understanding of correlations between the gut microbiome and mediation of infectious disease are 
significant.  Of particular interest are diseases for which we do not have an effective vaccine, such 
as malarial illnesses caused by infection with the parasite Plasmodium.  Plasmodium infections 
result in clinical presentations that range from asymptomatic to severe malaria resulting in 
approximately one million deaths annually.  In spite of this, the factors that determine disease 
severity remain poorly understood.  Here we show that the gut microbiota of mice influences the 
pathogenesis of malaria.  Genetically similar mice from different commercial vendors, which 
exhibited differences in their gut bacterial community, had significant differences in parasite 
burden and mortality after infection with multiple Plasmodium species.  Germ-free mice that 
received cecal content transplants from ‘resistant’ or ‘susceptible’ mice had low and high parasite 
burdens, respectively, demonstrating the gut microbiota shaped the severity of malaria.  Among 
differences in the gut flora were increased abundances of Lactobacillus and Bifidobacterium in 
resistant mice.  Susceptible mice treated with antibiotics followed by yogurt made from these 
bacterial genera displayed a decreased parasite burden.  Consistent with differences in parasite 
burden, resistant mice exhibited an elevated humoral immune response compared to susceptible 
mice.  Collectively, these results identify the composition of the gut microbiota as a novel risk 
factor for severe malaria and modulation of the gut microbiota (e.g. probiotics) as a potential 
treatment to decrease parasite burden.   
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II. INTRODUCTION 
 
Microbiomes across kingdoms have demonstrated remarkable similarity in their collective 
contributions to their hosts’ survival [1-3].  As was described in chapter 1, the gut microbiota 
impacts multiple facets of host physiology [4] including shaping susceptibility to numerous 
diseases [5-13].  The effects of the gut microbiota on the mammalian host are strongly influenced 
by the collective composition of the bacterial populations [14] and commensal flora are known to 
affect local pathogen burdens and host immunity [15-17].  Microbiome studies in other systems, 
such as the plant model Arabidopsis thaliana, describe the essential contribution of microbe-
microbe interactions on microbiome establishment and balance [18].  In addition to influencing 
local gut immunity, the gut microbiome also affects host immunity to extra-gastrointestinal tract 
viral infections [19], chronic diseases and a variety of infectious diseases [20, 21].   
 
Plasmodium infections are a global health burden causing over 200 million cases of malaria and 
around one million deaths annually, with the vast majority of fatalities being children under the 
age of 5 living in sub-Saharan Africa [22].  Many Plasmodium infections are either asymptomatic 
or cause only mild malaria. Yet, some infections progress to severe malaria that most often 
manifest as impaired consciousness (cerebral malaria), respiratory distress, and severe anemia 
[23].  The best correlate of disease severity following P. falciparum infection in humans is parasite 
density [24, 25]. 
 
Recent studies also support that the gut microbiome modulates Plasmodium infections in humans.  
Anti-α-gal antibodies, induced by the gut pathobiont E. coli O86:B7, cross-react with sporozoites 
from human and rodent Plasmodium species that impair transmission of the parasite between the 
vector and vertebrate host; however, this cross-reactive immunity did not affect blood stage 
parasite burden [26].  Additionally, the stool bacteria composition of Malian children correlated 
prospectively with risk of P. falciparum infection, but not progression to febrile malaria [27].  
Importantly, it remains unclear whether the gut microbiome also contributes to the development 
of severe malaria.  As has been shown in plants, microbiomes change in response to infection, 
resulting in a beneficial consortium of bacteria [28].  This consortium can be altered via additions 
with probiotics or removal with antibiotic treatment.  Use of probiotics has been shown to 
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beneficially influence both humoral and cellular systemic immunity in children via decrease of 
pro-inflammatory cytokines and increase in beneficial antibodies [29].  In addition, the use of 
probiotic therapies has been linked to benefits across a broad spectrum of diseases including HIV 
[30] and respiratory infections [31].   Similarly, here we used a probiotic cocktail to supplement 
the diet of mice treated with antibiotics.  Collectively, our data demonstrate that the gut 
microbiome effects blood stage parasite burden and the subsequent severity of malaria. 
 
III. MATERIALS AND METHODS 
 
Animals and housing   
Conventionally housed mice: Female C57BL/6J and BALB/cJ mice (6-8 weeks old) were 
purchased from The Jackson Laboratory (Bar Harbor, Maine); C57BL/6N and BALB/cN mice (6-
8 weeks old) were purchased from the National Cancer Institute (Frederick, MD), Charles River 
Laboratories (Wilmington, MD), Harlan Laboratories (Indianapolis, IN) and Taconic (Hudson, 
NY).  Mice were acclimatized for a minimum of 7 days prior to starting experiments. 
Germ–free mice: Female C57BL/6J mice (8-10 weeks old) were purchased from The National 
Gnotobiotic Rodent Resource Center at the University of North Carolina-Chapel Hill.  Upon 
arrival at the University of Tennessee the mice were kept in the transporting box until fecal 
transplant was done, then mice were housed in conventional (specific pathogen free) conditions.  
Animal experiments were carried out at The University of Tennessee adhering to the local and 
national regulations of laboratory animal welfare.  Procedures involving the care or use of mice 
were reviewed and approved by The University of Tennessee Institutional Animal Care and Use 
Committee. 
 
Diets   
Unless noted otherwise mice were fed NIH-31 Modified Open Formula Mouse/Rat Irradiated Diet 
(Harlan 7913) (Harlan, Indianapolis, IN).  In some experiments mice were fed Teklad 22/5 Rodent 
Diet (Harlan 8640; Harlan, Indianapolis, IN), Jackson Laboratory in-house diet (5K67; Cincinnati 
Lab & Pet Supply, Inc.; Cincinnati, OH) or NCI/CR in-house diet (5L79 Cincinnati Lab & Pet 
Supply, Inc.; Cincinnati, OH).  Mice were placed on the respective diets upon arrival at the facility 
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and maintained on the different diets for at least one week prior to P. yoelii infection or removal 
of intestinal tissues for bacterial population analysis. 
 
Plasmodium infection   
Mice were infected with P. yoelii 17XNL, P. chabaudi AS, or P. berghei ANKA.  For P. yoelii or 
P. berghei ANKA infections mice received 1x105 parasitized red blood cells (intravenously) 
prepared from frozen/thawed stabilites.  For P. chabaudi infections, experimental mice were 
infected intraperitoneally with freshly prepared 1x105 parasitized red blood cells after one in vivo 
passage in C57BL/6 mice. 
 
Evaluation of parasitemia   
Blood samples were taken from the tail at regular intervals from 3 to 35 days post-infection.  
Parasitemia was assessed by evaluation of thin blood smears or flow cytometry.  Thin blood 
smears–at least 5 high-power (1000x) fields were assessed for each sample.  Total red blood cells 
and parasitized red blood cells were counted in each field.  Flow cytometry–about 5-10 µl of blood 
was added to PBS and then fixed with 0.00625%% gluteraldehyde.  Cells were stained with 
CD45.2-APC (clone 104; Biolegend; San Diego, CA), Ter119-APC/Cy7 (clone TER-119; 
Biolegend; San Diego, CA), dihydroethidium (Sigma Aldrich; St. Louis, MO), and Hoechst 33342 
(Sigma Aldrich; St. Louis, MO).  Red blood cells (CD45.2-Ter119+) were gated on and 
Plasmodium infected cells were subsequently identified as dihydroethium+Hoechst 33342+.  
Parasitemia represents the percentage of red blood cells infected with P. yoelii, P. chabaudi or P. 
berghei. 
 
Enumeration of red blood cells and parasitized red blood cells   
Blood samples were collected and used to quantify red blood cells per mL using a hemocytometer, 
and percent parasitemia.  Red blood cells per mL and percent parasitemia were used to calculate 
the number of parasitized red blood cells per mL of blood. 
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Cecum transplant  
Cecal content was squeezed from donor mice (n=3-5 mice per group) into a sterile petri dish.  
Immediately after harvesting the cecum material, it was diluted with sterile saline (2 mL) and 
mixed gently for ~30 seconds.  Each germ-free mouse received the diluted cecum material (200 
µL/mouse) administered by oral gavage.  For each mouse, a new sterile oral gavage needle was 
used.  After the cecal transplant, mice were housed using conventional conditions.  Mice were 
infected with P. yoelii 3 weeks after the cecal transplant. 
Gut microbiota analysis 
Tissue collection: The distal half of the small intestine, cecum, and colon were excised from mice 
and flash frozen in liquid nitrogen.  Samples were then stored at -80°C. 
DNA isolation: DNA was extracted from samples using the MoBio PowerSoil DNA Isolation Kit 
(MoBio Laboratories Inc., Carlsbad, CA) according to manufacturer’s protocols.   No effort was 
made to separate mouse tissue from the bacterial component so as not to select against bacteria 
that were in close association with mouse tissue.  
Ribosomal 16S sequencing:  For amplification of bacterial 16S rRNA genes, bacteria specific PCR 
primers targeting the V4 region (bases 515-806) were used. 
Amplification, barcoding and sequencing were completed by the Genome Sequencing Center at 
the Hudson-Alpha Institute for Biotechnology (Huntsville, AL) using the MiSeq platform with 
150 bp paired-end reads.  
Community analysis.: We used the Mothur software package (version 1.33.1) [42] to process 
sequences of sufficient length and quality similarly to the Schloss MiSeq SOP 
(http://www.mothur.org/wiki/MiSeq_SOP).  Mothur was also used to cluster sequences into 
phylotypes and for phylogenetic classification and to sort our sequences into groups based on the 
region of the digestive tract from which the DNA was extracted.  The Primer-E software package 
(Version 6; [43]) was used to interrogate the relationships between phylotypes across samples and 
to derive correlations between phylotype presence/abundance and other parameters.  The “.shared” 
file (a matrix file containing phylotype abundances for each sample), created by Mothur, was 
imported directly into the Primer-E software package.  All phylotype abundances were 
standardized to the total number of sequences per barcoded library (proportional abundances).  
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Standardized abundances were square-root transformed to partially deemphasize more highly 
abundant phylotypes.  A Bray-Curtis similarity matrix was constructed and used to perform non-
metric multidimensional scaling analysis (NMDS) for visualization of community structure 
relationships between the different samples.   Detection of “biomarker” sequences was performed 
using the software package LEfSe  (http://huttenhower.sph.harvard.edu/galaxy/) [26]. 
Metabolomics analysis 
Collection of small intestine and cecum content samples:  Immediately after euthanasia, the 
abdominal cavity was exposed and the small intestine and the cecum were dissected from the other 
intestinal sections.  The small intestine and cecum contents were collected into petri dishes by 
squeezing the tissues from the proximal to distal ends of the organs.  In addition, extraction solvent 
(1mL) (40:40:20 HPLC grade methanol, acetonitrile, water with 0.1% formic acid) was used to 
flush the small intestine and the cecum using a needle and syringe.  The intestine contents were 
then transferred into separate cryotubes and flash frozen in liquid nitrogen.  The samples were kept 
on ice for approximately one hour until extraction. 
Collection of plasma samples:  Blood was collected from the peri-orbital sinus using heparinized 
capillary tubes under general anesthesia with isoflurane.  Immediately after collection, blood 
samples were transferred to centrifuge tubes and centrifuged for 10 minutes at 2,000 x g at room 
temperature.  Following centrifugation, plasma samples were transferred to cryotubes and flash 
frozen in liquid nitrogen.  The samples were kept on ice for approximately one hour until 
extraction. 
Sample extraction and analysis:  Extraction of samples was allowed to proceed at -78°C for 20 
minutes.  Samples were then centrifuged for 5 minutes (16.1 rcf) at 4°C.  The supernatant was 
transferred to new vials and the sample pellet was resuspended in 200 µL of chilled (4°C) 
extraction solvent.  The extraction was allowed to proceed for 15 min at -20°C at which time the 
samples were centrifuged for 5 min (16.1 rcf) at 4°C.  The supernatant was transferred to vials and 
another 50 µL of extraction solvent was added to the sample pellet where the extraction was 
repeated once more.  Vials containing all of the collected supernatant were dried under a stream 
of N2 until the extraction solvent had evaporated.  Solid residue was resuspended in 300 µL of 
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sterile water and transferred to autosampler vials.  Samples were immediately placed in 
autosampler trays for mass spectrometric analysis. 
Ultra Performance Liquid Chromatograpy—High Resolution Mass Spectrometric (UPLC-MS) 
Analysis:  Samples were placed in autosampler trays and kept at 4°C.  A 10 µL aliquot of each was 
injected through a Synergi 2.5 micron Hydro-RP 100, 100 x 2.00 mm LC column (Phenomenex) 
kept at 25°C.  The eluent was introduced into the MS via an electrospray ionization source 
conjoined to a Thermo Scientific Exactive Plus Orbitrap MS through a 0.1 mm internal diameter 
fused silica capillary tube, and the MS was run in fullscan mode with negative mode ionization 
using a method adapted from Rabinowitz [44].  Briefly, the samples were run with a spray voltage 
was 3 kV.  The nitrogen sheath gas was set to a flow rate of 10 psi with a capillary temperature of 
320°C. AGC target was set to 3e6.  The samples were analyzed with a resolution of 140,000 and 
a scan window of 85 to 800 m/z for from 0 to 9 minutes and 110 to 1000 m/z from 9 to 25 minutes.  
Solvent A consisted of 97:3 water:methanol, 10 mM tributylamine, and 15 mM acetic acid.  
Solvent B was methanol.  The gradient from 0 to 5 minutes was 0% B, from 5 to 13 minutes was 
20% B, from 13 to 15.5 minutes was 55% B, from 15.5 to 19 minutes was 95% B, and from 19 to 
25 minutes was 0% B with a flow rate of 200 µL/min. 
Metabolite feature extraction and data processing:  The RAW files generated by the instrumental 
data collection software Xcalibur (Thermo Scientific) were converted to the mzML format [45] 
using the ProteoWizard package [46].  The MAVEN software package (Princeton University) was 
used to automatically align the total ion chromatograms using the retention times of annotated 
metabolites and other dominant features from each sample [47, 48].  Metabolites were manually 
identified and integrated using known masses (± 5 ppm mass tolerance) and retention times (D ≤ 
1.5 min).  Metabolite ion counts were normalized via mass for cecum and small intestine samples, 
and fold changes were calculated between samples.  The resulting data were clustered using 
Cluster 3.0 [49] and heatmaps were then generated from clustered data using Java Treeview [50] 
software.  PCA analyses were performed and figures were generated using the statistical package 
R along with the ggplot2 [51] and ggbiplot [52] packages.  PLS-DA plots were also generated via 
R along with the mixOmics [53] package using metabolite areas as the predictors and mouse type 
as the discrete outcomes with a tolerance of 1 x 10–6 and a max iteration of 500. 
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Yogurt treatment   
Antibiotic treated mice were treated orally with an antibiotic cocktail consisting of ampicillin (0.5 
mg/ml) (Sigma Aldrich; St. Louis, MO), vancomycin (0.25 mg/ml) (Amnesco; Solon, OH), 
metronidazole (0.5 mg/ml) (Spectrum Chemical Mfg. Comp.; Gardena, CA), neomycin sulfate 
(0.5 mg/ml) (EMD Millipore; Billerica, MA), and gentamycin sulfate (0.5 mg/ml) (Corning; 
Manassas, VA).  Mice were treated ad libitum for 3 weeks.  Water bottles containing the antibiotic 
cocktail were changed weekly.  After 3 weeks antibiotic treatment ceased and half of the antibiotic 
treated mice were then treated with yogurt for 3 weeks prior to the P. yoelii infection. Yogurt was 
made using a starter culture containing Lactobacillus bulgaricus, L. acidophilus, L. lactis, 
Bifidobacterium lactis, and Streptococcus thermophilus (Yogurt Starter Culture #2, Custom 
Probiotics, Glendale, CA).  In addition, yogurt was enriched with a probiotic powder supplement 
containing L. acidophilus, L. rhamnosus, L. salivarius, L. plantarum, L. casei, L. lactis, B. breve, 
B. infantis, B. longum, B. bifidum, and B. lactis (11 Strain Probiotic Powder, Custom Probiotics, 
Glendale, CA).  Fresh yogurt was made for each treatment by adding the starter culture (1.2 grams) 
and the probiotic supplement (1.2 grams) to 15 mL of 2% reduced fat milk (Mayfield, Athens, TN) 
or organic 2% reduced fat milk–antibiotic pretreatment experiment (Organic Valley; La Farge, 
WI).  The yogurt was then incubated at 37°C for 6-8 hours before administration.  Mice were 
treated with yogurt as described in figure legends with 0.2 ml administered by oral gavage.   
Isolation and sequencing of Lactobacillus 
Fecal pellets from Jackson and NCI mice were processed separately.  Pellets were homogenized 
in buffered saline solution and plated onto lactobacillus selective MRS agar.  Plates were 
subsequently incubated at 37°C in anaerobic culture jars.  Single colonies were re-streaked three 
times to purify the strains.  DNA was extracted from bacterial colonies, lab-cultured yogurt, and 
probiotic powder using the MoBio Powersoil DNA extraction kit (MoBio, Carlsbad, CA) 
according to the manufacturer’s protocols.  An approximately 1500 bp segment of the 16S rRNA 
gene was amplified from isolate DNA, via PCR, using the 9F-1522R primer set.  PCR products 
were purified using the Qiaquick PCR purification kit (Qiagen, Valencia, CA) and sequenced at 
the University of Tennessee Molecular Biology Resource Facility using Sanger sequencing. 
  130 
Cellular immune response 
Spleens were disrupted to generate single-cell suspensions in Hyclone RPMI 1640 media (Thermo 
Fisher Scientific Inc., Waltham, MA) supplemented with 10% fetal bovine serum (FBS) (Atlanta 
Biologicals, Inc., Lawrenceville, GA).  RPMI 1640 was also supplemented with 1.19 mg/ml 
HEPES (Thermo Fisher Scientific Inc., Waltham, MA), 0.2 mg/ml L-glutamine (Research 
Products International Corp., Mt. Prospect, IL), (0.05 units/ml & 0.05 mg/ml) 
penicillin/streptomycin (Invitrogen, Grand Island, NY), 0.05 mg/ml gentamicin sulfate 
(Invitrogen, Grand Island, NY), and 0.05 µM 2-Mercaptoethanol (Thermo Fisher Scientific Inc., 
Waltham, MA).  Single cell suspensions were treated with ammonium chloride potassium to lyse 
red blood cells.  Spleens were harvested as indicated at the number of days post infection.   
 
Cells were stained with Fc block (anti-CD16/32; clone 2.4G2) and the following fluorescence-
conjugated antibodies (CD45.2; clone 104, CD4; clone RM4-5, CD8; clone 53-6.7, CD3; clone 
17A2, CD19; clone 6D5, Ter119; clone Ter-119, CD11a; clone M17/4, CD49d; clone R1-2, PD-
1; clone 29F.1A12, CD95; clone Jo2, GL7; clone GL7, biotion-CXCR5; clone 2G8, CD44; clone 
IM7) purchased from Biolegend (San Diego, CA) and BD Biosciences (San Diego, CA).  For 
CXCR5 staining cells were stained with biotinylated-CXCR5 for 30 minutes at room temperature 
prior to staining with fluorescence-conjugated streptavidin.  Antibodies were resuspended in 
FACS buffer (1x PBS, 1% FBS, 0.02% sodium azide) and cells were stained for 30 minutes at 
4°C.  Following staining cells were fixed and permeabilized with Fixation Buffer (Biolegend, San 
Diego, California).  Cells were acquired through an LSR II (BD Biosciences).  Data were analyzed 
by FlowJo software (Tree Star, Ashland, OR).  
Detection of P. yoelii MSP119-specific antibodies   
Serum was collected on the indicated days post P. yoelii infection and stored at -20°C.  MaxiSorp 
Immuno plates (Thermo Scientific) were coated with 1 µg/ml recombinant MSP119 (The following 
reagent was obtained through the MR4 as part of the BEI Resources Repository, NIAID, NIH: 
Plasmodium yoelii yP.y.MSP1-19(XL)/VQ1, MRA-48, deposited by DC Kaslow.)  Dilutions of 
serum were added to wells.  Total MSP119-specific IgM, IgG1, IgG2b, IgG2c, and IgG3 antibodies 
were detected with horseradish peroxidase–conjugated goat anti–mouse IgM, IgG1, IgG2b, IgG2c, 
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and IgG3, respectively, (Jackson ImmunoResearch) and 3,3′,5,5′-tetramethylbenzidine substrate 
(Arcos Organics).  Reactions were stopped by addition of 2M H2SO4.  Results are presented as 
average endpoint titers with absorbance readings below 0.1 (absorbance at 450 nm). 
 
Statistical analysis   
Descriptive and comparative statistical analyses of data, except the gut microbiota and 
metabolomics data, were done using GraphPad Software version 6 (La Jolla, CA, USA).  The area 
under the parasitemia curve (AUC) was estimated for each group following the trapezoidal rule 
with the following equation [54, 55]. 
AUCt1-t-last =0.5 Σ (Yi + Yi+1) * (ti+1-t i) 




Mice from different vendors exhibit differential susceptibility to malaria. 
Genetically similar inbred strains of mice (C57BL/6) maintained by different vendors (Jackson 
Laboratories and Taconic) have differences in their gut bacterial communities [32, 33].  To 
determine whether these differences had any effect on Plasmodium infections C57BL/6 mice from 
Jackson Laboratories (Jax), Taconic (Tac), National Cancer Institute/Charles River (NCI) and 
Harlan (Har) were infected with P. yoelii.  Following infection, profound differences in 
parasitemia (the fraction of red blood cells infected with P. yoelii) were observed among the four 
groups of mice (Figure 4.1A,B).  Whereas resistant mice (Jax and Tac) exhibited a maximum of 
approximately 10% parasitemia, they had no signs of morbidity (weight loss) or mortality, which 
was in contrast to the substantial weight loss and mortality observed in susceptible mice (NCI and 
Har) where parasitemia was >60% (Figure 4.1C,D).  Moreover, NCI and Har mice exhibited more 
profound and longer lasting anemia (loss of red blood cells (RBCs) per mL) compared to Jax and 
Tac mice (Figure 4.S1A).  Additionally, when total number of RBCs per mL was used to derive 
total pathogen burden, similarities were noted between the parasite burden as detected by 
parasitemia or parasitized RBCs (pRBCs) per mL of blood (Figure 4.S1B-E).  Of note, mice 
infected with different doses of P. yoelii pRBCs showed similar parasitemia kinetics between the 
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different doses and susceptibility to infection (Figure 4.S2) suggesting mice from different vendors 
are differentially susceptible to progression to severe malaria but not to blood stage infection. 
 
To determine the broader applicability of these data, another mouse strain and two Plasmodium 
species were tested.  BALB/c mice from Jax, Tac, Charles River (CR) and Har were infected with 
P. yoelii.  Mice were purchased from CR in lieu of NCI/CR.  Of note, C57BL/6 mice purchased 
from CR exhibit similar parasitemia and morbidity as NCI mice following infection with P. yoelii 
(Figure 4.S3).  Consistent with P. yoelii infections in C57BL/6 mice (Figure 4.S3), BALB/c mice 
from Jax and Tac exhibit reduced P. yoelii parasitemia compared to mice from CR and Har (Figure 
5.S4A,B).  Furthermore, C57BL/6 mice from Jax and Tac exhibited reduced parasitemia compared 
to CR and Har following Plasmodium chabaudi infection (Figure S4.4C,D).  Finally, we assessed 
the development of experimental cerebral malaria (ECM) in C57BL/6 mice infected with 
Plasmodium berghei ANKA.  Jax and Tac mice trended towards reduced parasitemia compared to 
NCI and Har mice at early time points, moreover there was a significant (p=0.04) difference in 
survival between these groups of mice (Figure 4.S4E,F).  In sum, these data indicate the severity 
of malaria was dependent on the source of mice. 
 
Diet is a strong modulator of organismal health as well as of the gut microbiome and its function 
[34].  To determine whether the diet could shape the severity of malaria, Jax and NCI mice were 
fed one of two commercially available rodent diets, either NIH-31 (used in Figure 4.1A-D or 
Teklad 22/5.  Parasitemia in NCI mice was unaffected; however, Jax mice had high levels of 
parasitemia when fed Teklad 22/5 (Figure 4.1E,F).  Consistent with the parasitemia data, Jax mice 
fed Teklad 22/5 also exhibited substantial weight loss and elevated mortality compared to Jax mice 
fed NIH-31 (Figure 4.1G,H).  Since these diets had no effect on parasite burden in NCI mice, the 
changes in parasitemia in Jax mice were unlikely due to a direct effect of these diets on the parasite 
burden.  Moreover, high parasite burdens in NCI mice fed NIH-31, suggest this diet supported the 
proliferative expansion of P. yoelii.  When Jax and NCI mice were placed on the reciprocal vendor-
specific diet and then infected with P. yoelii we noted a modest increase in parasite burden in Jax 
mice fed the NCI in-house diet, but no effect of the Jax in-house diet on NCI mice (Figure 4.S5).  
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Collectively, these data sets led to the hypothesis that the gut microbiota influenced Plasmodium 
infections. 
Gut bacterial community structure and function are different in resistant and susceptible mice. 
To directly test for differences in the gut microbiome, sections of the gastrointestinal tract from 
resistant (Jax and Tac) and susceptible (NCI and Har) mice were collected and the bacterial 
communities were characterized using 16S rRNA gene analysis (Figure 4.S15).  There was a high 
degree of similarity between the microbial community assemblages found within the cecum and 
the colon of mice from the same vendor (Figure 4.S6A), while there were clear differences between 
the microbial communities of these regions compared to the distal half of the small intestine within 
the same vendor.  Moreover, significant differences between mice from all vendors were apparent 
in the non-metric multidimensional scaling (NMDS) analysis of population structure within the 
cecum, with the susceptible NCI and Har libraries showing a comparative overlap with each other 
yet distinct differences when compared to the resistant Jax and Tac communities (Figure 4.S6B).  
Analysis of the cecal bacterial communities at the family level revealed substantial differences, 
with Clostridiaceae, Erysipelotrichaceae, Lactobacillaceae, and Peptostreptococcaceae (members 
of the Firmicutes phylum) being proportionally more abundant in resistant (Jax and Tac) mice, 
whereas Bacteroidaceae and Prevotellaceae (members of Bacteroidetes phylum), and 
Sutterellaceae (member of Proteobacteria phylum) were proportionally more abundant in 
susceptible (NCI and Har) mice (Figure 4.2A,B).  Finally, dietary changes are capable of inducing 
significant changes in the gut microbiome [35] that reach steady state within 3-4 days in mice [36].  
Consistent with these reports, we observed defined changes in the gut bacterial communities in 
Jax mice fed Teklad 22/5 or NIH-31 (Figure 4.S7-S8).  In Jax mice fed the Teklad diet, there was 
a noted decrease in Peptostreptococcaceae below that observed in either Jax or Tac mice resulting 
in an increased similarity to the susceptible NCI and Har mice (Figure 4.S7C).  These changes 
coincide with a shift in the severity of malaria between these two groups of mice (Figure 4.1E-H). 
 
Consistent with changes in the gut bacterial community, analysis of metabolites in the small 
intestine, cecum, and plasma of Jax and NCI mice revealed differential expression between each 
tissue (Figure 4.S9A).  An F-test of partial least squared discriminant analysis (PLS-DA) [37] used 
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to probe variation between metabolite profiles in Jax and NCI mice on a per tissue basis confirmed 
that the means of the variate-1 (component 1), which differentiated Jax from NCI mice in all 
tissues, were significantly different (p≤0.0003, 0.0001, 0.0001) for the small intestine, cecum, and 
plasma, respectively, (Figure 4.S9B-D; Figure 4.S16).  Several metabolites exhibited large (≥1.5 
fold) and statistically significant (p≤0.1) differences between Jax and NCI mice, with the top 25% 
of metabolites associated with distinct metabolic pathways (Figure 4.S9E,F; Figure 4.S173-S19).  
Therefore, differences in the gut bacterial populations and metabolites support the hypothesis that 
the severity of malaria was modulated by differences in gut bacterial communities. 
Differences in the gut microbiome shape susceptibility to malaria. 
To directly test this hypothesis, genetically identical germ-free (GF) C57BL/6 mice received cecal 
content transplants from either Jax or NCI mice.  Of note, GF C57BL/6J mice exhibited no 
difference in parasitemia compared to conventional C57BL/6J mice following infection with P. 
yoelii nigeriensis [38].  Sequence analyses demonstrated the bacterial communities in colonized, 
germ-free mice reflected that of the donor communities and were different than the communities 
in germ-free mice exposed to only environmental microbes (Figure 4.3A).  Furthermore, there was 
only a slight decrease in community diversity between respective donor and colonized germ-free 
mice (Figure 4.S10).  Following P. yoelii infection, germ-free mice that received either Jax or NCI 
cecal transplants had parasite burdens similar to control Jax and NCI mice (Figure 4.3B,C).  Both 
NCI control mice and germ-free mice that received NCI cecal transplants also had decreased 
survival compared to the Jax control mice and germ-free mice that received Jax cecal transplants 
(Figure 4.3D).  Collectively, these data provided a direct demonstration that the severity of malaria 
was modulated by the gut microbiota. 
Decreased parasite burden in mice treated with Lactobacillus and Bifidobacterium. 
To identify individual microbial phylotypes that may shape the severity of malaria, a deeper 
analysis was performed on the bacterial communities in the cecum.  When pooled by resistance 
(Jax/Tac) or susceptibility (NCI/Har) to P. yoelii, several phylotypes (referred to here as 
Operational Taxonomic Units, OTUs) emerged from a linear discriminant analysis (LDA) effect 
size (LEfSe)-driven analysis [39] as biomarkers of the resistant or susceptible phenotype.  Among 
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those differences, Lactobacillus and Bifidobacterium were overly abundant in the resistant mice 
compared to susceptible mice (Figure 4.S11), with differences in Lactobacillus being the greatest 
driver of the differential community structure between resistant and susceptible mice (Figure 
4.S11B).   
 
To evaluate the linkage between Lactobacillus and Bifidobacterium towards resistance to severe 
malaria, Jax and NCI mice were treated with lab-cultured yogurt supplemented with probiotics 
that contained Lactobacillus and Bifidobacterium species prior to and following infection with P. 
yoelii.  DNA sequencing of Lactobacillus isolated from fecal pellets from Jax and NCI mice or 
lab-cultured yogurt demonstrated phylogenetic congruence (Figure 4.S12).  Consumption of 
Lactobacillus and Bifidobacterium can modulate the gut microbial community structure [40] or 
function [41].  Following infection with P. yoelii, both Jax and NCI mice treated with yogurt had 
a modest, but significant (Jax p<0.0001; NCI p=0.0418), decrease in parasite burden compared to 
control untreated mice (Figure 4.S13).  Jax and NCI mice treated with milk used to make the yogurt 
showed a similar parasite burden as control Jax and NCI mice (mean AUCDay 5-34: Jax control (n=4) 
107.2±11.39 (S.D.) versus Jax milk (n=4) 83.55±24.83 (S.D.) p = 0.13; NCI control (n=4) 
447.1±85.65 (S.D.) versus NCI milk (n=3) 384.8±73.08 (S.D.) p = 0.36).  However, when mice 
were treated with antibiotics prior to yogurt treatment we observed a profound decrease (14-fold) 
in parasite burden in the susceptible NCI mice (Figure 4.4A-B), and no weight loss in those mice 
was noted when compared to the other NCI groups (Figure 4.4C).  These data support the ability 
of Lactobacillus and Bifidobacterium to contribute towards the modulation of Plasmodium parasite 
burden, yet other constituents of the gut microbiota may also contribute to regulating the severity 
of malaria. 
Severity of malaria tracts with the magnitude of the host immune response. 
The gut microbiota can shape host immunity to systemic viral infections [19], and T follicular 
helper (Tfh) produced IL-21 is required for GC B cell help and clearance of murine Plasmodium 
infections [42].  Consistent with these observations, resistant Jax mice exhibited an elevated P. 
yoelii-specific CD4+ T cell (CD49dhiCD11ahi [293], Tfh cell, and GC B cell responses compared 
to susceptible NCI mice (Figure 5.5A-C; Figure 5.S14).  Jax and NCI mice had similar titers of 
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IgM specific for the 19-kDa fragment of merozoite surface protein 1 (MSP119) from P. yoelii 
(Figure 4.5D), suggesting similar activation of B cell in both groups.  In contrast, Jax mice 
exhibited accelerated antibody class switching from MSP119-specific IgM to IgG isotypes, 4- to 
10-fold higher titers at day 14 post-infection, compared to NCI mice (Figure 4.5D).  Thus, one 
mechanism by which the gut microbiome shapes the severity of malaria following P. yoelii 




This study demonstrates that the murine gut microbiome influences the parasite burden of 
Plasmodium rodent species and modulates the severity of malaria in mice.  Importantly, parasite 
burden is currently the best-known correlate of disease severity following P. falciparum infection 
in humans [24, 25].  An association between the gut microbial community and Plasmodium 
parasites has been previously recognized in the mosquito vector [44-48].  Interestingly, the unique 
assemblage of skin bacteria on human skin, and particularly volatiles produced by these bacteria, 
have also been shown to impact the attractiveness of Anopheles mosquitoes to particular 
individuals [49-51]. 
 
Studies that followed this work further support that the gut microbiota affects mammalian stages 
of the Plasmodium life cycle. Overall, the studies concluded that malarial infection reshapes the 
gut microbiome via influencing parasite fitness [52]. One study demonstrated that specific gut 
bacteria could impact the transmission of P. berghei sporozoites from mosquitos to mice [26].  The 
authors showed that the gut pathobiont, E. coli O86:B7, induced the production of anti-α-gal 
antibodies.  When Plasmodium-infected mosquitoes injected sporozoites into the dermal tissue 
during a blood meal the anti-α-gal antibodies bound to the Plasmodium sporozoites, which 
prevented their migration to the liver [26].  These results also extended to humans where the 
presence of anti-α-gal IgM antibodies correlated with protection against P. falciparum infection.  
The effect of E. coli O86:B7 on Plasmodium infection was limited to transmission of sporozoites 
as there was no effect of the anti-α-gal antibodies on the symptomatic blood stage of the infection.  
Consistent with these findings, another report demonstrated that the unique composition of stool 
bacteria in Malian children correlated with prospective risk of P. falciparum infection, although 
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not progression to febrile malaria [27].  Although the mechanism responsible for this observation 
is unknown, the similarities between these two studies (i.e., susceptibility to infection but not 
severity of blood stage infection) suggest the prospective risk of P. falciparum infection 
differentiated by stool bacteria composition may be attributed to differences in anti-α-gal IgM 
antibodies.  In contrast to the details of the two publications described above, we show that the gut 
microbiota modulates the severity of P. yoelii blood stage infections in mice, implying a novel and 
independent mechanism.  Moreover, our findings show that the influence of the gut microbiome 
on Plasmodium infections is broad and not limited to the transmission of the parasite.  Taken 
together our observation and those of Yilmaz et al. [26], result in the intriguing speculation that 
the human intestinal microbiota might impact different stages of the Plasmodium life cycle in 
humans.  In conclusion, our findings confirm and support the ability of the gut microbiome to 
affect Plasmodium parasite fitness.  
 
One potential mechanism by which the gut microbiota regulates the severity of malaria is a direct 
effect on the parasite itself where gut microbiota-derived products either promote or inhibit its 
growth.  Whereas this possibility has not been formally excluded, we observe similar parasitemia 
expansion kinetics, when plotted on a log-scale, between days 5 and 11 post-infection in both 
resistant and susceptible mice.  This observation suggests that the gut microbiota does not have a 
direct effect on the parasite.  Consequently, it is more likely that the gut microbiota impacts the 
severity of malaria by modulating the host immune response to Plasmodium.  Consistent with this 
possibility, resistant Jax mice exhibited an elevated anti-Plasmodium immune response compared 
to susceptible NCI mice.  While these data correlate with the parasite burden in these mice, further 
experiments will be necessary to demonstrate the differential immune response is responsible for 
the difference in severity, and if so, how the gut microbiota modulates the host immune response 
to this extra-gastrointestinal infection.  It has been previously shown that the gut microbiome 
provides signals to monocytes/macrophages that primed those cells to respond to and help control 
systemic lymphocytic choriomeningitis virus infections [19].  Whether the gut microbiome 
modulates host immunity to Plasmodium through similar or different effects on the host immune 
system remains to be determined. 
 
  138 
As mentioned above, diet has a major role in shaping the composition and activity of the gut 
microbiota [35, 53, 54].  Consequently, manipulating the structure and function of these complex 
communities through the diet provides an opportunity to manipulate the host immune system [53].  
In our study, we identified that Lactobacillus and Bifidobacterium species in cecal content could 
have a protective role by modulating the parasite burden and attenuating the severity of the disease.  
It is also possible that these bacterial genera correlate with decreased parasitemia through niche 
competition that decreases the abundance of bacterial genera that cause elevated parasitemia.  
Since antibiotic treatment followed by yogurt treatment triggered a 14-fold reduction in parasite 
burden in susceptible mice, the results suggest that through optimization (e.g., identifying and 
treating with the most effective ‘protective’ bacterial species or eliminating bacteria that contribute 
to high parasitemia), modulating the gut microbiome has the potential be a novel prophylaxis to 
prevent severe malaria.  Consistent with this possibility, prior work has shown that children in a 
rural African village in Burkina Faso have an enrichment of the Bacteroidetes phylum and a 
depletion of the Firmicutes phylum, which contains Lactobacillus, compared to European children 
[55].  This resembles the community structure in susceptible mice that have increased 
Bacteroidetes and reduced Firmicutes compared to resistant mice (Figure 4.4S11).  Therefore, the 
commonality between the bacterial community structure in African children and Plasmodium 
susceptible mice suggests the possibility that probiotic modulation of the gut microbiota in mice 
to control severe malaria may work in humans.  To that end, there is great opportunity for future 
studies aimed at development of feasible and tractable probiotic interventions.  The plant 
microbiome is known to house bacterial taxa protective against Plasmodium infection, namely 
Firmicutes [56].  Yet to be explored are the viability and effectiveness of the use of edible or 
agricultural plants as probiotics.  Studies designed to determine plant colonization of mammalian 
immune-beneficial microbe and subsequent survival through the mammalian gastrointestinal tract 
are lacking.     
 
This report demonstrates the novel observation that the severity of malaria in mice is profoundly 
impacted by the composition of the gut microbiota.  The data lead to the hypothesis that differences 
in the gut microbiota may explain why some humans infected with Plasmodium progress to severe 
disease while others do not.  The results also support the possibility that manipulating the gut 
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microbiota has the potential to control the severity of malaria in humans.  Whereas modulating the 
gut microbiota may not prevent Plasmodium infections, altering the gut microbiome has the 
potential to ameliorate severe disease and save thousands of lives annually.  
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VIII. APPENDIX: FIGURES 
 
Figure 4.1. Plasmodium parasite burden, morbidity and mortality vary by mouse vendor 
and diet.   
C57BL/6 mice were infected with P. yoelii parasitized red blood cells.  (A) Fraction of red blood 
cells infected with P. yoelii (% parasitemia).  (B) Area under the parasitemia curve (AUC) analysis.  
Data were analyzed by one-way ANOVA and Tukey’s multiple comparison post-test.  (C) Percent 
weight loss following infection.  Data were analyzed by one-way ANOVA.  (D) Survival of mice 
following infection.  Survival curves were analyzed by Log-rank (Mantel-Cox) test.  (E-H) Mice 
were fed either NIH-31 or Teklad 22/5 diets before and after P. yoelii infection.  (E) Percent 
parasitemia following P. yoelii infection.  (F) AUC analysis.  Data were analyzed by one-way 
ANOVA and Tukey’s multiple comparison post-test.  (G) Percent weight loss following infection.  
Data were analyzed by one-way ANOVA.  (H) Survival of mice following infection.  Survival 
curves were analyzed by Log-rank (Mantel-Cox) test.  (A-F, H) Data (mean±S.E.) are cumulative 
results (n=8-10 mice/group) from two experiments.  (G) Data (mean±S.D.) are from 4-5 mice per 
group from one experiment.  * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, n.s. = not 
significant. 
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Figure 4.2.  Susceptibility to malaria correlates with differences in cecal bacteria populations.  
(A) Bacterial families that were identified as being significantly enriched in Jackson or Taconic 
mice. (B) Bacterial families identified as being significantly enriched in NCI or Harlan mice.  (A-
B) Data (mean±S.E.) are from 6 mice per group and extracted from analysis in Figure S6c.  Data 
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Figure 4.3.  Gut microbiome shapes susceptibility to severe malaria.   
 
Germ-free mice were colonized with cecal contents from Jax or NCI mice.  (A) Bacterial 
population analysis was performed using NMDS, as described in Figure S6. (B-D) Colonized 
germ-free mice and control Jax and NCI mice were infected with P. yoelii.  (B) Percent parasitemia 
following P. yoelii infection.  (C) AUC analysis.  (B-C) Data (mean±S.E.) from 4-5 mice/group 
are representative of two experiments.  Data were analyzed by one-way ANOVA and Tukey’s 
multiple comparison post-test.  (D) Survival of mice following infection.  Data are cumulative 
results (n=8-10 mice/group) from two experiments.   Survival curves were analyzed by Log-rank 
(Mantel-Cox) test.  **** p < 0.0001, n.s. = not significant. 
  
B



























































































  149 
 
Figure 4.4.  Susceptible mice treated with yogurt have decreased parasitemia and morbidity.  
 
Jax and NCI mice were left untreated (control), treated with antibiotics for three-weeks then left 
untreated for three additional weeks (Abx), left untreated for three-weeks followed by treatment 
with yogurt 5 times per week for three-weeks (Yogurt), or treated with antibiotics for three-weeks 
followed by treatment with yogurt 5 times per week for three-weeks (Abx+Yogurt).  Mice were 
then infected with P. yoelii.  Yogurt treated mice continued to receive yogurt 5 times per week 
following infection.  (A) Percent parasitemia following P. yoelii infection.  (B) AUC analysis.  
Data were analyzed by one-way ANOVA and Tukey’s multiple comparison post-test.  (C) Percent 
weight loss following infection.  Data were analyzed by one-way ANOVA.  (A-C) Data 
(mean±S.E.) are cumulative results (n=3-10 mice/group) from two experiments.  * p < 0.05, ** p 
< 0.01, *** p < 0.001, **** p < 0.0001, n.s. = not significant. 
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Figure 4.5.  Resistant Jax mice have an elevated cellular and humoral immune response to 
Plasmodium.  
Jax and NCI mice were infected with P. yoelii.  Total number of CD4+CD11ahiCD49dhi cells (A) 
T follicular helper cells (B) and germinal center (GC) B cells (C) per spleen on the indicated day.  
Data (mean±S.E.) are cumulative results (n=5-10 mice/data point) from three experiments.  (D) 
Serum MSP119-specific antibody endpoint titers.  Data (mean±S.E.) are cumulative results (n=3-7 
mice/data point) from two experiments.  Numbers in the panels represent the fold difference 
between the means of the Jax and NCI mice.  Data were analyzed by unpaired two-tailed t test.  * 
p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 
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Figure 4.S1. Differential anemia and circulating parasitized red blood cells between mice 
from different vendors.  
C57BL/6 mice were infected with 1x105 P. yoelii parasitized red blood cells. (A) Number of red 
blood cells (RBCs) per mL of blood. (B) Fraction of red blood cells infected with P. yoelii (% 
parasitemia). (C) Percent parasitemia AUC analysis. (D) Number of parasitized red blood cells 
(pRBCs) per mL of blood. (E) pRBCs/mL of blood AUC analysis. (A-E) Data (mean±S.E.) are 
from 3-4 mice/group. (A,C, and E) Data were analyzed by one-way ANOVA and Tukey’s multiple 
comparison post-test. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, n.s. = not significant.  
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Fig. S1.  Differential anemia and circulating parasitized red blood cells between mice from different vendors.
C57BL/6 mice were infected with 1x105 P. yoelii parasitized red blood cells. (A) Number of red blood cells (RBCs)
per L of blood.  (B) Fraction of red blood cells infected with P. yoelii (% parasitemia).  (C) Percent parasitemia AUC
analysis.  (D) Number of parasitized red blood cells (pRBCs) per mL of blood.  (E) pRBCs/mL of blood AUC analysis.
(A-E) Data (mean±S.E.) are from 3-4 mice/group.  (A,C, and E) Data were analyzed by one-way ANOVA and Tukey’s
multiple comparison post-test. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, n.s. = not significant.
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Figure 4.S2. Similar susceptibility to parasitized red blood cell infection between C57BL/6 
mice from different vendors.    
C57BL/6 mice from the indicated vendors were infected with the indicated number of P. yoelii 
parasitized red blood cells (pRBCs). (A) Fraction of RBCs infected with P. yoelii (% parasitemia). 
Each line represents parasitemia kinetics from an individual mouse (n=4 mice/dose/vendor). Data 
are representative of two experiments. (B) Number of mice from each vendor infected with the 
indicated dose of pRBCs and the total number of mice injected. Data are cumulative results from 
two experiments. Susceptibility to infection at the different doses between vendors was analyzed 
by two-tailed Fisher’s Exact Test.  
  
Fig. S2.  Similar susceptibility to parasitized red blood cell infection between C57BL/6 mice from different vendors.
C57BL/6 mice from the indicated vendors were infected with the indicated number of P. yoelii parasitized red blood cells
(pRBCs). (A) Fraction of RBCs infected with P. yoelii (% parasitemia). Each line represents parasitemia kinetics from an
individual ouse (n=4 mic /dose/vendor). Data are representative of two experiments. (B) Number of mice from each
vendor infected with the indicated dose of pRBCs and the total number of mice injected.  Data are cumulative results from
two experiments.  Susceptibility to infection at the different doses between vendors was analyzed by two-tailed Fisher’s
Exact Test.
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3/8 vs. 6/8 p = 0.31
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Figure 4.S3. C57BL/6 mice from Charles River are susceptible to high P. yoelii parasite 
burden.  
C57BL/6mice were infected with 1x105 P. yoelii parasitized red blood cells. (A) Fraction of red 
blood cells infected with P. yoelii (% parasitemia). (B) Area under the parasitemia curve (AUC) 
analysis. Data were analyzed by one-way ANOVA and Tukey’s multiple comparison test. (C) 
Percent weight loss following infection. Data were analyzed by one-way ANOVA. (A-C) Data 
(mean±S.E.) are from 3-5 mice/group and representative of two experiments. * p < 0.05, *** p < 





































































Fig. S3. C57BL/6 mice from Charles River are susceptible to high P. yoelii parasite burden.  C57BL/6 mice were
infected with 1x105 P. yoelii parasitized red blood cells.  (A) Fraction of red blood cells infected with P. yoelii (% parasitemia).
(B) Area under the parasitemia curve (AUC) analysis.  Data were analyzed by on -way ANOVA and Tukey’s multiple
comparison test.  (C) Percent weight loss following infection.  Data were analyzed by one-way ANOVA.  (A-C) Data
(mean±S.E.) are from 3-5 mice/group and representative of two experiments. * p < 0.05, *** p < 0.001, n.s. = not significant.
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Figure 4.S4. Modulation of malaria pathogenesis by the gut microbiota is generalizable to 
another mouse strain and Plasmodium species.  
Figure (A-B) BALB/c mice were infected with 1x105 P. yoelii parasitized red blood cells. (A) 
Fraction of red blood cells infected with P. yoelii (% parasitemia). (B) Area under the parasitemia 
curve (AUC) analysis. Data were analyzed by one-way ANOVA and Tukey’s multiple comparison 
test. (A-B) Data (mean±S.E.) are cumulative results (n=8 mice/group) from two experiments. (C-
D) C57BL/6 mice were infected with 1x105 P. chabaudi parasitized red blood cells. (C) Fraction 
of red blood cells infected with P. chabaudi (% parasitemia). (D) Area under the parasitemia curve 
(AUC) analysis. Data were analyzed by one-way ANOVA and Tukey’s multiple comparison test. 
(C-D) Data (mean±S.E.) are from 3-4 mice/group and representative of two experiments. (E-F) 
C57BL/6 mice were infected with 1x105 P. berhgei ANKA parasitized red blood cells. (E) 
Fraction of red blood cells infected with P. berghei (% parasitemia) from surviving mice. Data 
(mean±S.E.) are cumulative results (n=10 mice/group) from two experiments. (F) Survival of mice 
following infection (n=10 mice/group). Survival curves were analyzed by Log-rank (Mantel-Cox) 
test. ** p < 0.01, **** p < 0.0001, n.s. = not significant.  
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Fig. S4.  Modulation of malaria pathogenesis by the gut microbiota is generalizable to another mouse
strain and Plasmodium species.  (A-B) BALB/c mice were infected with 1x105 P. yoelii parasitized red
blood cells.  (A) Fraction of red blood cells infected with P. yoelii (% parasitemia).  (B) Area under the
parasitemia curve (AUC) analysis.  Data were analyzed by one-way ANOVA and Tukey’s multiple
comparison test.  (A-B) Data (mean±S.E.) are cumulative results (n=8 mice/group) from two experiments.
(C-D) C57BL/6 mice were infected with 1x105 P. chabaudi parasitized red blood cells.  (C) Fraction of red
blood cells infected with P. chabaudi (% parasitemia).  (D) Area under the parasitemia curve (AUC) analysis.
Data were analyzed by one-way ANOVA and Tukey’s multiple comparison test.  (C-D) Data (mean±S.E.) are
from 3-4 mice/group and representative of two experiments.  (E-F) C57BL/6 mice were infected with 1x105
P. berhgei ANKA parasitized red blood cells.  (E) Fraction of red blood cells infected with P. berghei (%
parasitemia) from surviving mice.  Data (mean±S.E.) are cumulative results (n=10 mice/group) from two
experiments.  (F) Survival of mice following infection (n=10 mice/group).  Survival curves were analyzed by
Log-rank (Mantel-Cox) test.  ** p < 0.01, **** p < 0.0001, n.s. = not significant.
P. bergheri ANKA C57BL/6E
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Figure 4.S5. Inversion of Jax and NCI in-house diets minimally effects severity of P. yoelii 
infection.  
C57BL/6 mice were placed on one of three different rodent chows; NIH-31, Jax in-house diet, or 
NCI in-house diet, for one-week prior to infection through resolution of infection. Mice were 
infected with 1x105 P. yoelii parasitized red blood cells. (A) Fraction of red blood cells infected 
with P. yoelii (% parasitemia). (B) Area under the parasitemia curve (AUC) analysis. (A-B) Data 
(mean±S.E.) are from 3-4 mice/group and representative of two experiments. * p < 0.05, ** p < 
0.01, *** p < 0.001, ****  
p < 0.0001, n.s. = not significant. (C) Survival of mice following infection (n=7-8 mice/group) 
from two experiments. Survival curves were analyzed by Log-rank (Mantel-Cox) test.  
Fig. S5.  Inversion of Jax and NCI in-house diets minimally effects severity of P. yoelii infection.
C57BL/6 mice were placed on one of three different rodent chows; NIH-31, Jax in-house diet, or NCI
in-house diet, for one-week prior to infection through res lution of infection.  Mice were infected with
1x105 P. yoelii parasitized red blood cells.  (A) Fraction of red blood cells infected with P. yoelii (%
parasitemia).  (B) Area under the parasitemia curve (AUC) analysis.  (A-B) Data (mean±S.E.) are from
3-4 mice/group and representative of two experiments.  * p < 0.05, ** p < 0.01, *** p < 0.001, ****
p < 0.0001, n.s. = not significant.  (C) Survival of mice following infection (n=7-8 mice/group) from
two experiments.  Survival curves were analyzed by Log-rank (Mantel-Cox) test.
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Figure 4.S6. Susceptibility to malaria correlates with differences in the gut microbial 
community structure. 
Bacterial population analysis was performed using NMDS. The closer together two points are the 
more similar the libraries are to one another. Libraries with similarities greater than 20%, 40%, 
60% or 80% are encircled with green, blue, teal or red dotted lines, respectively. Triangle=distal 
portion of the small intestine (DSI); Square=cecum; Diamond=colon (A) Analysis of all three 
regions of the digestive tract. (B) Analysis of only the cecum bacterial populations. (C) Percentage 
of 16S rRNA gene reads of bacterial families comprising at least 0.01% of reads from at least 1 
sample. Abundances of 16S reads at the Family level were first normalized to proportional 
abundances and then the average proportional abundance (n=6) for each family was calculated for 























Fig. S6.  Susceptibility to malaria correlates with differences in the gut microbial community structure.  Bacterial
population analysis was performed using NMDS.  The closer together two points are the more similar the libraries are to
one another.  Libraries with similarities greater than 20%, 40%, 60% or 80% are encircled with green, blue, teal or red
dotted lines, respectively. Triangle=distal portion of the small intestine (DSI); Square=cecum; Diamond=colon.
(A) Analysis of all three regions of the digestive tract.  (B) Analysis of only the cecum bacterial populations. (C) Percentage
of 16S rRNA gene reads of bacterial families comprising at least 0.01% of reads from at least 1 sample.  Abundances of
16S reads at the Family level were first normalized to proportional abundances and then the average proportional














































































Fig. S6.  Susceptibility to malaria correlates with differences in the gut microbial community structure.  Bacterial
population analysis was performed using NMDS.  The closer together two points are the more similar the libraries are to
one another.  Libraries with similarities greater than 20%, 40%, 60% or 80% are encircled with green, blue, teal or red
dotted lines, respectively. Triangle=distal portion of the small intestine (DSI); Square=cecum; Diamond=colon.
(A) Analysis of all three regions of the digestive tract.  (B) Analysis of only the cecum bacterial populations. (C) Percentage
of 16S rRNA gene reads of bacterial families comprising at least 0.01% of reads from at least 1 sample.  Abundances of
16S reads at the Family level were first normalized to proportional abundances and then the average proportional
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Figure 4.S7. Jackson mice fed Teklad 22/5 diet exhibit defined changes in cecal bacterial 
populations.  
All mice were fed NIH-31, except one group of Jackson mice that received Teklad 22/5 (Jax-Tek). 
(A) Cecal cacterial population analysis was performed using NMDS. The closer together two 
points are the more  similar the libraries are to one another. Libraries with similarities greater than 
20%, 40%, 60% or 80% are encircled with green, blue, teal or red dotted lines, respectively. 
Analysis of cecal bacterial populations. Each symbol represents an individual mouse. (B) 
Percentage of 16S rRNA gene reads of bacterial families comprising at least 0.01% of reads from 
at least 1 sample. Abundances of 16S reads at the Family level were first normalized to 
proportional abundances and then the average proportional abundance (n=6) for each family was 
calculated for mice from each of the groups.  (C) Bacterial families that were identified as being 
significantly enriched in Jackson or Taconic mice. (D) Bacterial families identified as being 
significantly enriched in NCI or Harlan mice. (C-D) Data (mean±S.E.) are from 6 mice per group 
and extracted from analysis in panel B. Data were analyzed by Kruskal-Wallis test.  
Fig. S7.  Jackson mice fed Teklad 22/5 di t exhibit define  changes in cecal bacterial populations.  All mi e were fed NIH-31,
except one group of Jackson mice that received Teklad 22/5 (Jax-Tek).  (A) Cecal cacterial population analysis was performed
using NMDS.  The closer together two points are the more similar the libraries are to one another.  Libraries with similarities greater
than 20%, 40%, 60% or 80% are encircled with green, blue, teal or red dotted lines, respectively.   Analysis of cecal bacterial
populations.  Each symbol represents an individual mouse.  (B) Percentage of 16S rRNA gene reads of bacterial families comprising
at least 0.01% of reads from at least 1 sample.  Abundances of 16S reads at the Family level were first normalized to proportional
abundances and then the average proportional abundance (n=6) for each family was calculat d for mice from each of the groups.
(C) Bacterial families that were identified as being significantly enriched in Jackson or Taconic mice.  (D) Bacterial families identified
as being significantly enriched in NCI or Harlan mice.  (C-D) Data (mean±S.E.) are from 6 mice per group and extracted from
analysis in panel B.  Data were analyzed by Kruskal-Wallis test.
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Figure 4.S8. Distinct bacterial community structure in Jackson mice fed separate diets.  
C57BL/6 mice from Jackson Laboratory (Jax) were fed two separate diets (NIH-31 (n=6) or 
Teklad 22/5 (n=6)) for one to three weeks prior to removal of gut contents and analysis of gut 
bacterial community. (A) NMDS plot displaying the similarity between bacterial populations 
within the cecum of mice fed the different diets. Each symbol represents a single mouse. The closer 
together two points are in the figure, the more similar the libraries are to one another. Libraries 
with similarities greater than 40%, 60% or 80% are encircled with blue, teal or red dashed lines, 
respectively. Selected vectors (lettered A-U), overlaid on the figure, were taken from a PCA plot 
made from all phylotype abundances in this study after identification by LEfSe analysis as having 
statistically significant differential abundances in mice fed different diets. (B) LEfSe output 
highlighting differentially abundant phylotypes between Jax mice fed the two separate diets. Some 
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Fig. S8.  Distinct bacterial community structure in Jackson mice fed separate diets.  C57BL/6 mice from Jackson
Laboratory (Jax) were fed two separate diets (NIH-31 (n=6) or Teklad 22/5 (n=6)) for one to three weeks prior to
removal of gut contents and analysis of gut bacterial community.  (A) NMDS plot displaying the similarity between
bacteri l populations within the cecum of mice fed the differen  diets.  Each symbol represents a si gle mouse.  The
closer together two points are in the figure, the more similar the libraries are to one another.  Libraries with similarities
greater than 40%, 60% or 80% are encircled with blue, teal or red dashed lines, respectively.  Selected vectors (lettered
A-U), overlaid on the figure, were taken from a PCA plot made from all phylotype abundances in this study after
identification by LEfSe analysis as having statistically significant differential abundances in mice fed different diets.
(B) LEfSe output highlighting differentially abundant phylotypes between Jax mice fed the two separate diets.  Some of
these phylotypes are included in (A) as vectors.
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Figure 4.S9. Changes in the gut microbial community structure correlate with changes in 
the gut and plasma metabolome in resistant and susceptible mice.  
(A) Principal component analysis of metabolite profiles for all sample types. Ellipses size indicates 
95% normal probability. Triangle=small intestine, square=cecum, circle=plasma. Each symbol 
represents an individual mouse. (B-D) Partial least squares discriminant analysis within individual 
samples types: small intestine, cecum, and plasma, respectively. Separation between points 
indicates relative amount of variability. (E) Color intensity indicates magnitude of the fold change 
with red being an increase and blue being a decrease in metabolite concentrations of Jax with 
respect to NCI mice. Asterisks in parentheses next to metabolite names indicate significance for 
the change for the corresponding row and column. *** p ≤ 0.01, ** p ≤ 0.05, * p ≤ 0.10, (–) not 
significant. (F) Metabolites grouped according to metabolic pathways that were major drivers in 
  160 
the differentiation of resistant and susceptible mice using PLS-DA. Data are expressed as a ratio 
of Jax/NCI with red shades representing metabolites higher in Jax mice and blue shades 
representing metabolites higher in NCI mice. (*) = Metabolite that was a driving factor in 
differentiating resistant and susceptible mice, respective to column order. (–) = Metabolite that 
was not a driving factor in variation for the respective column. 
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Figure 4.S10. Germ-free mice colonized wtih cecal content have similar bacterial diversity 
as donor sample. 
Germ-free mice were colonized with cecal contents from Jax or NCI mice.The 1-λ (Simpson 
Index) was calculated for 5 different mouse types (Jax-Donors (n=4), GF-Jax recipients post-cecal 
transplant (n=5), NCI Donors (n=3), GF-NCI recipients post-cecal transplant (n=5) and GF mice 
receiving no transplant (n=5)). Data are mean±SD. Communities with values closer to 1 are 
































Fig. S10. Germ-free mice colonized wtih cecal content have similar bacterial diversity as donor sample. Germ-free
mice were coloni ed with cecal contents from a  or  mice. he 1  ( impson nde ) was calculated for 5 different
mouse t pes ( a onors (n= ), a  recipients post cecal transplant (n=5),  onors (n= ),  recipients
post cecal transplant (n=5) and  mice receiving no transplant (n=5)).  ata are mean .  ommunities with values
closer to 1 are considered to be more diverse.
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Figure 4.S11. Lactobacillus and Bifidobacterium are among the bacteria that drive 
differences between the gut-associated bacterial communities of resistant and susceptible 
mice. 
(A) LEfSe cladogram illustrating all 313 phylotypes in this study. Red identifies phylotype 
biomarkers for resistance to malaria and green identifies phylotype biomarkers for susceptibility 
to malaria. Circle size reflects the sequence abundance within the samples. (B) Top ten phylotypes 
with largest effect sizes for susceptibility and resistance to malaria.  
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Figure 4.S12. Phylogenetic tree of bacteria isolated from stool samples and lab-cultured 
yogurt.  
A maximum likelihood tree was constructed from an alignment of 16S rRNA gene sequences 
approximately 573 base pairs long. Sequences used to construct the tree were obtained from 
bacterial isolates (cultured from Jackson and NCI mouse fecal pellets) and from PCR amplicons 
retrieved from DNA extracted from lab-cultured yogurt containing probiotic powder. Isolate 
sequences = purple circles, clone sequences (yogurt or powder) = tan squares. Distance bar 
represents 0.1 substitutions per base.  
  
Fig.  S12.  Phylogenetic tree of bacteria isolated from stool samples and lab-cultured yogurt.  A maximum likelihood tree
was constructed from an alignment of 16S rRNA gene sequences approximately 573 base pairs long.  Sequences used to
construct the tree were obtained from bacterial isolates (cultured from Jackson and NCI mouse fecal pellets) and from PCR
amplicons retrieved from DNA extracted from lab-cultured yogurt containing probiotic powder.  Isolate sequences = purple
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Figure 4.S13. Treatment of gut microbiota intact mice with yogurt has a modest effect on 
parasite burden.  
Mice were treated 5-6 times/week with yogurt for 3 weeks prior to P. yoelii infection and 3 times 
per week following infection. (A) Percent parasitemia following P. yoelii infection. (B) AUC 
analysis. Data were analyzed by unpaired two-tailed t test. (C) Survival of mice following 
infection. Survival curves were analyzed by Log-rank (Mantel-Cox) test. (A-C) Data (mean±S.E.) 































































































Fig. S13.  Treatment of gut microbio a intact mice with yogurt has a modest effect on parasite burden.  Mice were
treated 5-6 times/week with yogurt for 3 weeks prior to P. yoelii infection and 3 times per week following infection.  (A) 
Percent parasitemia following P. yoelii infection.  (B) AUC analysis.  Data were analyzed by unpaired two-tailed t test.
(C) Survival of mice following infection.  Survival curves were analyzed by Log-rank (Mantel-Cox) test.  (A-C) Data
(mean±S.E.) from 7-9 mice/group are cumulative data from two experiments.
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Figure 4.S14. Gating strategy for T cell and B cell populations in Jax and NCI mice 
infected with P. yoelii. 
Jax and NCI mice were infected with P. yoelii. Representative contour plots and histograms are 
from day 21-post infection. (A) Representative contour plots and histograms showing gating 
strategy of CD45.2+ cells. (B) Representative contour plots showing gating strategy for T cell 
subsets: CD4+ T cells, P. yoelii-specific CD4+ T cells (CD4+CD49dhiCD11ahi), and T follicular 
helper (Tfh) cells (CD4+ CD44hiCXCR5+PD-1+). (C) Total number of CD4+ cells per spleen. 
(D) Representative contour plots and histograms showing gating strategy of B cell subsets: CD19+ 
B cells and GC B cells (CD19+GL7+CD95+). (E) Total number of CD19+ cells per spleen. Data 
(mean±S.E.) are cumulative results (n=5-10 mice/data point) from three experiments. Data were 
analyzed by unpaired two-tailed t test. * p<0.05, **** p<0.0001.   
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Fig.  S14.  Gating strategy for T cell and B cell populations in Jax and NCI mice infected with P. yoelii.  Jax and NCI mice
were infected with P. yoelii.  Representative contour plots and histograms are from day 21-post infection.  (A) Representative
contour plots and histograms showing gating strategy of CD45.2+ cells.  (B) Representative contour plots showing gating strategy
for T cell subsets: CD4+ T cells, P. yoelii-specific CD4+ T cells (CD4+CD49dhiCD11ahi), and T follicular helper (Tfh) cells (CD4+
CD44hiCXCR5+PD-1+).  (C) Total number of CD4+ cells per spleen.  (D) Representative contour plots and histograms showing
gating strategy of B cell subsets: CD19+ B cells and GC B cells (CD19+GL7+CD95+).  (E) Total number of CD19+ cells per
spleen.  Data (mean±S.E.) are cumulative results (n=5-10 mice/data point) from three experiments.  Data were analyzed by
unpaired two-tailed t test.  * p<0.05, **** p<0.0001.  
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Figure 4.S15. Sequencing and diversity metrics from Jax, Har, NCI, and Tac mice. 
Total number of sequences from all samples = 8,665,599. S = species richness; N = number of 
sequences; d = Margalef species richness; J’ = Pielou’s evenness; H’ = Shannon index; 1/λ = 
Inverse Simpson. 
 
Supplementary Table 1.  Sequencing and diversity metrics from Jax, Har, NCI, and Tac mice.  Total number 
of sequences from all samples = 8,665,599.  S = species richness; N = number of sequences; d = Margalef 






















H_4612' Har' DSI$ N$ 85$ 103,055$ 7.28$ 0.25$ 0.48$ 0.52$
H_4613' Har' Cecum$ N$ 85$ 191,572$ 6.91$ 0.51$ 0.99$ 0.82$
H_4614' Har' Colon$ N$ 88$ 246,215$ 7.01$ 0.44$ 0.85$ 0.69$
H_4622' Har' DSI$ N$ 95$ 26,498$ 9.23$ 0.47$ 0.93$ 0.79$
H_4623' Har' Cecum$ N$ 77$ 144,414$ 6.40$ 0.51$ 0.97$ 0.78$
H_4624' Har' Colon$ N$ 123$ 140,969$ 10.29$ 0.49$ 1.03$ 0.77$
H_4632' Har' DSI$ N$ 94$ 22,480$ 9.28$ 0.49$ 0.96$ 0.82$
H_4633' Har' Cecum$ N$ 85$ 310,706$ 6.64$ 0.54$ 1.05$ 0.84$
H_4634' Har' Colon$ N$ 82$ 63,897$ 7.32$ 0.60$ 1.14$ 0.89$
H_4712' Har' DSI$ N$ 56$ 1,534$ 7.50$ 0.58$ 1.01$ 0.81$
H_4713' Har' Cecum$ N$ 89$ 299,579$ 6.98$ 0.47$ 0.92$ 0.79$
H_4714' Har' Colon$ N$ 80$ 188,189$ 6.50$ 0.48$ 0.91$ 0.79$
H_4722' Har' DSI$ N$ 63$ 44,509$ 5.79$ 0.27$ 0.49$ 0.50$
H_4723' Har' Cecum$ N$ 82$ 188,386$ 6.67$ 0.48$ 0.91$ 0.78$
H_4724' Har' Colon$ N$ 88$ 335,328$ 6.84$ 0.46$ 0.90$ 0.78$
H_4732' Har' DSI$ N$ 72$ 41,215$ 6.68$ 0.28$ 0.52$ 0.46$
H_4733' Har' Cecum$ N$ 74$ 168,137$ 6.07$ 0.51$ 0.96$ 0.81$
H_4734' Har' Colon$ N$ 84$ 215,138$ 6.76$ 0.50$ 0.97$ 0.80$
J_4612' Jax' DSI$ Y$ 58$ 10,220$ 6.17$ 0.50$ 0.89$ 0.76$
J_4613' Jax' Cecum$ Y$ 83$ 212,544$ 6.68$ 0.50$ 0.96$ 0.82$
J_4614' Jax' Colon$ Y$ 109$ 144,423$ 9.09$ 0.45$ 0.92$ 0.76$
J_4622' Jax' DSI$ Y$ 69$ 6,396$ 7.76$ 0.53$ 0.97$ 0.78$
J_4623' Jax' Cecum$ Y$ 74$ 290,135$ 5.80$ 0.50$ 0.94$ 0.81$
J_4624' Jax' Colon$ Y$ 87$ 171,168$ 7.14$ 0.53$ 1.03$ 0.85$
J_4632' Jax' DSI$ Y$ 78$ 32,429$ 7.41$ 0.32$ 0.61$ 0.53$
J_4633' Jax' Cecum$ Y$ 73$ 163,210$ 6.00$ 0.54$ 1.00$ 0.84$
J_4634' Jax' Colon$ Y$ 74$ 38,128$ 6.92$ 0.44$ 0.82$ 0.68$
J_4712' Jax' DSI' Y' 66' 141,766' 5.48' 0.45' 0.82' 0.72'
J_4713' Jax' Cecum$ Y$ 98$ 147,576$ 8.15$ 0.51$ 1.02$ 0.84$
J_4714' Jax' Colon$ Y$ 91$ 97,286$ 7.84$ 0.50$ 0.98$ 0.79$
J_4722' Jax' DSI$ Y$ 77$ 17,265$ 7.79$ 0.46$ 0.87$ 0.73$
J_4723' Jax' Cecum$ Y$ 73$ 128,780$ 6.12$ 0.45$ 0.84$ 0.75$
J_4724' Jax' Colon$ Y$ 81$ 149,433$ 6.71$ 0.50$ 0.96$ 0.81$
J_4732' Jax' DSI$ Y$ 69$ 17,351$ 6.97$ 0.24$ 0.44$ 0.35$
J_4733' Jax' Cecum$ Y$ 71$ 176,751$ 5.79$ 0.53$ 0.98$ 0.81$
J_4734' Jax' Colon$ Y$ 70$ 83,812$ 6.09$ 0.27$ 0.49$ 0.40$
N_4612' NCI' DSI$ N$ 78$ 5,862$ 8.87$ 0.57$ 1.08$ 0.81$
N_4613' NCI' Cecum$ N$ 81$ 153,710$ 6.70$ 0.48$ 0.91$ 0.75$
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Figure 4.S15. Continued  
 
  
Supplementary Table 1.  Sequencing and diversity metrics from Jax, Har, NCI, and Tac mice.  Total number 
of sequences from all samples = 8,665,599.  S = species richness; N = number of sequences; d = Margalef 






















H_4612' Har' DSI$ N$ 85$ 103,055$ 7.28$ 0.25$ 0.48$ 0.52$
H_4613' Har' Cecum$ N$ 85$ 191,572$ 6.91$ 0.51$ 0.99$ 0.82$
H_4614' Har' Colon$ N$ 88$ 246,215$ 7.01$ 0.44$ 0.85$ 0.69$
H_4622' Har' DSI$ N$ 95$ 26,498$ 9.23$ 0.47$ 0.93$ 0.79$
H_4623' Har' Cecum$ N$ 77$ 144,414$ 6.40$ 0.51$ 0.97$ 0.78$
H_4624' Har' Colon$ N$ 123$ 140,969$ 10.29$ 0.49$ 1.03$ 0.77$
H_4632' Har' DSI$ N$ 94$ 22,480$ 9.28$ 0.49$ 0.96$ 0.82$
H_4633' Har' Cecum$ N$ 85$ 310,706$ 6.64$ 0.54$ 1.05$ 0.84$
H_4634' Har' Colon$ N$ 82$ 63,897$ 7.32$ 0.60$ 1.14$ 0.89$
H_4712' Har' DSI$ N$ 56$ 1,534$ 7.50$ 0.58$ 1.01$ 0.81$
H_4713' Har' Cecum$ N$ 89$ 299,579$ 6.98$ 0.47$ 0.92$ 0.79$
H_4714' Har' Colon$ N$ 80$ 188,189$ 6.50$ 0.48$ 0.91$ 0.79$
H_4722' Har' DSI$ N$ 63$ 44,509$ 5.79$ 0.27$ 0.49$ 0.50$
H_4723' Har' Cecum$ N$ 82$ 188,386$ 6.67$ 0.48$ 0.91$ 0.78$
H_4724' Har' Colon$ N$ 88$ 335,328$ 6.84$ 0.46$ 0.90$ 0.78$
H_4732' Har' DSI$ N$ 72$ 41,215$ 6.68$ 0.28$ 0.52$ 0.46$
H_4733' Har' Cecum$ N$ 74$ 168,137$ 6.07$ 0.51$ 0.96$ 0.81$
H_4734' Har' Colon$ N$ 84$ 215,138$ 6.76$ 0.50$ 0.97$ 0.80$
J_4612' Jax' DSI$ Y$ 58$ 10,220$ 6.17$ 0.50$ 0.89$ 0.76$
J_4613' Jax' Cecum$ Y$ 83$ 212,544$ 6.68$ 0.50$ 0.96$ 0.82$
J_4614' Jax' Colon$ Y$ 109$ 144,423$ 9.09$ 0.45$ 0.92$ 0.76$
J_4622' Jax' DSI$ Y$ 69$ 6,396$ 7.76$ 0.53$ 0.97$ 0.78$
J_4623' Jax' Cecum$ Y$ 74$ 290,135$ 5.80$ 0.50$ 0.94$ 0.81$
J_4624' Jax' Colon$ Y$ 87$ 171,168$ 7.14$ 0.53$ 1.03$ 0.85$
J_4632' Jax' DSI$ Y$ 78$ 32,429$ 7.41$ 0.32$ 0.61$ 0.53$
J_4633' Jax' Cecum$ Y$ 73$ 163,210$ 6.00$ 0.54$ 1.00$ 0.84$
J_4634' Jax' Colon$ Y$ 74$ 38,128$ 6.92$ 0.44$ 0.82$ 0.68$
J_4712' Jax' DSI' Y' 66' 141,766' 5.48' 0.45' 0.82' 0.72'
J_4713' Jax' Cecum$ Y$ 98$ 147,576$ 8.15$ 0.51$ 1.02$ 0.84$
J_4714' Jax' Colon$ Y$ 91$ 97,286$ 7.84$ 0.50$ 0.98$ 0.79$
J_4722' Jax' DSI$ Y$ 77$ 17,265$ 7.79$ 0.46$ 0.87$ 0.73$
J_4723' Jax' Cecum$ Y$ 73$ 128,780$ 6.12$ 0.45$ 0.84$ 0.75$
J_4724' Jax' Colon$ Y$ 81$ 149,433$ 6.71$ 0.50$ 0.96$ 0.81$
J_4732' Jax' DSI$ Y$ 69$ 17,351$ 6.97$ 0.24$ 0.44$ 0.35$
J_4733' Jax' Cecum$ Y$ 71$ 176,751$ 5.79$ 0.53$ 0.98$ 0.81$
J_4734' Jax' Colon$ Y$ 70$ 83,812$ 6.09$ 0.27$ 0.49$ 0.40$
N_4612' NCI' DSI$ N$ 78$ 5,862$ 8.87$ 0.57$ 1.08$ 0.81$
N_4613' NCI' Cecum$ N$ 81$ 153,710$ 6.70$ 0.48$ 0.91$ 0.75$
N_4614' NCI' Colon$ N$ 73$ 60,882$ 6.54$ 0.53$ 0.99$ 0.83$
N_4622' NCI' DSI$ N$ 129$ 32,346$ 12.33$ 0.57$ 1.20$ 0.90$
N_4623' NCI' Cecum$ N$ 92$ 196,467$ 7.47$ 0.51$ 1.01$ 0.83$
N_4624' NCI' Colon$ N$ 88$ 155,236$ 7.28$ 0.53$ 1.02$ 0.84$
N_4632' NCI' DSI$ N$ 80$ 6,446$ 9.01$ 0.47$ 0.90$ 0.72$
N_4633' NCI' Cecum$ N$ 82$ 160,507$ 6.76$ 0.50$ 0.96$ 0.78$
N_4634' NCI' Colon$ N$ 85$ 170,630$ 6.97$ 0.47$ 0.91$ 0.79$
N_4712' NCI' DSI$ N$ 83$ 140,322$ 6.92$ 0.33$ 0.63$ 0.70$
N_4713' NCI' Cecum$ N$ 87$ 134,246$ 7.28$ 0.46$ 0.89$ 0.77$
N_4714' NCI' Colon$ N$ 149$ 148,733$ 12.43$ 0.39$ 0.84$ 0.61$
N_4722' NCI' DSI$ N$ 67$ 7,778$ 7.37$ 0.34$ 0.63$ 0.51$
N_4723' NCI' Cecum$ N$ 78$ 196,757$ 6.32$ 0.53$ 1.01$ 0.84$
N_4724' NCI' Colon$ N$ 76$ 219,072$ 6.10$ 0.57$ 1.07$ 0.87$
N_4732' NCI' DSI$ N$ 75$ 54,099$ 6.79$ 0.37$ 0.69$ 0.73$
N_4733' NCI' Cecu $ N$ 76$ 346,990$ 5.88$ 0.52$ 0.97$ 0.83$
N_4734' NCI' Colon$ N$ 77$ 170,635$ 6.31$ 0.48$ 0.90$ 0.75$
T_4612' Tac' SI$ Y$ 72$ 10,268$ 7.69$ 0.41$ 0.77$ 0.62$
T_4613' Tac' ec ' Y' 82' 129,923' 6.88' 0.50' 0.95' 0.79'
T_4614' Tac' Colon$ Y$ 89$ 119,367$ 7.53$ 0.46$ 0.90$ 0.73$
T_4622' Tac' SI$ Y$ 71$ 3, 09$ 8.64$ 0.62$ 1.15$ 0. 4$
T_4623' T c' c $ $ 80$ 16 ,273$ 6.59$ 0.49$ 0.94$ 0.77$
T_4624' T c' l $ $ 7 $ 37, 09$ 6.43$ 0.52$ 0.98$ 0.82$
T_4632' T c' I$ $ 6 $ 1,852$ 8.90$ 0.76$ 1.38$ 0.93$
T_4633' T c' $ $ 85$ 76,059$ 6.95$ 0.49$ 0.94$ 0.80$
T_4634' T c' l $ 4 ,5 5$ 4.75$ 0.56$ 0.92$ 0.78$
T_4712' T c' I$ $ 92$ 5,302$ 10.61$ 0.71$ 1.39$ 0.93$
T_4713' T c' $ 140$ 65,425$ 11. 7$ 0.43$ 0.93$ 0.71$
T_4714' T c' l $ 8 147,027$ 6.72$ 0.46$ 0. 8$ 0.76$
T_4722' T c' I$ $ 5 $ 2,676$ 7.10$ 0.60$ 1.05$ 0.80$
T_4723' T c' $ $ 8 $ 9,267$ 6.97$ 0.46$ 0.89$ 0.72$
T_4724' T c' l $ $ 8$ 90,087$ 7.63$ 0.55$ 1.06$ 0.87$
T_4732' Tac' SI$ Y$ 50$ 1, 85$ 6.77$ 0.70$ 1.18$ 0.86$
T_4733' Tac' Cecu $ Y$ 68$ 130,609$ 5.69$ 0.49$ 0.90$ 0.74$
T_4734' Tac' Colon$ Y$ 90$ 125,924$ 7.58$ 0.46$ 0.90$ 0.74$
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Figure 4.S16. Variability in each sample type for PLS-DA.  
For each sample type, the intra condition distance between the extreme values in each dimension 
are listed. Comparison is also shown for the distance between the average of the points for each 
condition in each dimension. Additionally, the p values are shown for the inter conditional 
comparison. Results show a high level of significance between the Jax and NCI samples in the 
variate 1 dimension.  
 
  
Supplementary Table 2.  Variability in each sample type for PLS-DA.  For each sample type, the intra 
condition distance between the extreme values in each dimension are listed.  Comparison is also shown for the 
distance between the average of the points for each condition in each dimension. Additionally, the p values are 
shown for the inter conditional comparison.  Results show a high level of significance between the Jax and NCI 
samples in the variate 1 dimension.  
 
Small Intestine 
Jax Variability NCI Variability 
Variate 1 Variate 2 Variate 1 Variate 2 
3.84 5.23 6.90 10.86 
    
 
Jax – NCI Variability 
 
 
Variate 1 Y 
 Avg. Distance 10.03 1.72 
 p-value 0.000269 0.411425   
    Cecum 
Jax Variability NCI Variability 
Variate 1 Variate 2 Variate 1 Variate 2 
3.03 12.35 2.32 11.47 
    
 
Jax – NCI Variability 
 
 
Variate 1 Variate 2 
 Avg. Distance 9.12 1.76 
 p value 0.000145 0.629464   
    Plasma 
Jax Variability NCI Variability 
Variate 1 Variate 2 Variate 1 Variate 2 
4.93 9.08 3.34 11.71 
    
 
Jax – NCI Variability 
 
 
Variate 1 Variate 2 
 Avg. Distance 8.23 2.36 
 p value 0.000104 0.432392   
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Figure 4.S17. Average small intestine metabolite ion counts and relative standard 
deviations (RSD) for Jax (n=5) and NCI (n=5) mice.  
Supplementary Table 3: Average small intestine metabolite ion counts and relative standard deviations (RSD) 




Metabolite Average RSD (%) Average RSD (%) 
lactate 1.12E+07 33.2 1.82E+07 43.1 
succinate 4.01E+06 22.6 5.72E+06 16.7 
valine 1.02E+05 72.0 3.22E+05 47.7 
nicotinamide N.D. N.D. 4.39E+03 N.D. 
nicotinate 1.43E+05 83.0 1.51E+05 59.7 
Taurine 2.32E+06 37.0 3.05E+06 39.2 
hydroxyproline 7.51E+05 41.3 1.63E+06 26.4 
leucine/isoleucine 7.75E+05 44.8 1.66E+06 31.3 
asparagine 6.12E+05 42.4 6.67E+05 84.4 
malate 3.44E+06 34.3 4.46E+06 37.6 
anthranilate 1.05E+05 61.0 7.04E+04 47.8 
Imidazoleacetic acid 1.43E+05 22.2 1.08E+05 53.7 
α-ketoglutarate 3.46E+08 56.0 2.18E+08 43.5 
glutamine 1.09E+08 106.2 2.07E+08 79.6 
lysine 3.10E+07 48.0 9.79E+07 45.1 
glutamate 4.94E+09 43.4 7.34E+09 31.7 
2-oxo-4-methylthiobutanoate 1.27E+06 69.1 1.02E+06 50.7 
2-Hydroxy-2-methylbutanedioic acid 1.58E+08 31.7 2.23E+08 31.4 
methionine 1.77E+08 36.8 4.47E+08 45.0 
3-methylphenylacetic acid 4.06E+06 44.7 2.18E+07 60.5 
guanine 4.10E+06 49.4 1.44E+06 56.7 
xanthine 1.83E+08 31.5 4.28E+08 46.4 
Hydroxyphenylacetic acid 1.61E+06 14.6 1.61E+06 22.8 
2,3-dihydroxybenzoic acid 6.52E+07 46.5 6.37E+07 75.5 
histidine 3.83E+07 50.3 8.95E+07 39.5 
orotate 2.28E+07 94.4 1.31E+07 114.1 
dihydroorotate 2.80E+06 74.7 2.85E+06 83.9 
allantoin 8.37E+07 46.2 7.90E+07 48.5 
Indole-3-carboxylic acid 3.09E+06 22.6 1.19E+06 42.0 
phenylpyruvate 2.40E+07 66.8 4.17E+07 39.2 
methionine sulfoxide 2.90E+06 27.9 4.17E+06 41.5 
phenylalanine 8.78E+08 16.8 1.72E+09 26.0 
Phenyllactic acid 1.09E+07 81.1 1.73E+07 39.5 
quinolinate 8.94E+07 110.6 3.48E+07 54.3 
N-Acetyltaurine 4.74E+08 25.8 1.75E+08 22.0 
phosphoenolpyruvate 4.22E+06 116.7 1.20E+06 41.5 
uric acid 2.79E+08 20.5 6.48E+08 41.2 
cysteate 3.12E+06 38.3 5.83E+06 52.9 
1-Methyl-Histidine 5.14E+05 69.6 4.27E+05 54.7 
Sulfolactate 5.32E+07 29.3 8.83E+07 67.5 
dihydroxy-acetone-phosphate 1.52E+08 93.8 1.18E+08 57.8 
sn-glycerol-3-phosphate 3.80E+09 41.0 2.74E+09 21.3 
aconitate 1.52E+08 53.2 1.35E+08 28.7 
N-acetyl-L-ornithine 7.59E+06 32.6 2.01E+07 34.6 
arginine 7.78E+07 47.5 2.04E+08 39.3 
citrulline 8.51E+06 37.7 1.56E+07 35.0 
ascorbic acid 4.94E+09 60.1 5.38E+09 47.9 
N-carbamoyl-L-aspartate 1.16E+07 66.5 1.89E+07 73.5 
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Figure 4.S17. Continued 
Supplementary Table 3: Average small intestine metabolite ion counts and relative standard deviations (RSD) 




Metabolite Average RSD (%) Average RSD (%) 
lactate 1.12E+07 33.2 1.82E+07 43.1 
succinate 4.01E+06 22.6 5.72E+06 16.7 
valine 1.02E+05 72.0 3.22E+05 47.7 
nicotinamide N.D. N.D. 4.39E+03 N.D. 
nicotinate 1.43E+05 83.0 1.51E+05 59.7 
Taurine 2.32E+06 37.0 3.05E+06 39.2 
hydroxyproline 7.51E+05 41.3 1.63E+06 26.4 
leucine/isoleucine 7.75E+05 44.8 1.66E+06 31.3 
asparagine 6.12E+05 42.4 6.67E+05 84.4 
malate 3.44E+06 34.3 4.46E+06 37.6 
anthranilate 1.05E+05 61.0 7.04E+04 47.8 
Imidazoleacetic acid 1.43E+05 22.2 1.08E+05 53.7 
α-ketoglutarate 3.46E+08 56.0 2.18E+08 43.5 
glutamine 1.09E+08 106.2 2.07E+08 79.6 
lysine 3.10E+07 48.0 9.79E+07 45.1 
glutamate 4.94E+09 43.4 7.34E+09 31.7 
2-oxo-4-methylthiobutanoate 1.27E+06 69.1 1.02E+06 50.7 
2-Hydroxy-2-methylbutanedioic acid 1.58E+08 31.7 2.23E+08 31.4 
methionine 1.77E+08 36.8 4.47E+08 45.0 
3-methylphenylacetic acid 4.06E+06 44.7 2.18E+07 60.5 
guanine 4.10E+06 49.4 1.44E+06 56.7 
xanthine 1.83E+08 31.5 4.28E+08 46.4 
Hydroxyphenylacetic acid 1.61E+06 14.6 1.61E+06 22.8 
2,3-dihydroxybenzoic acid 6.52E+07 46.5 6.37E+07 75.5 
histidine 3.83E+07 50.3 8.95E+07 39.5 
orotate 2.28E+07 94.4 1.31E+07 114.1 
dihydroorotate 2.80E+06 74.7 2.85E+06 83.9 
allantoin 8.37E+07 46.2 7.90E+07 48.5 
Indole-3-carboxylic acid 3.09E+06 22.6 1.19E+06 42.0 
phenylpyruvate 2.40E+07 66.8 4.17E+07 39.2 
methionine sulfoxide 2.90E+06 27.9 4.17E+06 41.5 
phenylalanine 8.78E+08 16.8 1.72E+09 26.0 
Phenyllactic acid 1.09E+07 81.1 1.73E+07 39.5 
quinolinate 8.94E+07 110.6 3.48E+07 54.3 
N-Acetyltaurine 4.74E+08 25.8 1.75E+08 22.0 
phosphoenolpyruvate 4.22E+06 116.7 1.20E+06 41.5 
uric acid 2.79E+08 20.5 6.48E+08 41.2 
cysteate 3.12E+06 38.3 5.83E+06 52.9 
1-Methyl-Histidine 5.14E+05 69.6 4.27E+05 54.7 
Sulfolactate 5.32E+07 29.3 8.83E+07 67.5 
dihydroxy-acetone-phosphate 1.52E+08 93.8 1.18E+08 57.8 
sn-glycerol-3-phosphate 3.80E+09 41.0 2.74E+09 21.3 
aconitate 1.52E+08 53.2 1.35E+08 28.7 
N-acetyl-L-ornithine 7.59E+06 32.6 2.01E+07 34.6 
arginine 7.78E+07 47.5 2.04E+08 39.3 
citrulline 8.51E+06 37.7 1.56E+07 35.0 
ascorbic acid 4.94E+09 60.1 5.38E+09 47.9 
N-carbamoyl-L-aspartate 1.16E+07 66.5 1.89E+07 73.5 
allanto 9.06E+06 63.4 4.25E+06 62.4 
2-Isopropylmalic acid 3.92E+06 32.1 7.89E+06 80.7 
gluco o-1,5-lactone 5.72E+08 56.8 4.60E+08 47.5 
glucos mine 8. E+05 73.6 5.28E+05 113.1 
myo-inositol 1.18E+09 63.1 8.00E+08 49.8 
tyrosine 6.6 E+08 22.9 1.33E+09 41.8 
4-Pyridoxic acid 4.11E+08 27.4 2.98E+08 44.7 
3-phosphoglycerate 4.79E+07 104.9 2.09E+07 59.5 
indoleacrylic acid 3.00E+04 89.4 2.55E+04 44.1 
kynurenic acid 3.75E+06 38.4 3.06E+06 44.3 
N-acetyl-glutamate 2.88E+08 57.6 3.97E+08 25.0 
5-hydroxyindoleacetic acid 8.00E+07 28.0 1.31E+08 57.8 
citrate/isocitrate 2.37E+09 62.5 1.73E+09 52.8 
2-dehydro-D-gluconate 4.88E+08 40.0 3.96E+08 42.2 
D-gluconate 1.51E+09 81.8 1.24E+09 37.3 
D-erythrose-4-phosphate 2.22E+05 48.8 1.70E+05 29.5 
Tryptophan 5.54E+08 21.6 7.72E+08 26.3 
xanthurenic acid 4.23E+06 24.4 4.34E+06 51.6 
Kynurenine 5.47E+05 40.7 7.39E+05 20.3 
D-glucarate 2.04E+08 107.9 9.91E+07 59.1 
pantothenate 4.01E+08 37.4 7.13E+08 28.6 
deoxyuridine 4.82E+06 79.8 1.30E+07 74.7 
Thymidine 2.56E+06 113.0 8.05E+06 70.5 
Uridine 2.26E+07 33.7 3.47E+07 17.5 
D-glucono-1,5-lactone-6-phosphate 1.06E+07 39.1 8.49E+06 40.3 
Acadesine 1.50E+06 42.3 7.16E+05 78.2 
glucose-6-phosphate 1.49E+08 74.3 1.62E+08 25.1 
Thiamine 8.16E+06 46.2 1.06E+07 24.2 
Adenosine 3.85E+06 27.9 2.71E+06 35.6 
Inosine 3.85E+08 51.7 3.58E+08 30.8 
6-phospho-D-gluconate 4.34E+07 63.  3.31E+07 32.6 
1-methyl denosine 5.30E+06 55.5 8.70E+06 66.0 
gua osine 2.51E+07 34.5 3.16E+07 58.6 
xanthosin  2. 3E+06 51.7 7.52E+06 65.3 
D-sedoheptulose-1/7-phosphate 8. 4E+06 34.0 1.21E+07 14.1 
N-acetyl-glucosamine-1/6-phosphate 7.25E+07 44.  9.33E+07 31.8 
dCMP 7.5 E+06 108.  3.06E+07 53.9 
glutathione 1. 9E+09 38.6 1.21E+09 33.2 
Geranyl-PP 8.73E+07 89.7 4.08E+07 76.4 
dTMP 1.40E+07 97.9 5.39E+07 51.6 
CMP 7.11E+07 62.0 7.53E+07 38.4 
UMP 5.08E+08 43.9 3.81E+08 46.7 
cyclic-AMP 5.33E+06 73.6 6.60E+06 39.1 
AICAR 1.59E+07 138.0 7.27E+06 71.3 
fructose-1-6-bisphosphate 7.71E+07 103.1 4.48E+07 97.5 
trehalose/sucrose 5.61E+07 22.8 4.55E+07 61.7 
thiamine-phosphate 6.50E+06 177.7 2.78E+07 113.1 
dGMP 2.45E+09 52.9 2.21E+09 47.6 
IMP 1.13E+08 43.0 8.29E+07 67.4 
S-adenosyl-L-methioninamine 1.78E+06 93.5 4.25E+06 84.5 
GMP 2.57E+08 77.5 2.49E+08 55.9 
riboflavin 8.67E+06 23.3 1.18E+07 33.5 
S-adenosyl-L-homocysteine 1.21E+07 122.5 3.99E+06 114.8 
octoluse bisphosphate 5.01E+06 61.3 3.11E+06 72.1 
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Supplementary Table 3: Average small intestine metabolite ion counts and relative standard deviations (RSD) 




Metabolite Average RSD (%) Average RSD (%) 
lactate 1.12E+07 33.2 1.82E+07 43.1 
succinate 4.01E+06 22.6 5.72E+06 16.7 
valine 1.02E+05 72.0 3.22E+05 47.7 
nicotinamide N.D. N.D. 4.39E+03 N.D. 
nicotinate 1.43E+05 83.0 1.51E+05 59.7 
Taurine 2.32E+06 37.0 3.05E+06 39.2 
hydroxyproline 7.51E+05 41.3 1.63E+06 26.4 
leucine/isoleucine 7.75E+05 44.8 1.66E+06 31.3 
asparagine 6.12E+05 42.4 6.67E+05 84.4 
malate 3.44E+06 34.3 4.46E+06 37.6 
anthranilate 1.05E+05 61.0 7.04E+04 47.8 
Imidazoleacetic acid 1.43E+05 22.2 1.08E+05 53.7 
α-ketoglutarate 3.46E+08 56.0 2.18E+08 43.5 
glutamine 1.09E+08 106.2 2.07E+08 79.6 
lysine 3.10E+07 48.0 9.79E+07 45.1 
glutamate 4.94E+09 43.4 7.34E+09 31.7 
2-oxo-4-methylthiobutanoate 1.27E+06 69.1 1.02E+06 50.7 
2-Hydroxy-2-methylbutanedioic acid 1.58E+08 31.7 2.23E+08 31.4 
methionine 1.77E+08 36.8 4.47E+08 45.0 
3-methylphenylacetic acid 4.06E+06 44.7 2.18E+07 60.5 
guanine 4.10E+06 49.4 1.44E+06 56.7 
xanthine 1.83E+08 31.5 4.28E+08 46.4 
Hydroxyphenylacetic acid 1.61E+06 14.6 1.61E+06 22.8 
2,3-dihydroxybenzoic acid 6.52E+07 46.5 6.37E+07 75.5 
histidine 3.83E+07 50.3 8.95E+07 39.5 
orotate 2.28E+07 94.4 1.31E+07 114.1 
dihydroorotate 2.80E+06 74.7 2.85E+06 83.9 
allantoin 8.37E+07 46.2 7.90E+07 48.5 
Indole-3-carboxylic acid 3.09E+06 22.6 1.19E+06 42.0 
phenylpyruvate 2.40E+07 66.8 4.17E+07 39.2 
methionine sulfoxide 2.90E+06 27.9 4.17E+06 41.5 
phenylalanine 8.78E+08 16.8 1.72E+09 26.0 
Phenyllactic acid 1.09E+07 81.1 1.73E+07 39.5 
quinolinate 8.94E+07 110.6 3.48E+07 54.3 
N-Acetyltaurine 4.74E+08 25.8 1.75E+08 22.0 
phosphoenolpyruvate 4.22E+06 116.7 1.20E+06 41.5 
uric acid 2.79E+08 20.5 6.48E+08 41.2 
cysteate 3.12E+06 38.3 5.83E+06 52.9 
1-Methyl-Histidine 5.14E+05 69.6 4.27E+05 54.7 
Sulfolactate 5.32E+07 29.3 8.83E+07 67.5 
dihydroxy-acetone-phosphate 1.52E+08 93.8 1.18E+08 57.8 
sn-glycerol-3-phosphate 3.80E+09 41.0 2.74E+09 21.3 
aconitate 1.52E+08 53.2 1.35E+08 28.7 
N-acetyl-L-ornithine 7.59E+06 32.6 2.01E+07 34.6 
arginine 7.78E+07 47.5 2.04E+08 39.3 
citrulline 8.51E+06 37.7 1.56E+07 35.0 
ascorbic acid 4.94E+09 60.1 5.38E+09 47.9 
N-carbamoyl-L-aspartate 1.16E+07 66.5 1.89E+07 73.5 
dTDP 3.22E+05 48.4 2.37E+05 57.3 
UDP 4.83E+06 70.7 2.13E+06 49.1 
Cholic acid 4.67E+10 95.8 5.50E+10 52.7 
Thiamine pyrophosphate 4.69E+06 143.0 2.55E+06 75.8 
ADP 3.88E+08 72.6 1.64E+08 71.7 
GDP 1.96E+07 89.7 8.97E+06 89.4 
CDP-ethanolamine 1.30E+07 62.7 1.09E+07 40.3 
5-methyl-THF 4.72E+06 87.5 2.02E+06 40.0 
dCTP 1.51E+05 12.3 2.21E+05 185.0 
UTP 1.28E+07 89.6 2.03E+06 151.3 
taurodeoxycholic acid 7.36E+10 15.2 6.05E+10 39.2 
ATP 1.16E+08 87.5 2.15E+07 107.4 
GTP 7.16E+06 79.0 6.73E+05 126.0 
UDP-D-glucose 2.67E+08 49.8 1.66E+08 45.7 
UDP-D-glucuronate 1.34E+08 64.2 5.55E+07 48.5 
ADP-D-glucose 2.08E+07 69.0 1.80E+07 36.9 
UDP-N-acetyl-glucosamine 5.12E+08 44.0 3.42E+08 52.9 
glutathione disulfide 6.76E+07 50.1 8.28E+07 99.5 
NAD+ 5.17E+07 39.8 2.68E+07 62.5 
NADH 1.54E+07 54.1 8.20E+06 56.3 
dephospho-CoA 1.15E+07 56.7 3.72E+07 61.9 
NADP+ 1.03E+07 74.8 6.33E+06 49.5 
FAD 8.96E+06 50.2 1.04E+07 36.2 
acetyl-CoA 9.78E+06 52.2 6.30E+06 66.3 
butyryl-CoA 3.72E+06 108.5 3.30E+06 13 .6 
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Figure 4.S18.  Average cecum metabolite ion counts and relative standard 
deviations (RDS) for Jax (n=4) and NCI (n=5) mice. 
Supplementary Table 4: Average cecum metabolite ion counts and relative standard deviations (RSD) for Jax 
(n=4) and NCI (n=5) mice. 
 
 Jax NCI 
Metabolite Average RSD (%) Average RSD (%) 
lactate 5.88E+05 166.1 1.60E+06 59.4 
succinate 2.44E+06 29.4 3.46E+06 29.6 
valine 8.80E+03 35.1 1.12E+04 44.7 
nicotinamide 9.65E+05 45.6 1.70E+05 47.2 
nicotinate 6.21E+05 19.3 6.73E+05 53.8 
Taurine 1.22E+06 48.8 5.98E+05 40.2 
hydroxyproline 4.02E+04 45.3 3.31E+04 30.8 
leucine/isoleucine 4.16E+04 51.5 3.07E+04 51.3 
asparagine 7.73E+04 79.6 2.83E+05 64.0 
malate 1.87E+06 35.9 3.78E+06 37.6 
anthranilate 1.58E+06 128.8 3.62E+06 98.1 
Imidazoleacetic acid 7.05E+05 21.2 8.54E+05 22.2 
α-ketoglutarate 1.28E+09 38.7 9.21E+08 50.8 
glutamine 4.56E+07 24.9 1.16E+08 46.4 
lysine 8.64E+06 37.8 5.88E+06 45.1 
glutamate 1.09E+10 28.1 7.20E+09 25.1 
2-oxo-4-methylthiobutanoate 7.00E+05 33.5 7.43E+05 22.0 
2-hydroxy-2-methylbutanedioic acid 1.68E+09 19.4 1.33E+09 14.1 
methionine 5.04E+07 29.2 4.51E+07 25.9 
3-methylphenylacetic acid 3.60E+07 45.0 6.00E+09 35.4 
guanine 1.08E+07 32.5 9.73E+06 35.0 
xanthine 1.63E+08 34.6 2.07E+08 56.8 
hydroxyphenylacetic acid 1.49E+07 48.8 1.50E+07 26.9 
2,3-dihydroxybenzoic acid 2.99E+08 40.6 3.87E+08 57.6 
histidine 3.85E+06 50.9 3.95E+06 71.0 
orotate 5.31E+07 41.2 5.09E+07 56.3 
dihydroorotate 5.35E+06 44.4 2.64E+06 72.4 
allantoin 1.93E+06 87.1 2.59E+06 41.6 
indole-3-carboxylic acid 1.51E+07 16.9 7.40E+06 45.7 
phenylpyruvate 2.09E+06 10.4 2.52E+06 27.0 
methionine sulfoxide 1.93E+07 72.0 1.92E+07 26.9 
phenylalanine 5.28E+07 54.2 5.40E+07 43.6 
phenyllactic acid 1.14E+10 29.1 2.37E+09 43.4 
quinolinate 5.08E+07 46.3 4.57E+07 30.6 
N-Acetyltaurine 1.53E+09 24.2 2.30E+08 69.7 
phosphoenolpyruvate 4.24E+07 94.6 2.31E+07 63.3 
uric acid 2.53E+07 53.8 3.75E+07 37.3 
cysteate 7.38E+07 39.1 7.81E+07 38.1 
1-methyl-histidine 4.90E+05 66.1 4.97E+05 61.5 
sulfolactate 1.21E+08 32.4 1.31E+08 42.1 
dihydroxy-acetone-phosphate 4.24E+07 50.1 5.63E+07 49.8 
sn-glycerol-3-phosphate 5.90E+08 33.8 7.63E+08 44.7 
aconitate 9.50E+07 85.0 7.01E+07 56.0 
N-acetyl-L-ornithine 5.22E+06 33.9 5.47E+06 24.3 
arginine 9.06E+06 29.4 5.32E+06 65.1 
citrulline 9.84E+06 74.0 1.54E+07 57.7 
ascorbic acid 6.55E+06 23.3 3.64E+07 168.3 
N-carbamoyl-L-aspartate 3.36E+07 42.1 1.68E+07 52.0 
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Figure 4.S18. Continued 
Supplementary Table 3: Average small intestine metabolite ion counts and relative standard deviations (RSD) 




Metabolite Average RSD (%) Average RSD (%) 
lactate 1.12E+07 33.2 1.82E+07 43.1 
succinate 4.01E+06 22.6 5.72E+06 16.7 
valine 1.02E+05 72.0 3.22E+05 47.7 
nicotinamide N.D. N.D. 4.39E+03 N.D. 
nicotinate 1.43E+05 83.0 1.51E+05 59.7 
Taurine 2.32E+06 37.0 3.05E+06 39.2 
hydroxyproline 7.51E+05 41.3 1.63E+06 26.4 
leucine/isoleucine 7.75E+05 44.8 1.66E+06 31.3 
asparagine 6.12E+05 42.4 6.67E+05 84.4 
malate 3.44E+06 34.3 4.46E+06 37.6 
anthranilate 1.05E+05 61.0 7.04E+04 47.8 
Imidazoleacetic acid 1.43E+05 22.2 1.08E+05 53.7 
α-ketoglutarate 3.46E+08 56.0 2.18E+08 43.5 
glutamine 1.09E+08 106.2 2.07E+08 79.6 
lysine 3.10E+07 48.0 9.79E+07 45.1 
glutamate 4.94E+09 43.4 7.34E+09 31.7 
2-oxo-4-methylthiobutanoate 1.27E+06 69.1 1.02E+06 50.7 
2-Hydroxy-2-methylbutanedioic acid 1.58E+08 31.7 2.23E+08 31.4 
methionine 1.77E+08 36.8 4.47E+08 45.0 
3-methylphenylacetic acid 4.06E+06 44.7 2.18E+07 60.5 
guanine 4.10E+06 49.4 1.44E+06 56.7 
xanthine 1.83E+08 31.5 4.28E+08 46.4 
Hydroxyphenylacetic acid 1.61E+06 14.6 1.61E+06 22.8 
2,3-dihydroxybenzoic acid 6.52E+07 46.5 6.37E+07 75.5 
histidine 3.83E+07 50.3 8.95E+07 39.5 
orotate 2.28E+07 94.4 1.31E+07 114.1 
dihydroorotate 2.80E+06 74.7 2.85E+06 83.9 
allantoin 8.37E+07 46.2 7.90E+07 48.5 
Indole-3-carboxylic acid 3.09E+06 22.6 1.19E+06 42.0 
phenylpyruvate 2.40E+07 66.8 4.17E+07 39.2 
methionine sulfoxide 2.90E+06 27.9 4.17E+06 41.5 
phenylalanine 8.78E+08 16.8 1.72E+09 26.0 
Phenyllactic acid 1.09E+07 81.1 1.73E+07 39.5 
quinolinate 8.94E+07 110.6 3.48E+07 54.3 
N-Acetyltaurine 4.74E+08 25.8 1.75E+08 22.0 
phosphoenolpyruvate 4.22E+06 116.7 1.20E+06 41.5 
uric acid 2.79E+08 20.5 6.48E+08 41.2 
cysteate 3.12E+06 38.3 5.83E+06 52.9 
1-Methyl-Histidine 5.14E+05 69.6 4.27E+05 54.7 
Sulfolactate 5.32E+07 29.3 8.83E+07 67.5 
dihydroxy-acetone-phosphate 1.52E+08 93.8 1.18E+08 57.8 
sn-glycerol-3-phosphate 3.80E+09 41.0 2.74E+09 21.3 
aconitate 1.52E+08 53.2 1.35E+08 28.7 
N-acetyl-L-ornithine 7.59E+06 32.6 2.01E+07 34.6 
arginine 7.78E+07 47.5 2.04E+08 39.3 
citrulline 8.51E+06 37.7 1.56E+07 35.0 
ascorbic acid 4.94E+09 60.1 5.38E+09 47.9 
N-carbamoyl-L-aspartate 1.16E+07 66.5 1.89E+07 73.5 
allantoate 2.21E+05 100.0 2.50E+05 66.9 
2-Isopropylmalic acid 2.04E+08 69.0 2.01E+08 72.3 
glucono-1,5-lactone 3.20E+08 28.2 4.09E+08 44.2 
glucosamine 1.35E+06 87.3 1.59E+06 40.7 
myo-inositol 1.35E+09 37.2 1.49E+ 9 38.0 
tyrosine 7.94E+07 31.6 8.28E+07 22.8 
4-pyridoxic acid 1.29E+09 13.6 1.55E+09 19.1 
3-phosphoglycerate 1.32E+08 116.6 1.14E+08 44.3 
indoleacrylic acid 6.97E+05 49.6 3.51E+04 68.7 
kynurenic acid 1.38E+ 7 60.1 1.42E+ 7 70.5 
N-acetyl-glut mate 1.58E+09 30.7 1.54E+ 9 24.6 
5-hydroxyindoleacetic acid 8.76E+08 33.3 2.66E+09 25.2 
citrate/isocitrate 4.46E+ 8 21.4 5.46E+ 8 90.3 
2-dehydro-D-gluconate 6.62E+07 23.5 5.30E+07 36.3 
D-gluconate 1.05E+08 53.4 1.30E+08 50.8 
D-erythr se-4-p osphate 8.66E+05 39.5 6.65E+ 5 25.5 
tryptophan 4.33E+07 41.7 5.00E+07 41.2 
xanthurenic acid 1.14E+07 71.1 5.07E+06 49.5 
kynurenine 2.52E+04 107.7 4.10E+04 84.9 
D-glucarate 2.78E+06 125.1 1.76E+06 120.4 
pantothenate 4.25E+08 43.5 3.35E+08 30.6 
deoxyuridine 4.12E+06 41.0 3.25E+06 52.3 
thymidine 4.01E+06 49.1 2.51E+06 52.9 
uridine 2.63E+06 42.3 3.90E+06 43.6 
D-glucono-1,5-lactone-6-phosphate 4.94E+07 20.9 4.10E+07 15.9 
acadesine 4.55E+06 33.8 4.19E+06 19.7 
glucose-6-phosphate 3.96E+08 46.9 3.09E+08 54.2 
thiamine 8.28E+06 66.0 7.20E+06 34.0 
adenosine 1.57E+07 37.5 3.36E+07 31.3 
inosine 2.33E+08 25.8 2.21E+08 49.6 
6-phospho- D-gluconate 7.61E+05 147.6 1.11E+05 74.4 
1-methyladenosine 7.74E+06 51.7 8.61E+06 52.6 
guanosine 2.52E+07 14.3 3.47E+07 32.6 
xanthosine 8.31E+06 61.7 6.16E+06 61.9 
D-sedoheptulose-1/7-phosphate 5.73E+07 54.0 4.90E+07 45.2 
N-acetyl-glucosamine-1/6-phosphate 4.60E+08 32.6 3.17E+08 13.9 
dCMP 1.54E+06 40.8 1.52E+06 70.1 
glutathione 1.12E+08 52.1 2.47E+08 34.6 
geranyl-PP 5.23E+07 41.1 2.25E+07 29.0 
dTMP 1.35E+07 46.6 2.12E+07 38.6 
CMP 2.51E+07 26.4 2.33E+07 22.2 
UMP 1.43E+08 34.1 1.40E+08 23.4 
cyclic-AMP 2.82E+05 59.2 1.73E+05 95.6 
AICAR 1.59E+06 9.1 1.10E+06 24.9 
fructose-1-6-bisphosphate 1.32E+07 94.5 1.53E+07 73.1 
trehalose/sucrose 4.72E+07 39.9 2.31E+07 49.0 
thiamine-phosphate 6.54E+05 37.6 5.43E+05 85.1 
dGMP 4.88E+08 42.8 5.82E+08 27.7 
IMP 2.69E+07 47.1 2.58E+07 23.6 
S-adenosyl-L-methioninamine 3.92E+05 138.2 9.79E+05 100.7 
GMP 2.73E+07 48.6 3.25E+07 32.1 
riboflavin 1.40E+06 31.3 1.29E+06 24.7 
S-adenosyl-L-homocysteine 1.35E+06 34.1 1.02E+06 39.2 
octoluse bisphosphate 1.41E+06 39.8 1.91E+05 54.6 
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Supplementary Table 3: Average small intestine metabolite ion counts and relative standard deviations (RSD) 




Metabolite Average RSD (%) Average RSD (%) 
lactate 1.12E+07 33.2 1.82E+07 43.1 
succinate 4.01E+06 22.6 5.72E+06 16.7 
valine 1.02E+05 72.0 3.22E+05 47.7 
nicotinamide N.D. N.D. 4.39E+03 N.D. 
nicotinate 1.43E+05 83.0 1.51E+05 59.7 
Taurine 2.32E+06 37.0 3.05E+06 39.2 
hydroxyproline 7.51E+05 41.3 1.63E+06 26.4 
leucine/isoleucine 7.75E+05 44.8 1.66E+06 31.3 
asparagine 6.12E+05 42.4 6.67E+05 84.4 
malate 3.44E+06 34.3 4.46E+06 37.6 
anthranilate 1.05E+05 61.0 7.04E+04 47.8 
Imidazoleacetic acid 1.43E+05 22.2 1.08E+05 53.7 
α-ketoglutarate 3.46E+08 56.0 2.18E+08 43.5 
glutamine 1.09E+08 106.2 2.07E+08 79.6 
lysine 3.10E+07 48.0 9.79E+07 45.1 
glutamate 4.94E+09 43.4 7.34E+09 31.7 
2-oxo-4-methylthiobutanoate 1.27E+06 69.1 1.02E+06 50.7 
2-Hydroxy-2-methylbutanedioic acid 1.58E+08 31.7 2.23E+08 31.4 
methionine 1.77E+08 36.8 4.47E+08 45.0 
3-methylphenylacetic acid 4.06E+06 44.7 2.18E+07 60.5 
guanine 4.10E+06 49.4 1.44E+06 56.7 
xanthine 1.83E+08 31.5 4.28E+08 46.4 
Hydroxyphenylacetic acid 1.61E+06 14.6 1.61E+06 22.8 
2,3-dihydroxybenzoic acid 6.52E+07 46.5 6.37E+07 75.5 
histidine 3.83E+07 50.3 8.95E+07 39.5 
orotate 2.28E+07 94.4 1.31E+07 114.1 
dihydroorotate 2.80E+06 74.7 2.85E+06 83.9 
allantoin 8.37E+07 46.2 7.90E+07 48.5 
Indole-3-carboxylic acid 3.09E+06 22.6 1.19E+06 42.0 
phenylpyruvate 2.40E+07 66.8 4.17E+07 39.2 
methionine sulfoxide 2.90E+06 27.9 4.17E+06 41.5 
phenylalanine 8.78E+08 16.8 1.72E+09 26.0 
Phenyllactic acid 1.09E+07 81.1 1.73E+07 39.5 
quinolinate 8.94E+07 110.6 3.48E+07 54.3 
N-Acetyltaurine 4.74E+08 25.8 1.75E+08 22.0 
phosphoenolpyruvate 4.22E+06 116.7 1.20E+06 41.5 
uric acid 2.79E+08 20.5 6.48E+08 41.2 
cysteate 3.12E+06 38.3 5.83E+06 52.9 
1-Methyl-Histidine 5.14E+05 69.6 4.27E+05 54.7 
Sulfolactate 5.32E+07 29.3 8.83E+07 67.5 
dihydroxy-acetone-phosphate 1.52E+08 93.8 1.18E+08 57.8 
sn-glycerol-3-phosphate 3.80E+09 41.0 2.74E+09 21.3 
aconitate 1.52E+08 53.2 1.35E+08 28.7 
N-acetyl-L-ornithine 7.59E+06 32.6 2.01E+07 34.6 
arginine 7.78E+07 47.5 2.04E+08 39.3 
citrulline 8.51E+06 37.7 1.56E+07 35.0 
ascorbic acid 4.94E+09 60.1 5.38E+09 47.9 
N-carbamoyl-L-aspartate 1.16E+07 66.5 1.89E+07 73.5 
dTDP 4.88E+06 79.7 6.85E+06 85.5 
UDP 9.10E+05 71.1 7.80E+05 74.5 
cholic acid 2.44E+09 49.4 2.91E+09 56.6 
thiamine pyrophosphate 5.60E+04 135.8 1.72E+05 110.0 
ADP 3.52E+07 72.7 6.28E+07 68.9 
GDP 1.20E+06 140.5 2.10E+06 89.5 
CDP-ethanolamine 4.18E+05 50.1 7.92E+05 56.8 
5-methyl-THF 1.07E+06 91.8 5.97E+05 46.4 
dCTP N.D. N.D. N.D. N.D. 
UTP 1.95E+06 132.2 3.67E+06 128.5 
taurodeoxycholic acid 3.16E+09 77.6 3.64E+08 33.7 
ATP 4.59E+06 111.7 1.23E+07 90.4 
GTP 1.00E+05 N.D. 2.23E+05 97.0 
UDP-D-glucose 6.35E+07 35.8 8.77E+07 68.5 
UDP-D-glucuronate 5. 7E+06 48.1 8.12E+0  86.0 
ADP-D-glucose 4.30E+06 41.  5.86E+06 58.9 
UDP-N-acetyl-glucosamine 2.00E+08 31.3 2.39E+0  52.5 
glutathione disulfide 2.37E+06 75.1 1.00E+0  55.2 
NAD+ 5.65E+07 18.1 6.10E+07 70.6 
NADH 2. 0E+06 68.  1.47E+06 86.2 
dephospho-CoA 1.54E+07 97.6 9.03E+0  33.9 
NADP+ 9.81E+06 47.1 1.16E+07 74.8 
FAD 3.31E+07 25.5 3.06E+07 53.8 
acetyl-CoA 5.55E+07 48.3 7.84E+07 98.7 
butyryl-CoA 3.00E+07 52.1 5.82E+07 135.0 
 
  175 
 
Figure 4.S19. Average plasma metabolite ion counts and relative standard deviations (RSD) 
for Jax (n=5) and NCI (n=5) mice. 
 
Supplementary Table 5: Average plasma metabolite ion counts and relative standard deviations (RSD) for Jax 




Metabolite Average RSD (%) Average RSD (%) 
lactate 4.14E+06 16.2 3.43E+06 40.5 
succinate 6.30E+05 42.4 4.53E+05 31.6 
valine 6.67E+04 25.1 4.71E+04 33.8 
nicotinamide 6.91E+03 22.1 4.36E+03 N.D. 
nicotinate N.D. N.D. N.D. N.D. 
taurine 3.66E+05 48.7 2.31E+05 73.2 
hydroxyproline 9.15E+04 30.6 8.26E+04 22.2 
leucine/isoleucine 9.92E+04 29.5 8.62E+04 17.0 
asparagine 1.10E+05 32.8 9.79E+04 39.5 
malate 9.03E+05 57.4 7.42E+05 28.4 
anthranilate 3.00E+04 66.8 2.73E+04 27.8 
imidazoleacetic acid 5.41E+03 14.6 5.53E+03 6.0 
α-ketoglutarate 6.83E+08 46.1 6.14E+08 20.7 
glutamine 6.38E+08 13.5 6.74E+08 12.8 
lysine 3.56E+06 32.6 4.40E+06 40.4 
glutamate 2.26E+08 22.1 1.82E+08 43.4 
2-oxo-4-methylthiobutanoate 1.21E+05 68.7 1.55E+05 27.7 
2-hydroxy-2-methylbutanedioic acid 1.24E+08 28.3 1.44E+08 53.9 
methionine 1.16E+08 26.9 1.28E+08 19.1 
3-methylphenylacetic acid 1.74E+06 84.7 3.46E+07 23.3 
guanine 2.04E+04 90.5 9.86E+03 52.1 
xanthine 5.63E+07 97.6 8.89E+07 39.5 
hydroxyphenylacetic acid 5.21E+06 43.2 3.29E+06 21.5 
2,3-dihydroxybenzoic acid 6.49E+07 35.3 7.53E+07 35.5 
histidine 2.54E+06 24.0 2.55E+06 26.7 
orotate 1.33E+07 40.6 1.38E+07 33.6 
dihydroorotate 5.11E+05 34.4 3.85E+05 29.8 
allantoin 1.24E+08 21.4 1.03E+08 21.3 
indole-3-carboxylic acid 5.50E+05 39.6 4.45E+05 25.9 
phenylpyruvate 2.13E+06 48.0 4.53E+06 65.6 
methionine sulfoxide 1.11E+07 134.3 9.10E+06 45.1 
phenylalanine 2.03E+08 22.9 2.09E+08 13.9 
phenyllactic acid 1.48E+07 58.8 4.90E+06 35.0 
quinolinate 7.89E+05 67.0 1.60E+06 82.4 
N-acetyltaurine 4.69E+07 32.3 3.41E+07 29.9 
phosphoenolpyruvate 5.96E+06 132.3 9.50E+06 175.9 
uric acid 1.92E+08 23.7 1.97E+08 21.8 
cysteate 1.84E+05 30.9 1.15E+05 30.6 
1-methyl-histidine 1.08E+05 42.1 6.62E+04 42.5 
sulfolactate 2.24E+06 36.9 3.35E+06 53.2 
dihydroxy-acetone-phosphate 1.62E+07 33.9 7.62E+06 57.8 
sn-glycerol-3-phosphate 1.64E+08 29.2 1.51E+08 32.7 
aconitate 1.78E+08 28.5 2.03E+08 34.8 
N-acetyl-L-ornithine 4.09E+06 27.0 2.76E+06 15.0 
arginine 2.56E+06 36.1 3.22E+06 45.1 
citrulline 6.72E+07 24.1 6.06E+07 33.1 
ascorbic acid 4.81E+06 134.9 9.80E+04 55.5 
N-carbamoyl-L-aspartate 5.98E+05 62.1 4.41E+05 13.4 
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Figure 4.S19. Continued 
Supplementary Table 3: Average small intestine metabolite ion counts and relative standard deviations (RSD) 




Metabolite Average RSD (%) Average RSD (%) 
lactate 1.12E+07 33.2 1.82E+07 43.1 
succinate 4.01E+06 22.6 5.72E+06 16.7 
valine 1.02E+05 72.0 3.22E+05 47.7 
nicotinamide N.D. N.D. 4.39E+03 N.D. 
nicotinate 1.43E+05 83.0 1.51E+05 59.7 
Taurine 2.32E+06 37.0 3.05E+06 39.2 
hydroxyproline 7.51E+05 41.3 1.63E+06 26.4 
leucine/isoleucine 7.75E+05 44.8 1.66E+06 31.3 
asparagine 6.12E+05 42.4 6.67E+05 84.4 
malate 3.44E+06 34.3 4.46E+06 37.6 
anthranilate 1.05E+05 61.0 7.04E+04 47.8 
Imidazoleacetic acid 1.43E+05 22.2 1.08E+05 53.7 
α-ketoglutarate 3.46E+08 56.0 2.18E+08 43.5 
glutamine 1.09E+08 106.2 2.07E+08 79.6 
lysine 3.10E+07 48.0 9.79E+07 45.1 
glutamate 4.94E+09 43.4 7.34E+09 31.7 
2-oxo-4-methylthiobutanoate 1.27E+06 69.1 1.02E+06 50.7 
2-Hydroxy-2-methylbutanedioic acid 1.58E+08 31.7 2.23E+08 31.4 
methionine 1.77E+08 36.8 4.47E+08 45.0 
3-methylphenylacetic acid 4.06E+06 44.7 2.18E+07 60.5 
guanine 4.10E+06 49.4 1.44E+06 56.7 
xanthine 1.83E+08 31.5 4.28E+08 46.4 
Hydroxyphenylacetic acid 1.61E+06 14.6 1.61E+06 22.8 
2,3-dihydroxybenzoic acid 6.52E+07 46.5 6.37E+07 75.5 
histidine 3.83E+07 50.3 8.95E+07 39.5 
orotate 2.28E+07 94.4 1.31E+07 114.1 
dihydroorotate 2.80E+06 74.7 2.85E+06 83.9 
allantoin 8.37E+07 46.2 7.90E+07 48.5 
Indole-3-carboxylic acid 3.09E+06 22.6 1.19E+06 42.0 
phenylpyruvate 2.40E+07 66.8 4.17E+07 39.2 
methionine sulfoxide 2.90E+06 27.9 4.17E+06 41.5 
phenylalanine 8.78E+08 16.8 1.72E+09 26.0 
Phenyllactic acid 1.09E+07 81.1 1.73E+07 39.5 
quinolinate 8.94E+07 110.6 3.48E+07 54.3 
N-Acetyltaurine 4.74E+08 25.8 1.75E+08 22.0 
phosphoenolpyruvate 4.22E+06 116.7 1.20E+06 41.5 
uric acid 2.79E+08 20.5 6.48E+08 41.2 
cysteate 3.12E+06 38.3 5.83E+06 52.9 
1-Methyl-Histidine 5.14E+05 69.6 4.27E+05 54.7 
Sulfolactate 5.32E+07 29.3 8.83E+07 67.5 
dihydroxy-acetone-phosphate 1.52E+08 93.8 1.18E+08 57.8 
sn-glycerol-3-phosphate 3.80E+09 41.0 2.74E+09 21.3 
aconitate 1.52E+08 53.2 1.35E+08 28.7 
N-acetyl-L-ornithine 7.59E+06 32.6 2.01E+07 34.6 
arginine 7.78E+07 47.5 2.04E+08 39.3 
citrulline 8.51E+06 37.7 1.56E+07 35.0 
ascorbic acid 4.94E+09 60.1 5.38E+09 47.9 
N-carbamoyl-L-aspartate 1.16E+07 66.5 1.89E+07 73.5 
allantoate 2.81E+05 46.1 1.51E+05 25.4 
2-isopropylmalic acid 5.97E+06 51.5 7.82 6 76.9 
glucono-1,5-lactone 1.54E+06 35.9 1.6  37.1 
glucosamine 3.02E+04 N.D. N.D. N.D. 
myo-inos t l 4.86E+07 9.8 3 85 7 38.0 
tyrosine 1.96E+08 30.0 2 23 8 14.2 
4-pyridoxic acid 5.91E+06 48.7 3 75 19.9 
3-phosphoglycerate 4.18E+07 54.2 9 50 7 133.5 
indole crylic acid 7.75E+05 47.8 6.79  34.9 
kynurenic acid 3.54E+05 42.3 3.82 5 47.7 
N-acetyl-glutamate 1.20E+07 34.2 1. 6 7 28.7 
5-hydroxyindoleacetic acid 1.08E+06 44.0 2.31 06 12.1 
citrate/isocitrate 8.59E+09 27.2 8.66E+09 25.8 
2-dehydro-D-gluconate 1.98E+07 25.5 1.86E+07 19.6 
D-gluconate 1.54E+08 19.4 1.64E+08 18.9 
D-erythrose-4-phosphate 4.01E+06 31.7 1.96E+06 50.4 
tryptophan 1.74E+08 33.4 1.91E+08 14.9 
xanthurenic acid 2.41E+05 60.1 1.08E+06 160.5 
kynurenine 5.00E+05 40.6 8.34E+05 51.6 
D-glucarate 4.34E+06 62.4 8.36E+06 112.4 
pantothenate 2.87E+08 20.8 1.98E+08 13.7 
deoxyuridine 5.99E+06 34.0 2.34E+06 36.7 
thymidine 1.17E+06 88.6 1.23E+06 33.3 
uridine 9.53E+06 26.5 7.90E+06 7.3 
D-glucono-1,5-lactone-6-phosphate 1.59E+04 61.1 1.46E+04 37.4 
acadesine 3.80E+04 39.2 2.24E+04 14.8 
glucose-6-phosphate 2.02E+07 28.6 1.63E+07 45.4 
thiamine 1.30E+05 50.1 2.12E+05 62.6 
adenosine 7.65E+03 50.9 3.51E+03 N.D. 
inosine 6.87E+06 106.4 1.53E+07 56.7 
6-phospho- D-gluconate 1.72E+06 85.1 2.33E+06 62.1 
1-methyladenosine 4.73E+05 33.8 5.47E+05 20.7 
guanosine 2.64E+05 128.1 .02 5 61.0 
xanthosine 1.19E+05 86.2 8.36 4 90.0 
D-sedoheptulose-1/7-phosphate 1.61E+06 90.1 2 11 6 162.  
N-acetyl-glucosamine-1/6-
phosphate 7.37E+06 27.8 5 61 6 34.4 
dCMP 4.08E+05 163.7 1 92 4 106.8 
glutathion  1.73E+07 173.8 2 49 6 110.8 
geranyl-PP 6.31E+04 78.9 9.28 4 147.2 
dTMP 7.99E+05 123.3 7. 3 3 39.0 
CMP 2.98E+06 32.2 2.09 6 80.  
UMP 6.54E+06 86.5 3.02E+06 162.4 
cyclic-AMP 5.31E+04 36.7 7.49E+04 63.0 
AICAR 5.32E+03 N.D. N.D. N.D. 
fructose-1-6-bisphosphate 3.44E+07 58.8 1.30E+07 54.1 
trehalose/sucrose 1.13E+06 63.9 7.31E+05 43.3 
thiamine-phosphate N.D. N.D. N.D. N.D. 
dGMP 4.16E+07 80.2 7.03E+06 172.1 
IMP 4.84E+06 120.2 5.97E+06 201.2 
S-adenosyl-L-methioninamine 4.38E+07 30.5 3.97E+07 34.5 
GMP 6.15E+06 59.4 7.59E+06 165.9 
riboflavin 8.96E+03 9.3 5.60E+03 N.D. 
S-adenosyl-L-homoCysteine 2.12E+03 5.9 N.D. N.D. 
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Supplementary Table 5: Average plasma metabolite ion counts and relative standard deviations (RSD) for Jax 




Metabolite Average RSD (%) Average RSD (%) 
lactate 4.14E+06 16.2 3.43E+06 40.5 
succinate 6.30E+05 42.4 4.53E+05 31.6 
valine 6.67E+04 25.1 4.71E+04 33.8 
nicotinamide 6.91E+03 22.1 4.36E+03 N.D. 
nicotinate N.D. N.D. N.D. N.D. 
taurine 3.66E+05 48.7 2.31E+05 73.2 
hydroxyproline 9.15E+04 30.6 8.26E+04 22.2 
leucine/isoleucine 9.92E+04 29.5 8.62E+04 17.0 
asparagine 1.10E+05 32.8 9.79E+04 39.5 
malate 9.03E+05 57.4 7.42E+05 28.4 
anthranilate 3.00E+04 66.8 2.73E+04 27.8 
imidazoleacetic acid 5.41E+03 14.6 5.53E+03 6.0 
α-ketoglutarate 6.83E+08 46.1 6.14E+08 20.7 
glutamine 6.38E+08 13.5 6.74E+08 12.8 
lysine 3.56E+06 32.6 4.40E+06 40.4 
glutamate 2.26E+08 22.1 1.82E+08 43.4 
2-oxo-4-methylthiobutanoate 1.21E+05 68.7 1.55E+05 27.7 
2-hydroxy-2-methylbutanedioic acid 1.24E+08 28.3 1.44E+08 53.9 
methionine 1.16E+08 26.9 1.28E+08 19.1 
3-methylphenylacetic acid 1.74E+06 84.7 3.46E+07 23.3 
guanine 2.04E+04 90.5 9.86E+03 52.1 
xanthine 5.63E+07 97.6 8.89E+07 39.5 
hydroxyphenylacetic acid 5.21E+06 43.2 3.29E+06 21.5 
2,3-dihydroxybenzoic acid 6.49E+07 35.3 7.53E+07 35.5 
histidine 2.54E+06 24.0 2.55E+06 26.7 
orotate 1.33E+07 40.6 1.38E+07 33.6 
dihydroorotate 5.11E+05 34.4 3.85E+05 29.8 
allantoin 1.24E+08 21.4 1.03E+08 21.3 
indole-3-carboxylic acid 5.50E+05 39.6 4.45E+05 25.9 
phenylpyruvate 2.13E+06 48.0 4.53E+06 65.6 
methionine sulfoxide 1.11E+07 134.3 9.10E+06 45.1 
phenylalanine 2.03E+08 22.9 2.09E+08 13.9 
phenyllactic acid 1.48E+07 58.8 4.90E+06 35.0 
quinolinate 7.89E+05 67.0 1.60E+06 82.4 
N-acetyltaurine 4.69E+07 32.3 3.41E+07 29.9 
phosphoenolpyruvate 5.96E+06 132.3 9.50E+06 175.9 
uric acid 1.92E+08 23.7 1.97E+08 21.8 
cysteate 1.84E+05 30.9 1.15E+05 30.6 
1-methyl-histidine 1.08E+05 42.1 6.62E+04 42.5 
sulfolactate 2.24E+06 36.9 3.35E+06 53.2 
dihydroxy-acetone-phosphate 1.62E+07 33.9 7.62E+06 57.8 
sn-glycerol-3-phosphate 1.64E+08 29.2 1.51E+08 32.7 
aconitate 1.78E+08 28.5 2.03E+08 34.8 
N-acetyl-L-ornithine 4.09E+06 27.0 2.76E+06 15.0 
arginine 2.56E+06 36.1 3.22E+06 45.1 
citrulline 6.72E+07 24.1 6.06E+07 33.1 
ascorbic acid 4.81E+06 134.9 9.80E+04 55.5 
N-carbamoyl-L-aspartate 5.98E+05 62.1 4.41E+05 13.4 
octoluse Bisphosphate N.D. N.D. 5.09E+03 15.1 
dTDP 1.23E+05 111.3 N.D. N.D. 
UDP 2.73E+04 112.7 1.48E+04 26.0 
Cholic acid 8.82E+07 130.8 1.57E+07 71.2 
thiamine pyrophosphate 1.30E+06 100.1 1.54E+06 78.9 
ADP 3.77E+07 100.8 6.70E+06 70.7 
GDP 3.16E+06 135.6 7.24E+05 141.8 
CDP-eth nolamine 1.84E+05 4.5 7.31E+04 122.4 
5-methyl-THF .43E+04 57.4 9.4 E+03 N.D. 
dCTP N.D. N.D. N.D. N.D. 
UTP 5.72E+05 127.6 9.94E+03 17.7 
taurodeoxycholic acid 2.04E+07 70.4 1.00E+07 62.8 
ATP 1.85E+07 116.3 1.70E+06 79.7 
GTP 2.15E+06 177.7 9.97E+04 79.7 
UDP-D-glucose 1.31E+06 111.5 8.52E+05 164.0 
UDP-D-glucuronate 1.41E+05 138.4 1.15E+05 174.6 
ADP-D-glucose 1.49E+05 85.2 7.88E+04 132.1 
UDP-N-acetyl-glucosamine 1.56E+06 52.7 8.15E+05 106.9 
glutathione disulfide 5.14E+07 50.0 5.66E+07 56.2 
NAD+ 2.71E+05 157.1 3.24E+04 58.0 
NADH 1.03E+04 13.6 N.D. N.D. 
dephospho-CoA 9.94E+04 92.2 N.D. N.D. 
NADP+ 7.06E+05 113.1 1.63E+05 N.D. 
FAD 1.18E+06 2.2 2.48E+06 68.8 
acetyl CoA 1.87E+07 159.6 9.9 E+03 N.D. 
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Distinct microbiomes are found within various host tissues and in free living environments.  
Assemblages of microbes inhabit multiple surfaces and sites within and on hosts across kingdoms 
of life [1].  Due to a number of selective pressures, host-associated microbiomes are often very 
different than their surrounding environmental inocula [2].  Further, internal and external host 
microenvironments vary and may sometimes functionally overlap, suggesting niche microbial 
modifications to best serve the host and the microbiome.  [3-6]. Perhaps not surprisingly, the 
human gut alone is the home to bacterial abundances in accordance with whole human body cell 
totals [7].  Thus, microbial influence on hosts and other microbes is a fundamental component of 
life on Earth.  Host and microbe co-evolution has allowed for optimization of these relationships, 
often resulting in shared benefits such as nutrient acquisition [8], abiotic stress tolerance (e.g. 
drought) [9], and protection from pathogens [10, 11].  Taxa comprising microbiomes are often 
host-specific and can tip the balance from host death to survival [12, 13].  Significantly, taxa 
abundance within a microbiome does not always correlate with influence or importance, as rare or 
transient members sometimes disproportionately influence their host [14].  Exploration of 
composition in relation to function suggest that less important is the individual taxa, rather of 
significance is what the microbe can do to meet a functional need of the community and host [3, 
6, 15-17].   
 
Microbiome assembly and stability cues are complex, and many are largely unknown.  Host-
microbe interactions and commensal community establishment requires contributions from both 
microbes and hosts, namely immune modulation of the host and microbial tolerance of co-dwelling 
members.  Of note, assembly timing is host-specific [18, 19] and may be dynamic.   Stability is 
not always achievable, and resulting dysbiosis is known to disrupt microbiomes and can result in 
host pathology [4, 20-23] and even seemingly unrelated host physiologies [24].  The powerful 
relationships between hosts and microbiomes offer endless opportunities to determine functional 
and mechanistic microbiome assemblage attributes for application in therapies to improve health 
and wellness.   
 
Microbial treatment of plants to improve plant health or disease resistance is not novel, and 
technological advancements have highlighted the importance of identification of plant growth 
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promoting (PGP) genes as well as application of our current knowledge of disease-suppressive 
organisms such as strains of Pseudomonas spp [25-28]. Discovery of plant-mediated microbiome 
modifications to control diseases are ongoing.  For example, tomato plants root exudate profiles 
change in the presence of a pathogen, resulting in altered microbiome composition [29].  Also, 
barley increases antifungal traits when infected with a root pathogen [30].   Disease suppressive 
soils are known to influence pathogen survival and contribute to plant health [12].  Common 
microbial members of disease suppressive soils are Pseudomonales, Streptomycetaceae and 
Micromonosporaceae [12].  Study of three potato cultivars in two different soils found taxonomic 
differences in rhizosphere microbiomes. Specifically, the authors discovered an abundance of 
disease-suppressive taxa listed above, suggesting plant genotype can influence plant selection of 
microbes for protective purposes [31].  We suggest that new approaches and strategies in 
sustainable agriculture may soon be called for.  A recent review details the use of beneficial 
microbes as seed coats prior to use in agriculture [32].   The review highlights the possibilities of 
using endophytic and rhizosphere-associated organisms, such as endophytic Achromobacter 
xylosoxidans for treatment of rice [33] and Beauveria bassiana  for treatment of pine trees [34]. 
 
While the potential exists, specific challenges related to scale, production and ultimately 
colonization and microbial survival persist.  Considerations of beneficial consortia versus 
individual taxa further create complexity [25].  Phyla with beneficial potential are growing and 
regularly include Proteobacteria, Firmicutes, Bacteroidetes and Actinobacteria [10, 25]. While not 
abundant in the root microbiome, members of the Actinobacteria phylum, Streptomyces are being 
recognized for their potential application [10].   Known for their robust metabolic potential [35] as 
well as presence within roots of a variety of plants [36-38], Actinobacteria are routinely included 
in plant-beneficial consortia [39]. Thus far, and largely legitimately, many Actinobacteria 
communities for agricultural application are composed of larger grouping of phyla members, with 
the intention of generalized treatment to maximize plant benefit.  While these strategies may work, 
they may not achieve optimal results, meaning plant energy output dedicated to assimilation of 
many different microbes may outweigh benefit.  As described in Chapter 3, we propose that 
microbial interactions may influence treatment potency and suggest the need for targeted 
exploration of Actinobacteria isolate monoapplications.  In addition, unique microbial metabolites, 
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such as melanin (Chapter 2) or those predicted via antiSMASH (Chapter 3), may induce the desired 
plant-beneficial outcome and thus necessitate more simplified applications of fewer taxa or even 
the product itself.  Much can be learned from lower complexity and monoculture experiments.  As 
we discover more about lower complexity relationships, the opportunity exists to identify 
functional benefits and construct consortia with exponential host benefits.  However, complex 
agriculture systems will likely require fine-tuned, consistent and tractable applications, regardless 
of the diversity of the proposed beneficial bacteria.   
 
Additional sequencing results of samples treated as described in Chapter 3 were recently made 
available to our lab for inclusion in our community studies.  In some cases, these samples will 
contribute to our power via addition of new technical replicates, and in other cases, we will add 
new experimental samples to our studies. We will use the QIIME 2 pipeline and analyses described 
above to determine appropriate inclusion and new results.  In addition, we anticipate 
monoinoculation vertical plate assays with members of our 11 isolate synthetic community 
(SynCom, Chapter 3) for assessment of root morphology, as well as colonization phenotypes.  Our 
collection of isolates as well as those of collaborators allow additional testing of new isolates from 
genera identified in individual family relative abundances in Chapter 3.  We are specifically 
interested in plant associated Azospirillaceae and Moraxellaceae as these genera proved 
inconsistent colonizers, and they both originated from the tertiary open-air inoculum or secondary 
wild soil slurry (Chapter 3).  These experiments would help tease apart genus from species 
influence and further inform isolates include in future low complexity SynCom.   
 
To make functional and mechanistic microbiome assembly and stability inferences, we must move 
beyond identification of genes suspected to be important to transcriptional studies.  We will design 
experiments to determine transcriptional profiles from our four Streptomyces and select SynCom 
members when challenged with other Streptomyces or SynCom isolates as well as in the context 
of the plant.  We are particularly interested in transcriptomic profiles of 299 and 303 as they were 
shown to be a significant primary inoculum with potential microbiome sculpting activities both 
via alpha diversity metrics and relative abundances of Streptomycetaceae (Chapter 3).  
Additionally, we will select members from each family of interest for transcriptional profiling.  
  182 
Ultimately, building on our 16S rRNA gene sequence databases, we would like to identify genes 
up and downregulated during microbiome colonization events, helping to tease apart plant from 
microbial-driven microbiome assemblage mechanisms.  
 
Significantly, antiSMASH results provide a rich set of data primed for hypothesis generation and 
testing.  AntiSMASH provided valuable evidence that the pigmentation in 299 and 303 cultures 
was as a result of melanin production (Chapter 2). In addition, the analysis predicted various strain-
specific antimicrobial metabolites, several of which are overlapping, suggesting resistance, and 
functional redundancy.  These discoveries provide possibilities of testing functional groups of 
organisms for comparison to taxonomically defined groups.  
 
The use of lower complexity SynCom, co-culture in vitro, and monoculture in vivo studies to 
inform community level interactions is generating more attention [40].  We suggest that these 
techniques combined with community genomics and transcriptomics will provide increasingly 
robust conclusions and identification of important mechanisms that can be developed into 
applications improving plant growth and productivity.  These techniques should also be considered 
in relation to study of the mammalian microbiome.  Complexity of plant-microbiome interactions 
are similar to those described when attempting to determine the individual and combined influence 
of multiple and often simultaneous environmental exposures in humans [41].  Though host systems 
are distinct, strategies for making mechanistic conclusions and development of 
applications/therapies may align across host systems and have begun to be explored in various 
experimental forums [8, 42].   
 
With these things in mind, strategies to combine plant and gut microbiome benefits seem likely.  
Increasingly, disease etiologies are associated with dysbiosis [43-45].  If not dysbiosis, as in the 
case of malaria (Chapter 4) protective and susceptible disease phenotypes correlate with divergent 
microbiome composition and abundances [46].  Capitalizing on data such as these suggest the need 
to development of therapies joining plant and gut microbiome research.  The previously described 
use of probiotic seed coating to protect crops from specific pathogens provides a starting point for 
efforts such as these [32].  I would suggest the need to bridge the gap between diseases such as 
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malaria and probiotic therapies in planta.  Perhaps seed coatings that are crop and gut beneficial 
and anti-malarial could both feed and protect individuals.  Alternatively, studies of plant microbes 
that induce host genes involved in pathogen suppression may inform recognition similar patterns 
in mammals, creating opportunities to develop targeted functional microbial therapies.  For 
example, further exploration of Lactobacillus genes significant in modulation of malarial illness 
could allow identification of agriculturally relevant plant-specific taxa harboring homologous 
gene(s).   Growing evidence of microbiome assembly structures and cues across plant species, 
provides great opportunity for advancements in paired plant-mammal microbiome therapeutics.  
 
Here we have provided evidence of microbiome potential in influencing hosts or competing 
microbes.  Significantly, we suggest the metabolic potential of Streptomyces to both protect 
themselves from common plant root phenolics (Chapter 2) and persist when challenged with 
communities of varying complexities (Chapter 3).  While not robust colonizers, Streptomyces’ 
consistent presence in microbiomes across plant species suggests their importance and signals their 
value for further explorations.  Further, it affirms that abundance may not be as influential as 
function or capability of less abundant taxa.  These studies also suggest the value of employing 
multiple techniques to more fully understand microbial relationships.  Further, using communities 
with varying levels of complexity provides insights that could otherwise be overlooked.  Similarly, 
while mammalian gut taxa have been previously identified as beneficial for gut health, complex 
gut microbiomes are not well understood.  Probiotic therapies are not regulated and still not well 
understood.  Further, even less is known about how gut microbiome composition modulates 
pathogen infection.  In Chapter 4 we describe that gut microbiome taxa abundances are divergent 
for malaria-susceptible and malaria-resistant mice.  However, we know much less about the 
mechanisms involved in these phenotypes.  Application of reductionist approaches, multiple levels 
of microbiome complexity and employing various techniques may help to tease apart functions of 
taxa aligned with disease suppression. Great opportunity exists to extend our knowledge of 
microbiomes and host associations across kingdoms of life.  Likely a central node linking these 
studies are network analyses, identifying overlapping genes and functions.  
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My future research efforts will likely focus on the overlap of the mammalian microbiome and liver 
diseases.  I am interested in development of microbial therapies to reduce T-cell mediated allograft 
rejection of transplanted livers.  The ideas explored throughout my dissertation significantly 
contribute to the direction and intention of my future work.  Likely with much assistance and 
training, I intend to apply emerging ideas suggesting the importance of network analyses to create 
a network of mammalian gut  and A. thaliana root genes.  These systems are similar in that they 
require host immune modulation for microbe assimilation.  I can then introduce known 
microbiome members in each system and query the network for  genes significant in immune 
regulation.  I also plan to design SynCom for mammalian application using methods learned here, 
and further look for functional redundancy to determine taxonomic versus functional host-
mediated selective pressures.  Overall, I intend to design agricultural microbial therapies that can 
be applied in mammalian systems to provide specific immune suppression.  Opportunities for cross 
kingdom investigation are great.  However, use of a less complex plant system for application to 
a more complex mammalian system is be challenging.  Studies of microbiomes must be more 
dynamic and multidisciplinary to incorporate the needs of a growing population with increased 
demands on crop production as well as rising chronic and infectious disease prevalence. 
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